mp:VDraft3.0.0 testgegevens medicatiegegevensMGBMGR MTD addendum: verschil tussen versies
| Regel 35: | Regel 35: | ||
| Scenario|| Screenshots?|| Beschrijving|| MBH id|| MTD id | | Scenario|| Screenshots?|| Beschrijving|| MBH id|| MTD id | ||
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
| − | |2.1|| || Medicatie toediening met gevulde toelichting|| MBH_300_toelichting|| MBH_300_toelichting_MTD | + | |2.1|| || Medicatie toediening met gevulde toelichting|| MBH_300_toelichting-mgb|| MBH_300_toelichting_MTD-mgb |
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
| − | |2.2|| || Medicatie toediening met een afwijkende toedieningsweg|| MBH_300_Toedieningsweg|| MBH_300_Toedieningsweg_MTD | + | |2.2|| || Medicatie toediening met een afwijkende toedieningsweg|| MBH_300_Toedieningsweg-mgb|| MBH_300_Toedieningsweg_MTD-mgb |
|} | |} | ||
<section end=overview-MGB-2 /> | <section end=overview-MGB-2 /> | ||
| Regel 46: | Regel 46: | ||
| Scenario|| Screenshots?|| Beschrijving|| MBH id|| MTD id | | Scenario|| Screenshots?|| Beschrijving|| MBH id|| MTD id | ||
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
| − | |3.11|| || Een MTD wordt opgeschort en vervolgens later toegediend|| MBH_300_MTDopschorten|| MBH_300_MTDopschorten_MTD1<br/>MBH_300_MTDopschorten_MTD2 | + | |3.11|| || Een MTD wordt opgeschort en vervolgens later toegediend|| MBH_300_MTDopschorten-mgb|| MBH_300_MTDopschorten_MTD1-mgb<br/>MBH_300_MTDopschorten_MTD2-mgb |
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
| − | |3.12|| || Een MTD wijkt af van de MA/TA met de toegediende hoeveelheid|| mbh_300_AfwijkendeToediening|| mbh_300_AfwijkendeToediening_MTD_normaal<br/>mbh_300_AfwijkendeToediening_MTD_afwijkendeQty | + | |3.12|| || Een MTD wijkt af van de MA/TA met de toegediende hoeveelheid|| mbh_300_AfwijkendeToediening-mgb|| mbh_300_AfwijkendeToediening_MTD_normaal-mgb<br/>mbh_300_AfwijkendeToediening_MTD_afwijkendeQty-mgb |
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
| − | |3.13|| || Een extra MTD voor de juiste hoeveelheid|| MBH_300_CorrectieToediening || MBH_300_CorrectieToediening_MTD_normaal<br/>MBH_300_CorrectieToediening_MTD_extraHoeveelheid | + | |3.13|| || Een extra MTD voor de juiste hoeveelheid|| MBH_300_CorrectieToediening -mgb|| MBH_300_CorrectieToediening_MTD_normaal-mgb<br/>MBH_300_CorrectieToediening_MTD_extraHoeveelheid-mgb |
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
| − | |3.14|| || MTD correctie met negatieve hoeveelheid|| MBH_300_CorrectieOpToediening|| MBH_300_CorrectieOpToediening_MTD_verkeerdeQty<br/> | + | |3.14|| || MTD correctie met negatieve hoeveelheid|| MBH_300_CorrectieOpToediening-mgb|| MBH_300_CorrectieOpToediening_MTD_verkeerdeQty-mgb<br/>MBH_300_CorrectieOpToediening_correctie_MTD-mgb<br/>MBH_300_CorrectieOpToediening_CorrecteHoeveelheid_MTD-mgb |
|} | |} | ||
<section end=overview-MGB-3 /> | <section end=overview-MGB-3 /> | ||
| Regel 61: | Regel 61: | ||
| Scenario|| Screenshots?|| Beschrijving|| MBH id|| MTD id | | Scenario|| Screenshots?|| Beschrijving|| MBH id|| MTD id | ||
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
| − | |6.13|| || Toedieningssnelheid en prikplaklocatie met lateraliteit|| MBH_300_toedieningssnelheid|| MBH_300_toedieningssnelheid_MTD | + | |6.13|| || Toedieningssnelheid en prikplaklocatie met lateraliteit|| MBH_300_toedieningssnelheid-mgb|| MBH_300_toedieningssnelheid_MTD-mgb |
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
| − | |6.14|| || Prikplaklocatie zonder lateraliteit|| MBH_300_toedieningsduur|| MBH_300_toedieningsduur_MTD | + | |6.14|| || Prikplaklocatie zonder lateraliteit|| MBH_300_toedieningsduur-mgb|| MBH_300_toedieningsduur_MTD-mgb |
|} | |} | ||
<section end=overview-MGB-6 /> | <section end=overview-MGB-6 /> | ||
| Regel 72: | Regel 72: | ||
| Scenario|| Screenshots?|| Beschrijving|| MBH id|| MTD id | | Scenario|| Screenshots?|| Beschrijving|| MBH id|| MTD id | ||
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
| − | |7.1|| Maak screenshot(s) waarop zichtbaar is dat er ingrediënten ingevoerd/gekozen kunnen worden|| Alle ingrediënten|| MBH_300_magistraalalleingredienten|| MBH_300_magistraalalleingredienten_MTD | + | |7.1|| Maak screenshot(s) waarop zichtbaar is dat er ingrediënten ingevoerd/gekozen kunnen worden|| Alle ingrediënten|| MBH_300_magistraalalleingredienten-mgb|| MBH_300_magistraalalleingredienten_MTD-mgb |
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
| − | |7.2|| Maak screenshot(s) waarop zichtbaar is dat er een ingrediënt ingevoerd/gekozen kan worden|| Actief ingrediënt|| MBH_300_magistraalactieveingredient|| MBH_300_magistraalactieveingredient_MTD | + | |7.2|| Maak screenshot(s) waarop zichtbaar is dat er een ingrediënt ingevoerd/gekozen kan worden|| Actief ingrediënt|| MBH_300_magistraalactieveingredient-mgb|| MBH_300_magistraalactieveingredient_MTD-mgb |
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
| − | |7.3|| Maak screenshot(s) waarop zichtbaar is dat het eigen artikel gekozen wordt|| 90 miljoen nummer|| MBH_300_magistraal90miljoennr|| MBH_300_magistraal90miljoennr_MTD | + | |7.3|| Maak screenshot(s) waarop zichtbaar is dat het eigen artikel gekozen wordt|| 90 miljoen nummer|| MBH_300_magistraal90miljoennr-mgb|| MBH_300_magistraal90miljoennr_MTD-mgb |
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
| − | |7.4|| Maak screenshot(s) waarop zichtbaar is dat het vrije tekst product gekozen wordt|| Vrije tekst product|| MBH_300_vrijetekstproduct|| MBH_300_vrijetekstproduct_MTD | + | |7.4|| Maak screenshot(s) waarop zichtbaar is dat het vrije tekst product gekozen wordt|| Vrije tekst product|| MBH_300_vrijetekstproduct-mgb|| MBH_300_vrijetekstproduct_MTD-mgb |
|} | |} | ||
<section end=overview-MGB-7 /> | <section end=overview-MGB-7 /> | ||
| Regel 87: | Regel 87: | ||
| Scenario|| Screenshots?|| Beschrijving|| MBH id|| MTD id | | Scenario|| Screenshots?|| Beschrijving|| MBH id|| MTD id | ||
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
| − | |10.1|| || ZI-nr geneesmiddel|| MBH_300_ZINRvoorschrijven|| MBH_300_ZINRvoorschrijven_MTD | + | |10.1|| || ZI-nr geneesmiddel|| MBH_300_ZINRvoorschrijven-mgb|| MBH_300_ZINRvoorschrijven_MTD-mgb |
|} | |} | ||
<section end=overview-MGB-10 /> | <section end=overview-MGB-10 /> | ||
| Regel 96: | Regel 96: | ||
| Scenario|| Screenshots?|| Beschrijving|| MBH id|| MTD id | | Scenario|| Screenshots?|| Beschrijving|| MBH id|| MTD id | ||
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
| − | |11.1|| || Toediening met relatie naar WDS|| MBH_300_wdsmtd1|| MBH_300_wdsmtd1_MTD | + | |11.1|| || Toediening met relatie naar WDS|| MBH_300_wdsmtd1-mgb|| MBH_300_wdsmtd1_MTD-mgb |
|} | |} | ||
<section end=overview-MGB-11 /> | <section end=overview-MGB-11 /> | ||
| Regel 105: | Regel 105: | ||
| Scenario|| Screenshots?|| Beschrijving|| MBH id|| MTD id | | Scenario|| Screenshots?|| Beschrijving|| MBH id|| MTD id | ||
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
| − | |13.4|| || Contact Episode|| MBH_300_contactepisode|| MBH_300_contactepisode_MTD1 | + | |13.4|| || Contact Episode|| MBH_300_contactepisode-mgb|| MBH_300_contactepisode_MTD1-mgb |
|} | |} | ||
<section end=overview-MGB-13 /> | <section end=overview-MGB-13 /> | ||
| Regel 114: | Regel 114: | ||
| Scenario|| Screenshots?|| Beschrijving|| MBH id|| MTD id | | Scenario|| Screenshots?|| Beschrijving|| MBH id|| MTD id | ||
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
| − | |16.1|| || Medicatietoediening met reden van afwijken|| MBH_300_redenvanafwijken|| MBH_300_redenvanafwijken_MTD | + | |16.1|| || Medicatietoediening met reden van afwijken|| MBH_300_redenvanafwijken-mgb|| MBH_300_redenvanafwijken_MTD-mgb |
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
| − | |16.2|| || Ad-hoc medicatietoediening (zonder relatie naar afspraak bouwsteen)|| MBH_300_adhoctoediening|| MBH_300_adhoctoediening_MTD | + | |16.2|| || Ad-hoc medicatietoediening (zonder relatie naar afspraak bouwsteen)|| MBH_300_adhoctoediening-mgb|| MBH_300_adhoctoediening_MTD-mgb |
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
| − | |16.3|| || Medicatietoediening met patiënt als toediener|| MBH_300_afwijkendeToediener|| MBH_300_afwijkendeToediener_MTD_Patient | + | |16.3|| || Medicatietoediening met patiënt als toediener|| MBH_300_afwijkendeToediener-mgb|| MBH_300_afwijkendeToediener_MTD_Patient-mgb |
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
| − | |16.4|| || Medicatietoediening met mantelzorger als toediener|| MBH_300_afwijkendeToediener|| MBH_300_afwijkendeToediener_MTD_Mantelzorger | + | |16.4|| || Medicatietoediening met mantelzorger als toediener|| MBH_300_afwijkendeToediener-mgb|| MBH_300_afwijkendeToediener_MTD_Mantelzorger-mgb |
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
| − | |16.5|| || Medicatietoediening met relatieMA|| MBH_300_toedieningRelatieMA|| MBH_300_toedieningRelatieMA_MTD | + | |16.5|| || Medicatietoediening met relatieMA|| MBH_300_toedieningRelatieMA-mgb|| MBH_300_toedieningRelatieMA_MTD-mgb |
|} | |} | ||
<section end=overview-MGB-16 /> | <section end=overview-MGB-16 /> | ||
| Regel 156: | Regel 156: | ||
| Scenario|| Beschrijving|| MBH id|| MTD id | | Scenario|| Beschrijving|| MBH id|| MTD id | ||
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
| − | |2.1|| Medicatie toediening met gevulde toelichting|| MBH_300_toelichting|| MBH_300_toelichting_MTD | + | |2.1|| Medicatie toediening met gevulde toelichting|| MBH_300_toelichting-mgb|| MBH_300_toelichting_MTD-mgb |
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
| − | |2.2|| Medicatie toediening met een afwijkende toedieningsweg|| MBH_300_Toedieningsweg|| MBH_300_Toedieningsweg_MTD | + | |2.2|| Medicatie toediening met een afwijkende toedieningsweg|| MBH_300_Toedieningsweg-mgb|| MBH_300_Toedieningsweg_MTD-mgb |
|} | |} | ||
<section end=overview-MGR-2 /> | <section end=overview-MGR-2 /> | ||
| Regel 167: | Regel 167: | ||
| Scenario|| Beschrijving|| MBH id|| MTD id | | Scenario|| Beschrijving|| MBH id|| MTD id | ||
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
| − | |3.11|| Een MTD wordt opgeschort en vervolgens later toegediend|| MBH_300_MTDopschorten|| MBH_300_MTDopschorten_MTD1<br/>MBH_300_MTDopschorten_MTD2 | + | |3.11|| Een MTD wordt opgeschort en vervolgens later toegediend|| MBH_300_MTDopschorten-mgb|| MBH_300_MTDopschorten_MTD1-mgb<br/>MBH_300_MTDopschorten_MTD2-mgb |
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
| − | |3.12|| Een MTD wijkt af van de MA/TA met de toegediende hoeveelheid|| mbh_300_AfwijkendeToediening|| mbh_300_AfwijkendeToediening_MTD_normaal<br/>mbh_300_AfwijkendeToediening_MTD_afwijkendeQty | + | |3.12|| Een MTD wijkt af van de MA/TA met de toegediende hoeveelheid|| mbh_300_AfwijkendeToediening-mgb|| mbh_300_AfwijkendeToediening_MTD_normaal-mgb<br/>mbh_300_AfwijkendeToediening_MTD_afwijkendeQty-mgb |
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
| − | |3.13|| Een extra MTD voor de juiste hoeveelheid|| MBH_300_CorrectieToediening || MBH_300_CorrectieToediening_MTD_normaal<br/>MBH_300_CorrectieToediening_MTD_extraHoeveelheid | + | |3.13|| Een extra MTD voor de juiste hoeveelheid|| MBH_300_CorrectieToediening -mgb|| MBH_300_CorrectieToediening_MTD_normaal-mgb<br/>MBH_300_CorrectieToediening_MTD_extraHoeveelheid-mgb |
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
| − | |3.14|| MTD correctie met negatieve hoeveelheid|| MBH_300_CorrectieOpToediening|| MBH_300_CorrectieOpToediening_MTD_verkeerdeQty<br/> | + | |3.14|| MTD correctie met negatieve hoeveelheid|| MBH_300_CorrectieOpToediening-mgb|| MBH_300_CorrectieOpToediening_MTD_verkeerdeQty-mgb<br/>MBH_300_CorrectieOpToediening_correctie_MTD-mgb<br/>MBH_300_CorrectieOpToediening_CorrecteHoeveelheid_MTD-mgb |
|} | |} | ||
<section end=overview-MGR-3 /> | <section end=overview-MGR-3 /> | ||
| Regel 182: | Regel 182: | ||
| Scenario|| Beschrijving|| MBH id|| MTD id | | Scenario|| Beschrijving|| MBH id|| MTD id | ||
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
| − | |6.13|| Toedieningssnelheid en prikplaklocatie met lateraliteit|| MBH_300_toedieningssnelheid|| MBH_300_toedieningssnelheid_MTD | + | |6.13|| Toedieningssnelheid en prikplaklocatie met lateraliteit|| MBH_300_toedieningssnelheid-mgb|| MBH_300_toedieningssnelheid_MTD-mgb |
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
| − | |6.14|| Prikplaklocatie zonder lateraliteit|| MBH_300_toedieningsduur|| MBH_300_toedieningsduur_MTD | + | |6.14|| Prikplaklocatie zonder lateraliteit|| MBH_300_toedieningsduur-mgb|| MBH_300_toedieningsduur_MTD-mgb |
|} | |} | ||
<section end=overview-MGR-6 /> | <section end=overview-MGR-6 /> | ||
| Regel 193: | Regel 193: | ||
| Scenario|| Beschrijving|| MBH id|| MTD id | | Scenario|| Beschrijving|| MBH id|| MTD id | ||
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
| − | |7.1|| Alle ingrediënten|| MBH_300_magistraalalleingredienten|| MBH_300_magistraalalleingredienten_MTD | + | |7.1|| Alle ingrediënten|| MBH_300_magistraalalleingredienten-mgb|| MBH_300_magistraalalleingredienten_MTD-mgb |
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
| − | |7.2|| Actief ingrediënt|| MBH_300_magistraalactieveingredient|| MBH_300_magistraalactieveingredient_MTD | + | |7.2|| Actief ingrediënt|| MBH_300_magistraalactieveingredient-mgb|| MBH_300_magistraalactieveingredient_MTD-mgb |
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
| − | |7.3|| 90 miljoen nummer|| MBH_300_magistraal90miljoennr|| MBH_300_magistraal90miljoennr_MTD | + | |7.3|| 90 miljoen nummer|| MBH_300_magistraal90miljoennr-mgb|| MBH_300_magistraal90miljoennr_MTD-mgb |
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
| − | |7.4|| Vrije tekst product|| MBH_300_vrijetekstproduct|| MBH_300_vrijetekstproduct_MTD | + | |7.4|| Vrije tekst product|| MBH_300_vrijetekstproduct-mgb|| MBH_300_vrijetekstproduct_MTD-mgb |
|} | |} | ||
<section end=overview-MGR-7 /> | <section end=overview-MGR-7 /> | ||
| Regel 208: | Regel 208: | ||
| Scenario|| Beschrijving|| MBH id|| MTD id | | Scenario|| Beschrijving|| MBH id|| MTD id | ||
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
| − | |10.1|| ZI-nr geneesmiddel|| MBH_300_ZINRvoorschrijven|| MBH_300_ZINRvoorschrijven_MTD | + | |10.1|| ZI-nr geneesmiddel|| MBH_300_ZINRvoorschrijven-mgb|| MBH_300_ZINRvoorschrijven_MTD-mgb |
|} | |} | ||
<section end=overview-MGR-10 /> | <section end=overview-MGR-10 /> | ||
| Regel 217: | Regel 217: | ||
| Scenario|| Beschrijving|| MBH id|| MTD id | | Scenario|| Beschrijving|| MBH id|| MTD id | ||
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
| − | |11.1|| Toediening met relatie naar WDS|| MBH_300_wdsmtd1|| MBH_300_wdsmtd1_MTD | + | |11.1|| Toediening met relatie naar WDS|| MBH_300_wdsmtd1-mgb|| MBH_300_wdsmtd1_MTD-mgb |
|} | |} | ||
<section end=overview-MGR-11 /> | <section end=overview-MGR-11 /> | ||
| Regel 226: | Regel 226: | ||
| Scenario|| Beschrijving|| MBH id|| MTD id | | Scenario|| Beschrijving|| MBH id|| MTD id | ||
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
| − | |13.4|| Contact Episode|| MBH_300_contactepisode|| MBH_300_contactepisode_MTD1 | + | |13.4|| Contact Episode|| MBH_300_contactepisode-mgb|| MBH_300_contactepisode_MTD1-mgb |
|} | |} | ||
<section end=overview-MGR-13 /> | <section end=overview-MGR-13 /> | ||
| Regel 235: | Regel 235: | ||
| Scenario|| Beschrijving|| MBH id|| MTD id | | Scenario|| Beschrijving|| MBH id|| MTD id | ||
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
| − | |16.1|| Medicatietoediening met reden van afwijken|| MBH_300_redenvanafwijken|| MBH_300_redenvanafwijken_MTD | + | |16.1|| Medicatietoediening met reden van afwijken|| MBH_300_redenvanafwijken-mgb|| MBH_300_redenvanafwijken_MTD-mgb |
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
| − | |16.2|| Ad-hoc medicatietoediening (zonder relatie naar afspraak bouwsteen)|| MBH_300_adhoctoediening|| MBH_300_adhoctoediening_MTD | + | |16.2|| Ad-hoc medicatietoediening (zonder relatie naar afspraak bouwsteen)|| MBH_300_adhoctoediening-mgb|| MBH_300_adhoctoediening_MTD-mgb |
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
| − | |16.3|| Medicatietoediening met patiënt als toediener|| MBH_300_afwijkendeToediener|| MBH_300_afwijkendeToediener_MTD_Patient | + | |16.3|| Medicatietoediening met patiënt als toediener|| MBH_300_afwijkendeToediener-mgb|| MBH_300_afwijkendeToediener_MTD_Patient-mgb |
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
| − | |16.4|| Medicatietoediening met mantelzorger als toediener|| MBH_300_afwijkendeToediener|| MBH_300_afwijkendeToediener_MTD_Mantelzorger | + | |16.4|| Medicatietoediening met mantelzorger als toediener|| MBH_300_afwijkendeToediener-mgb|| MBH_300_afwijkendeToediener_MTD_Mantelzorger-mgb |
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
| − | |16.5|| Medicatietoediening met relatieMA|| MBH_300_toedieningRelatieMA|| MBH_300_toedieningRelatieMA_MTD | + | |16.5|| Medicatietoediening met relatieMA|| MBH_300_toedieningRelatieMA-mgb|| MBH_300_toedieningRelatieMA_MTD-mgb |
|} | |} | ||
<section end=overview-MGR-16 /> | <section end=overview-MGR-16 /> | ||
| Regel 287: | Regel 287: | ||
|style="background-color: white;"|Man (code = 'M' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') | |style="background-color: white;"|Man (code = 'M' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') | ||
|}<section end=patient-mg-mp-mg-tst-MTD-Scenarioset0-v30-0-1 /><section begin=mbhs-mg-mp-mg-tst-MTD-Scenarioset0-v30-0-1 /> | |}<section end=patient-mg-mp-mg-tst-MTD-Scenarioset0-v30-0-1 /><section begin=mbhs-mg-mp-mg-tst-MTD-Scenarioset0-v30-0-1 /> | ||
| − | ==== Scenario 0.1 - MBH_300_QA1==== | + | ==== Scenario 0.1 - MBH_300_QA1-mgb==== |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatietoediening MBH_300_QA1_MTD | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatietoediening MBH_300_QA1_MTD-mgb |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
| Regel 297: | Regel 297: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
| − | |style="background-color: white;"|MBH_300_QA1_MTD (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.18629005.1) | + | |style="background-color: white;"|MBH_300_QA1_MTD-mgb (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.18629005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|RegistratieDatumTijd |
|style="background-color: white;"|T - 18 dagen om 10:04:22 uur | |style="background-color: white;"|T - 18 dagen om 10:04:22 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|ToedieningsDatumTijd |
|style="background-color: white;"|T - 18 dagen om 10:04:22 uur | |style="background-color: white;"|T - 18 dagen om 10:04:22 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|ToegediendeHoeveelheid |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
| Regel 334: | Regel 334: | ||
|style="background-color: white;"|IBUPROFEN TABLET 600MG (code = '42080' in codeSystem 'G-Standaard GPK') | |style="background-color: white;"|IBUPROFEN TABLET 600MG (code = '42080' in codeSystem 'G-Standaard GPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|RelatieMedicatieafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
| Regel 341: | Regel 341: | ||
|style="background-color: white;"|MBH_300_QA1_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |style="background-color: white;"|MBH_300_QA1_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|RelatieToedieningsafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
| Regel 349: | Regel 349: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
| − | |style="background-color: white;"|MBH_300_QA1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | + | |style="background-color: white;"|MBH_300_QA1-mgb (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
| − | ==== Scenario 0.1 - MBH_300_QA2==== | + | ==== Scenario 0.1 - MBH_300_QA2-mgb==== |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatietoediening MBH_300_QA2_MTD | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatietoediening MBH_300_QA2_MTD-mgb |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
| Regel 361: | Regel 361: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
| − | |style="background-color: white;"|MBH_300_QA2_MTD (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.18629005.1) | + | |style="background-color: white;"|MBH_300_QA2_MTD-mgb (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.18629005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|RegistratieDatumTijd |
|style="background-color: white;"|T - 99 dagen om 13:10:40 uur | |style="background-color: white;"|T - 99 dagen om 13:10:40 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|ToedieningsDatumTijd |
|style="background-color: white;"|T - 99 dagen om 13:10:40 uur | |style="background-color: white;"|T - 99 dagen om 13:10:40 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|ToegediendeHoeveelheid |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
| Regel 389: | Regel 389: | ||
|style="background-color: white;"|Zie [[#JANTIEN_TOEDIEN|Zorgverlener: JANTIEN_TOEDIEN]] | |style="background-color: white;"|Zie [[#JANTIEN_TOEDIEN|Zorgverlener: JANTIEN_TOEDIEN]] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|MedicatietoedieningRedenVanAfwijken |
|style="background-color: white;"|onvoldoende medicatie op voorraad (code = '705046008' in codeSystem '<span title="2.16.840.1.113883.6.96">SNOMED CT</span>') | |style="background-color: white;"|onvoldoende medicatie op voorraad (code = '705046008' in codeSystem '<span title="2.16.840.1.113883.6.96">SNOMED CT</span>') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 401: | Regel 401: | ||
|style="background-color: white;"|SENNOSIDEN A+B 2MG/ML (code = '10960' in codeSystem 'G-Standaard GPK') | |style="background-color: white;"|SENNOSIDEN A+B 2MG/ML (code = '10960' in codeSystem 'G-Standaard GPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|RelatieMedicatieafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
| Regel 408: | Regel 408: | ||
|style="background-color: white;"|MBH_300_QA2_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |style="background-color: white;"|MBH_300_QA2_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|RelatieToedieningsafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
| Regel 416: | Regel 416: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
| − | |style="background-color: white;"|MBH_300_QA2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | + | |style="background-color: white;"|MBH_300_QA2-mgb (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
| − | ==== Scenario 0.1 - MBH_300_QA3==== | + | ==== Scenario 0.1 - MBH_300_QA3-mgb==== |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatietoediening MBH_300_QA3_MTD | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatietoediening MBH_300_QA3_MTD-mgb |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
| Regel 428: | Regel 428: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
| − | |style="background-color: white;"|MBH_300_QA3_MTD (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.18629005.1) | + | |style="background-color: white;"|MBH_300_QA3_MTD-mgb (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.18629005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|RegistratieDatumTijd |
|style="background-color: white;"|T - 45 dagen om 11:26:44 uur | |style="background-color: white;"|T - 45 dagen om 11:26:44 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|ToedieningsDatumTijd |
|style="background-color: white;"|T - 45 dagen om 11:26:44 uur | |style="background-color: white;"|T - 45 dagen om 11:26:44 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|ToegediendeHoeveelheid |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
| Regel 465: | Regel 465: | ||
|style="background-color: white;"|VLOEIBARE VOEDING MET O.A. VITAMINE K (code = '130575' in codeSystem 'G-Standaard GPK') | |style="background-color: white;"|VLOEIBARE VOEDING MET O.A. VITAMINE K (code = '130575' in codeSystem 'G-Standaard GPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|RelatieMedicatieafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
| Regel 472: | Regel 472: | ||
|style="background-color: white;"|MBH_300_QA3_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |style="background-color: white;"|MBH_300_QA3_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|RelatieToedieningsafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
| Regel 480: | Regel 480: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
| − | |style="background-color: white;"|MBH_300_QA3 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | + | |style="background-color: white;"|MBH_300_QA3-mgb (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
| − | ==== Scenario 0.1 - MBH_300_QA4==== | + | ==== Scenario 0.1 - MBH_300_QA4-mgb==== |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatietoediening MBH_300_QA4_MTD | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatietoediening MBH_300_QA4_MTD-mgb |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
| Regel 492: | Regel 492: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
| − | |style="background-color: white;"|MBH_300_QA4_MTD (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.18629005.1) | + | |style="background-color: white;"|MBH_300_QA4_MTD-mgb (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.18629005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|RegistratieDatumTijd |
|style="background-color: white;"|T - 9 dagen om 17:01:01 uur | |style="background-color: white;"|T - 9 dagen om 17:01:01 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|ToedieningsDatumTijd |
|style="background-color: white;"|T - 9 dagen om 17:01:01 uur | |style="background-color: white;"|T - 9 dagen om 17:01:01 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|ToegediendeHoeveelheid |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
| Regel 529: | Regel 529: | ||
|style="background-color: white;"|ACETYLSALICYLZUUR TABLET 100MG (code = '12548' in codeSystem 'G-Standaard GPK') | |style="background-color: white;"|ACETYLSALICYLZUUR TABLET 100MG (code = '12548' in codeSystem 'G-Standaard GPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|RelatieMedicatieafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
| Regel 536: | Regel 536: | ||
|style="background-color: white;"|MBH_300_QA4_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |style="background-color: white;"|MBH_300_QA4_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|RelatieToedieningsafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
| Regel 544: | Regel 544: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
| − | |style="background-color: white;"|MBH_300_QA4 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | + | |style="background-color: white;"|MBH_300_QA4-mgb (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
| − | ==== Scenario 0.1 - MBH_300_QA5==== | + | ==== Scenario 0.1 - MBH_300_QA5-mgb==== |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatietoediening MBH_300_QA5_MTD | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatietoediening MBH_300_QA5_MTD-mgb |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
| Regel 556: | Regel 556: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
| − | |style="background-color: white;"|MBH_300_QA5_MTD (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.18629005.1) | + | |style="background-color: white;"|MBH_300_QA5_MTD-mgb (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.18629005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|RegistratieDatumTijd |
|style="background-color: white;"|T - 49 dagen om 13:54:35 uur | |style="background-color: white;"|T - 49 dagen om 13:54:35 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|ToedieningsDatumTijd |
|style="background-color: white;"|T - 49 dagen om 13:54:35 uur | |style="background-color: white;"|T - 49 dagen om 13:54:35 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|ToegediendeHoeveelheid |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
| Regel 593: | Regel 593: | ||
|style="background-color: white;"|PARACETAMOL 500MG TABLET (code = '2194' in codeSystem 'G-Standaard GPK') | |style="background-color: white;"|PARACETAMOL 500MG TABLET (code = '2194' in codeSystem 'G-Standaard GPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|RelatieMedicatieafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
| Regel 600: | Regel 600: | ||
|style="background-color: white;"|MBH_300_QA5_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |style="background-color: white;"|MBH_300_QA5_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|RelatieToedieningsafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
| Regel 608: | Regel 608: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
| − | |style="background-color: white;"|MBH_300_QA5 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | + | |style="background-color: white;"|MBH_300_QA5-mgb (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
| − | ==== Scenario 0.1 - MBH_300_QA6==== | + | ==== Scenario 0.1 - MBH_300_QA6-mgb==== |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatietoediening MBH_300_QA6_MTD | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatietoediening MBH_300_QA6_MTD-mgb |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
| Regel 620: | Regel 620: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
| − | |style="background-color: white;"|MBH_300_QA6_MTD (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.18629005.1) | + | |style="background-color: white;"|MBH_300_QA6_MTD-mgb (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.18629005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|RegistratieDatumTijd |
|style="background-color: white;"|T - 4 dagen om 08:08:08 uur | |style="background-color: white;"|T - 4 dagen om 08:08:08 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|ToedieningsDatumTijd |
|style="background-color: white;"|T - 4 dagen om 08:08:08 uur | |style="background-color: white;"|T - 4 dagen om 08:08:08 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|ToegediendeHoeveelheid |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
| Regel 657: | Regel 657: | ||
|style="background-color: white;"|OXAZEPAM TABLET 10MG (code = '1023' in codeSystem 'G-Standaard GPK') | |style="background-color: white;"|OXAZEPAM TABLET 10MG (code = '1023' in codeSystem 'G-Standaard GPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|RelatieMedicatieafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
| Regel 664: | Regel 664: | ||
|style="background-color: white;"|MBH_300_QA6_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |style="background-color: white;"|MBH_300_QA6_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|RelatieToedieningsafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
| Regel 672: | Regel 672: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
| − | |style="background-color: white;"|MBH_300_QA6 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | + | |style="background-color: white;"|MBH_300_QA6-mgb (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
==== Bouwstenen ==== | ==== Bouwstenen ==== | ||
| Regel 686: | Regel 686: | ||
|rowspan="7"| | |rowspan="7"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|ZorgverlenerIdentificatienummer |
|style="background-color: white;"|222220000 (in identificerend systeem: UZI Personen) | |style="background-color: white;"|222220000 (in identificerend systeem: UZI Personen) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 706: | Regel 706: | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|ZorgaanbiederIdentificatienummer |
|style="background-color: white;"|11110000 (in identificerend systeem: URA) | |style="background-color: white;"|11110000 (in identificerend systeem: URA) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|OrganisatieNaam |
|style="background-color: white;"|Thuiszorg Om en Bij | |style="background-color: white;"|Thuiszorg Om en Bij | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|OrganisatieType |
|style="background-color: white;"|Thuiszorg (code = 'T2' in codeSystem '<span title="2.16.840.1.113883.2.4.15.1060">HL7 RoleCodeNL Care provider type (organizations)</span>') | |style="background-color: white;"|Thuiszorg (code = 'T2' in codeSystem '<span title="2.16.840.1.113883.2.4.15.1060">HL7 RoleCodeNL Care provider type (organizations)</span>') | ||
|}<section end=mbhs-mg-mp-mg-tst-MTD-Scenarioset0-v30-0-1 /><section end=mg-mp-mg-tst-MTD-Scenarioset0-v30-0-1 /> | |}<section end=mbhs-mg-mp-mg-tst-MTD-Scenarioset0-v30-0-1 /><section end=mg-mp-mg-tst-MTD-Scenarioset0-v30-0-1 /> | ||
| Regel 756: | Regel 756: | ||
|style="background-color: white;"|Man (code = 'M' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') | |style="background-color: white;"|Man (code = 'M' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') | ||
|}<section end=patient-mg-mp-mg-tst-MTD-Scenarioset0-v30-0-2 /><section begin=mbhs-mg-mp-mg-tst-MTD-Scenarioset0-v30-0-2 /> | |}<section end=patient-mg-mp-mg-tst-MTD-Scenarioset0-v30-0-2 /><section begin=mbhs-mg-mp-mg-tst-MTD-Scenarioset0-v30-0-2 /> | ||
| − | ==== Scenario 0.2 - MBH_300_QA1==== | + | ==== Scenario 0.2 - MBH_300_QA1-mgb==== |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatietoediening MBH_300_QA1_MTD | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatietoediening MBH_300_QA1_MTD-mgb |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
| Regel 766: | Regel 766: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
| − | |style="background-color: white;"|MBH_300_QA1_MTD (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.18629005.1) | + | |style="background-color: white;"|MBH_300_QA1_MTD-mgb (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.18629005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|RegistratieDatumTijd |
|style="background-color: white;"|T - 18 dagen om 10:04:22 uur | |style="background-color: white;"|T - 18 dagen om 10:04:22 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|ToedieningsDatumTijd |
|style="background-color: white;"|T - 18 dagen om 10:04:22 uur | |style="background-color: white;"|T - 18 dagen om 10:04:22 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|ToegediendeHoeveelheid |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
| Regel 803: | Regel 803: | ||
|style="background-color: white;"|IBUPROFEN TABLET 600MG (code = '42080' in codeSystem 'G-Standaard GPK') | |style="background-color: white;"|IBUPROFEN TABLET 600MG (code = '42080' in codeSystem 'G-Standaard GPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|RelatieMedicatieafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
| Regel 810: | Regel 810: | ||
|style="background-color: white;"|MBH_300_QA1_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |style="background-color: white;"|MBH_300_QA1_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|RelatieToedieningsafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
| Regel 818: | Regel 818: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
| − | |style="background-color: white;"|MBH_300_QA1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | + | |style="background-color: white;"|MBH_300_QA1-mgb (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
==== Bouwstenen ==== | ==== Bouwstenen ==== | ||
| Regel 832: | Regel 832: | ||
|rowspan="7"| | |rowspan="7"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|ZorgverlenerIdentificatienummer |
|style="background-color: white;"|222220000 (in identificerend systeem: UZI Personen) | |style="background-color: white;"|222220000 (in identificerend systeem: UZI Personen) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 852: | Regel 852: | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|ZorgaanbiederIdentificatienummer |
|style="background-color: white;"|11110000 (in identificerend systeem: URA) | |style="background-color: white;"|11110000 (in identificerend systeem: URA) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|OrganisatieNaam |
|style="background-color: white;"|Thuiszorg Om en Bij | |style="background-color: white;"|Thuiszorg Om en Bij | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|OrganisatieType |
|style="background-color: white;"|Thuiszorg (code = 'T2' in codeSystem '<span title="2.16.840.1.113883.2.4.15.1060">HL7 RoleCodeNL Care provider type (organizations)</span>') | |style="background-color: white;"|Thuiszorg (code = 'T2' in codeSystem '<span title="2.16.840.1.113883.2.4.15.1060">HL7 RoleCodeNL Care provider type (organizations)</span>') | ||
|}<section end=mbhs-mg-mp-mg-tst-MTD-Scenarioset0-v30-0-2 /><section end=mg-mp-mg-tst-MTD-Scenarioset0-v30-0-2 /> | |}<section end=mbhs-mg-mp-mg-tst-MTD-Scenarioset0-v30-0-2 /><section end=mg-mp-mg-tst-MTD-Scenarioset0-v30-0-2 /> | ||
| Regel 902: | Regel 902: | ||
|style="background-color: white;"|Man (code = 'M' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') | |style="background-color: white;"|Man (code = 'M' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') | ||
|}<section end=patient-mg-mp-mg-tst-MTD-Scenarioset0-v30-0-3optioneel /><section begin=mbhs-mg-mp-mg-tst-MTD-Scenarioset0-v30-0-3optioneel /> | |}<section end=patient-mg-mp-mg-tst-MTD-Scenarioset0-v30-0-3optioneel /><section begin=mbhs-mg-mp-mg-tst-MTD-Scenarioset0-v30-0-3optioneel /> | ||
| − | ==== Scenario 0.3 - MBH_300_QA4==== | + | ==== Scenario 0.3 - MBH_300_QA4-mgb==== |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatietoediening MBH_300_QA4_MTD | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatietoediening MBH_300_QA4_MTD-mgb |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
| Regel 912: | Regel 912: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
| − | |style="background-color: white;"|MBH_300_QA4_MTD (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.18629005.1) | + | |style="background-color: white;"|MBH_300_QA4_MTD-mgb (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.18629005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|RegistratieDatumTijd |
|style="background-color: white;"|T - 9 dagen om 17:01:01 uur | |style="background-color: white;"|T - 9 dagen om 17:01:01 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|ToedieningsDatumTijd |
|style="background-color: white;"|T - 9 dagen om 17:01:01 uur | |style="background-color: white;"|T - 9 dagen om 17:01:01 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|ToegediendeHoeveelheid |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
| Regel 949: | Regel 949: | ||
|style="background-color: white;"|ACETYLSALICYLZUUR TABLET 100MG (code = '12548' in codeSystem 'G-Standaard GPK') | |style="background-color: white;"|ACETYLSALICYLZUUR TABLET 100MG (code = '12548' in codeSystem 'G-Standaard GPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|RelatieMedicatieafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
| Regel 956: | Regel 956: | ||
|style="background-color: white;"|MBH_300_QA4_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |style="background-color: white;"|MBH_300_QA4_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|RelatieToedieningsafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
| Regel 964: | Regel 964: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
| − | |style="background-color: white;"|MBH_300_QA4 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | + | |style="background-color: white;"|MBH_300_QA4-mgb (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
==== Bouwstenen ==== | ==== Bouwstenen ==== | ||
| Regel 978: | Regel 978: | ||
|rowspan="7"| | |rowspan="7"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|ZorgverlenerIdentificatienummer |
|style="background-color: white;"|222220000 (in identificerend systeem: UZI Personen) | |style="background-color: white;"|222220000 (in identificerend systeem: UZI Personen) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 998: | Regel 998: | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|ZorgaanbiederIdentificatienummer |
|style="background-color: white;"|11110000 (in identificerend systeem: URA) | |style="background-color: white;"|11110000 (in identificerend systeem: URA) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|OrganisatieNaam |
|style="background-color: white;"|Thuiszorg Om en Bij | |style="background-color: white;"|Thuiszorg Om en Bij | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|OrganisatieType |
|style="background-color: white;"|Thuiszorg (code = 'T2' in codeSystem '<span title="2.16.840.1.113883.2.4.15.1060">HL7 RoleCodeNL Care provider type (organizations)</span>') | |style="background-color: white;"|Thuiszorg (code = 'T2' in codeSystem '<span title="2.16.840.1.113883.2.4.15.1060">HL7 RoleCodeNL Care provider type (organizations)</span>') | ||
|}<section end=mbhs-mg-mp-mg-tst-MTD-Scenarioset0-v30-0-3optioneel /><section end=mg-mp-mg-tst-MTD-Scenarioset0-v30-0-3optioneel /> | |}<section end=mbhs-mg-mp-mg-tst-MTD-Scenarioset0-v30-0-3optioneel /><section end=mg-mp-mg-tst-MTD-Scenarioset0-v30-0-3optioneel /> | ||
| Regel 1.048: | Regel 1.048: | ||
|style="background-color: white;"|Man (code = 'M' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') | |style="background-color: white;"|Man (code = 'M' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') | ||
|}<section end=patient-mg-mp-mg-tst-MTD-Scenarioset0-v30-0-4 /><section begin=mbhs-mg-mp-mg-tst-MTD-Scenarioset0-v30-0-4 /> | |}<section end=patient-mg-mp-mg-tst-MTD-Scenarioset0-v30-0-4 /><section begin=mbhs-mg-mp-mg-tst-MTD-Scenarioset0-v30-0-4 /> | ||
| − | ==== Scenario 0.4 - MBH_300_QA1==== | + | ==== Scenario 0.4 - MBH_300_QA1-mgb==== |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatietoediening MBH_300_QA1_MTD | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatietoediening MBH_300_QA1_MTD-mgb |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
| Regel 1.058: | Regel 1.058: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
| − | |style="background-color: white;"|MBH_300_QA1_MTD (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.18629005.1) | + | |style="background-color: white;"|MBH_300_QA1_MTD-mgb (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.18629005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|RegistratieDatumTijd |
|style="background-color: white;"|T - 18 dagen om 10:04:22 uur | |style="background-color: white;"|T - 18 dagen om 10:04:22 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|ToedieningsDatumTijd |
|style="background-color: white;"|T - 18 dagen om 10:04:22 uur | |style="background-color: white;"|T - 18 dagen om 10:04:22 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|ToegediendeHoeveelheid |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
| Regel 1.095: | Regel 1.095: | ||
|style="background-color: white;"|IBUPROFEN TABLET 600MG (code = '42080' in codeSystem 'G-Standaard GPK') | |style="background-color: white;"|IBUPROFEN TABLET 600MG (code = '42080' in codeSystem 'G-Standaard GPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|RelatieMedicatieafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
| Regel 1.102: | Regel 1.102: | ||
|style="background-color: white;"|MBH_300_QA1_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |style="background-color: white;"|MBH_300_QA1_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|RelatieToedieningsafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
| Regel 1.110: | Regel 1.110: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
| − | |style="background-color: white;"|MBH_300_QA1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | + | |style="background-color: white;"|MBH_300_QA1-mgb (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
| − | ==== Scenario 0.4 - MBH_300_QA4==== | + | ==== Scenario 0.4 - MBH_300_QA4-mgb==== |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatietoediening MBH_300_QA4_MTD | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatietoediening MBH_300_QA4_MTD-mgb |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
| Regel 1.122: | Regel 1.122: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
| − | |style="background-color: white;"|MBH_300_QA4_MTD (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.18629005.1) | + | |style="background-color: white;"|MBH_300_QA4_MTD-mgb (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.18629005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|RegistratieDatumTijd |
|style="background-color: white;"|T - 9 dagen om 17:01:01 uur | |style="background-color: white;"|T - 9 dagen om 17:01:01 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|ToedieningsDatumTijd |
|style="background-color: white;"|T - 9 dagen om 17:01:01 uur | |style="background-color: white;"|T - 9 dagen om 17:01:01 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|ToegediendeHoeveelheid |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
| Regel 1.159: | Regel 1.159: | ||
|style="background-color: white;"|ACETYLSALICYLZUUR TABLET 100MG (code = '12548' in codeSystem 'G-Standaard GPK') | |style="background-color: white;"|ACETYLSALICYLZUUR TABLET 100MG (code = '12548' in codeSystem 'G-Standaard GPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|RelatieMedicatieafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
| Regel 1.166: | Regel 1.166: | ||
|style="background-color: white;"|MBH_300_QA4_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |style="background-color: white;"|MBH_300_QA4_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|RelatieToedieningsafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
| Regel 1.174: | Regel 1.174: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
| − | |style="background-color: white;"|MBH_300_QA4 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | + | |style="background-color: white;"|MBH_300_QA4-mgb (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
| − | ==== Scenario 0.4 - MBH_300_QA6==== | + | ==== Scenario 0.4 - MBH_300_QA6-mgb==== |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatietoediening MBH_300_QA6_MTD | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatietoediening MBH_300_QA6_MTD-mgb |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
| Regel 1.186: | Regel 1.186: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
| − | |style="background-color: white;"|MBH_300_QA6_MTD (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.18629005.1) | + | |style="background-color: white;"|MBH_300_QA6_MTD-mgb (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.18629005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|RegistratieDatumTijd |
|style="background-color: white;"|T - 4 dagen om 08:08:08 uur | |style="background-color: white;"|T - 4 dagen om 08:08:08 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|ToedieningsDatumTijd |
|style="background-color: white;"|T - 4 dagen om 08:08:08 uur | |style="background-color: white;"|T - 4 dagen om 08:08:08 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|ToegediendeHoeveelheid |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
| Regel 1.223: | Regel 1.223: | ||
|style="background-color: white;"|OXAZEPAM TABLET 10MG (code = '1023' in codeSystem 'G-Standaard GPK') | |style="background-color: white;"|OXAZEPAM TABLET 10MG (code = '1023' in codeSystem 'G-Standaard GPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|RelatieMedicatieafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
| Regel 1.230: | Regel 1.230: | ||
|style="background-color: white;"|MBH_300_QA6_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |style="background-color: white;"|MBH_300_QA6_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|RelatieToedieningsafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
| Regel 1.238: | Regel 1.238: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
| − | |style="background-color: white;"|MBH_300_QA6 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | + | |style="background-color: white;"|MBH_300_QA6-mgb (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
==== Bouwstenen ==== | ==== Bouwstenen ==== | ||
| Regel 1.252: | Regel 1.252: | ||
|rowspan="7"| | |rowspan="7"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|ZorgverlenerIdentificatienummer |
|style="background-color: white;"|222220000 (in identificerend systeem: UZI Personen) | |style="background-color: white;"|222220000 (in identificerend systeem: UZI Personen) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 1.272: | Regel 1.272: | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|ZorgaanbiederIdentificatienummer |
|style="background-color: white;"|11110000 (in identificerend systeem: URA) | |style="background-color: white;"|11110000 (in identificerend systeem: URA) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|OrganisatieNaam |
|style="background-color: white;"|Thuiszorg Om en Bij | |style="background-color: white;"|Thuiszorg Om en Bij | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|OrganisatieType |
|style="background-color: white;"|Thuiszorg (code = 'T2' in codeSystem '<span title="2.16.840.1.113883.2.4.15.1060">HL7 RoleCodeNL Care provider type (organizations)</span>') | |style="background-color: white;"|Thuiszorg (code = 'T2' in codeSystem '<span title="2.16.840.1.113883.2.4.15.1060">HL7 RoleCodeNL Care provider type (organizations)</span>') | ||
|}<section end=mbhs-mg-mp-mg-tst-MTD-Scenarioset0-v30-0-4 /><section end=mg-mp-mg-tst-MTD-Scenarioset0-v30-0-4 /> | |}<section end=mbhs-mg-mp-mg-tst-MTD-Scenarioset0-v30-0-4 /><section end=mg-mp-mg-tst-MTD-Scenarioset0-v30-0-4 /> | ||
| Regel 1.322: | Regel 1.322: | ||
|style="background-color: white;"|Man (code = 'M' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') | |style="background-color: white;"|Man (code = 'M' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') | ||
|}<section end=patient-mg-mp-mg-tst-MTD-Scenarioset0-v30-0-5 /><section begin=mbhs-mg-mp-mg-tst-MTD-Scenarioset0-v30-0-5 /> | |}<section end=patient-mg-mp-mg-tst-MTD-Scenarioset0-v30-0-5 /><section begin=mbhs-mg-mp-mg-tst-MTD-Scenarioset0-v30-0-5 /> | ||
| − | ==== Scenario 0.5 - MBH_300_QA2==== | + | ==== Scenario 0.5 - MBH_300_QA2-mgb==== |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatietoediening MBH_300_QA2_MTD | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatietoediening MBH_300_QA2_MTD-mgb |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
| Regel 1.332: | Regel 1.332: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
| − | |style="background-color: white;"|MBH_300_QA2_MTD (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.18629005.1) | + | |style="background-color: white;"|MBH_300_QA2_MTD-mgb (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.18629005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|RegistratieDatumTijd |
|style="background-color: white;"|T - 99 dagen om 13:10:40 uur | |style="background-color: white;"|T - 99 dagen om 13:10:40 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|ToedieningsDatumTijd |
|style="background-color: white;"|T - 99 dagen om 13:10:40 uur | |style="background-color: white;"|T - 99 dagen om 13:10:40 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|ToegediendeHoeveelheid |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
| Regel 1.360: | Regel 1.360: | ||
|style="background-color: white;"|Zie [[#JANTIEN_TOEDIEN|Zorgverlener: JANTIEN_TOEDIEN]] | |style="background-color: white;"|Zie [[#JANTIEN_TOEDIEN|Zorgverlener: JANTIEN_TOEDIEN]] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|MedicatietoedieningRedenVanAfwijken |
|style="background-color: white;"|onvoldoende medicatie op voorraad (code = '705046008' in codeSystem '<span title="2.16.840.1.113883.6.96">SNOMED CT</span>') | |style="background-color: white;"|onvoldoende medicatie op voorraad (code = '705046008' in codeSystem '<span title="2.16.840.1.113883.6.96">SNOMED CT</span>') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 1.372: | Regel 1.372: | ||
|style="background-color: white;"|SENNOSIDEN A+B 2MG/ML (code = '10960' in codeSystem 'G-Standaard GPK') | |style="background-color: white;"|SENNOSIDEN A+B 2MG/ML (code = '10960' in codeSystem 'G-Standaard GPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|RelatieMedicatieafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
| Regel 1.379: | Regel 1.379: | ||
|style="background-color: white;"|MBH_300_QA2_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |style="background-color: white;"|MBH_300_QA2_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|RelatieToedieningsafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
| Regel 1.387: | Regel 1.387: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
| − | |style="background-color: white;"|MBH_300_QA2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | + | |style="background-color: white;"|MBH_300_QA2-mgb (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
| − | ==== Scenario 0.5 - MBH_300_QA3==== | + | ==== Scenario 0.5 - MBH_300_QA3-mgb==== |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatietoediening MBH_300_QA3_MTD | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatietoediening MBH_300_QA3_MTD-mgb |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
| Regel 1.399: | Regel 1.399: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
| − | |style="background-color: white;"|MBH_300_QA3_MTD (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.18629005.1) | + | |style="background-color: white;"|MBH_300_QA3_MTD-mgb (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.18629005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|RegistratieDatumTijd |
|style="background-color: white;"|T - 45 dagen om 11:26:44 uur | |style="background-color: white;"|T - 45 dagen om 11:26:44 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|ToedieningsDatumTijd |
|style="background-color: white;"|T - 45 dagen om 11:26:44 uur | |style="background-color: white;"|T - 45 dagen om 11:26:44 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|ToegediendeHoeveelheid |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
| Regel 1.436: | Regel 1.436: | ||
|style="background-color: white;"|VLOEIBARE VOEDING MET O.A. VITAMINE K (code = '130575' in codeSystem 'G-Standaard GPK') | |style="background-color: white;"|VLOEIBARE VOEDING MET O.A. VITAMINE K (code = '130575' in codeSystem 'G-Standaard GPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|RelatieMedicatieafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
| Regel 1.443: | Regel 1.443: | ||
|style="background-color: white;"|MBH_300_QA3_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |style="background-color: white;"|MBH_300_QA3_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|RelatieToedieningsafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
| Regel 1.451: | Regel 1.451: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
| − | |style="background-color: white;"|MBH_300_QA3 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | + | |style="background-color: white;"|MBH_300_QA3-mgb (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
| − | ==== Scenario 0.5 - MBH_300_QA5==== | + | ==== Scenario 0.5 - MBH_300_QA5-mgb==== |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatietoediening MBH_300_QA5_MTD | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatietoediening MBH_300_QA5_MTD-mgb |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
| Regel 1.463: | Regel 1.463: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
| − | |style="background-color: white;"|MBH_300_QA5_MTD (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.18629005.1) | + | |style="background-color: white;"|MBH_300_QA5_MTD-mgb (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.18629005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|RegistratieDatumTijd |
|style="background-color: white;"|T - 49 dagen om 13:54:35 uur | |style="background-color: white;"|T - 49 dagen om 13:54:35 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|ToedieningsDatumTijd |
|style="background-color: white;"|T - 49 dagen om 13:54:35 uur | |style="background-color: white;"|T - 49 dagen om 13:54:35 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|ToegediendeHoeveelheid |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
| Regel 1.500: | Regel 1.500: | ||
|style="background-color: white;"|PARACETAMOL 500MG TABLET (code = '2194' in codeSystem 'G-Standaard GPK') | |style="background-color: white;"|PARACETAMOL 500MG TABLET (code = '2194' in codeSystem 'G-Standaard GPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|RelatieMedicatieafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
| Regel 1.507: | Regel 1.507: | ||
|style="background-color: white;"|MBH_300_QA5_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |style="background-color: white;"|MBH_300_QA5_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|RelatieToedieningsafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
| Regel 1.515: | Regel 1.515: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
| − | |style="background-color: white;"|MBH_300_QA5 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | + | |style="background-color: white;"|MBH_300_QA5-mgb (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
==== Bouwstenen ==== | ==== Bouwstenen ==== | ||
| Regel 1.529: | Regel 1.529: | ||
|rowspan="7"| | |rowspan="7"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|ZorgverlenerIdentificatienummer |
|style="background-color: white;"|222220000 (in identificerend systeem: UZI Personen) | |style="background-color: white;"|222220000 (in identificerend systeem: UZI Personen) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 1.549: | Regel 1.549: | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|ZorgaanbiederIdentificatienummer |
|style="background-color: white;"|11110000 (in identificerend systeem: URA) | |style="background-color: white;"|11110000 (in identificerend systeem: URA) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|OrganisatieNaam |
|style="background-color: white;"|Thuiszorg Om en Bij | |style="background-color: white;"|Thuiszorg Om en Bij | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|OrganisatieType |
|style="background-color: white;"|Thuiszorg (code = 'T2' in codeSystem '<span title="2.16.840.1.113883.2.4.15.1060">HL7 RoleCodeNL Care provider type (organizations)</span>') | |style="background-color: white;"|Thuiszorg (code = 'T2' in codeSystem '<span title="2.16.840.1.113883.2.4.15.1060">HL7 RoleCodeNL Care provider type (organizations)</span>') | ||
|}<section end=mbhs-mg-mp-mg-tst-MTD-Scenarioset0-v30-0-5 /><section end=mg-mp-mg-tst-MTD-Scenarioset0-v30-0-5 /> | |}<section end=mbhs-mg-mp-mg-tst-MTD-Scenarioset0-v30-0-5 /><section end=mg-mp-mg-tst-MTD-Scenarioset0-v30-0-5 /> | ||
| Regel 1.599: | Regel 1.599: | ||
|style="background-color: white;"|Man (code = 'M' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') | |style="background-color: white;"|Man (code = 'M' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') | ||
|}<section end=patient-mg-mp-mg-tst-MTD-Scenarioset0-v30-0-6 /><section begin=mbhs-mg-mp-mg-tst-MTD-Scenarioset0-v30-0-6 /> | |}<section end=patient-mg-mp-mg-tst-MTD-Scenarioset0-v30-0-6 /><section begin=mbhs-mg-mp-mg-tst-MTD-Scenarioset0-v30-0-6 /> | ||
| − | ==== Scenario 0.6 - MBH_300_QA1==== | + | ==== Scenario 0.6 - MBH_300_QA1-mgb==== |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatietoediening MBH_300_QA1_MTD | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatietoediening MBH_300_QA1_MTD-mgb |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
| Regel 1.609: | Regel 1.609: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
| − | |style="background-color: white;"|MBH_300_QA1_MTD (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.18629005.1) | + | |style="background-color: white;"|MBH_300_QA1_MTD-mgb (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.18629005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|RegistratieDatumTijd |
|style="background-color: white;"|T - 18 dagen om 10:04:22 uur | |style="background-color: white;"|T - 18 dagen om 10:04:22 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|ToedieningsDatumTijd |
|style="background-color: white;"|T - 18 dagen om 10:04:22 uur | |style="background-color: white;"|T - 18 dagen om 10:04:22 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|ToegediendeHoeveelheid |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
| Regel 1.646: | Regel 1.646: | ||
|style="background-color: white;"|IBUPROFEN TABLET 600MG (code = '42080' in codeSystem 'G-Standaard GPK') | |style="background-color: white;"|IBUPROFEN TABLET 600MG (code = '42080' in codeSystem 'G-Standaard GPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|RelatieMedicatieafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
| Regel 1.653: | Regel 1.653: | ||
|style="background-color: white;"|MBH_300_QA1_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |style="background-color: white;"|MBH_300_QA1_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|RelatieToedieningsafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
| Regel 1.661: | Regel 1.661: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
| − | |style="background-color: white;"|MBH_300_QA1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | + | |style="background-color: white;"|MBH_300_QA1-mgb (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
| − | ==== Scenario 0.6 - MBH_300_QA4==== | + | ==== Scenario 0.6 - MBH_300_QA4-mgb==== |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatietoediening MBH_300_QA4_MTD | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatietoediening MBH_300_QA4_MTD-mgb |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
| Regel 1.673: | Regel 1.673: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
| − | |style="background-color: white;"|MBH_300_QA4_MTD (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.18629005.1) | + | |style="background-color: white;"|MBH_300_QA4_MTD-mgb (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.18629005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|RegistratieDatumTijd |
|style="background-color: white;"|T - 9 dagen om 17:01:01 uur | |style="background-color: white;"|T - 9 dagen om 17:01:01 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|ToedieningsDatumTijd |
|style="background-color: white;"|T - 9 dagen om 17:01:01 uur | |style="background-color: white;"|T - 9 dagen om 17:01:01 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|ToegediendeHoeveelheid |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
| Regel 1.710: | Regel 1.710: | ||
|style="background-color: white;"|ACETYLSALICYLZUUR TABLET 100MG (code = '12548' in codeSystem 'G-Standaard GPK') | |style="background-color: white;"|ACETYLSALICYLZUUR TABLET 100MG (code = '12548' in codeSystem 'G-Standaard GPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|RelatieMedicatieafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
| Regel 1.717: | Regel 1.717: | ||
|style="background-color: white;"|MBH_300_QA4_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |style="background-color: white;"|MBH_300_QA4_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|RelatieToedieningsafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
| Regel 1.725: | Regel 1.725: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
| − | |style="background-color: white;"|MBH_300_QA4 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | + | |style="background-color: white;"|MBH_300_QA4-mgb (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
==== Bouwstenen ==== | ==== Bouwstenen ==== | ||
| Regel 1.739: | Regel 1.739: | ||
|rowspan="7"| | |rowspan="7"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|ZorgverlenerIdentificatienummer |
|style="background-color: white;"|222220000 (in identificerend systeem: UZI Personen) | |style="background-color: white;"|222220000 (in identificerend systeem: UZI Personen) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 1.759: | Regel 1.759: | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|ZorgaanbiederIdentificatienummer |
|style="background-color: white;"|11110000 (in identificerend systeem: URA) | |style="background-color: white;"|11110000 (in identificerend systeem: URA) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|OrganisatieNaam |
|style="background-color: white;"|Thuiszorg Om en Bij | |style="background-color: white;"|Thuiszorg Om en Bij | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|OrganisatieType |
|style="background-color: white;"|Thuiszorg (code = 'T2' in codeSystem '<span title="2.16.840.1.113883.2.4.15.1060">HL7 RoleCodeNL Care provider type (organizations)</span>') | |style="background-color: white;"|Thuiszorg (code = 'T2' in codeSystem '<span title="2.16.840.1.113883.2.4.15.1060">HL7 RoleCodeNL Care provider type (organizations)</span>') | ||
|}<section end=mbhs-mg-mp-mg-tst-MTD-Scenarioset0-v30-0-6 /><section end=mg-mp-mg-tst-MTD-Scenarioset0-v30-0-6 /> | |}<section end=mbhs-mg-mp-mg-tst-MTD-Scenarioset0-v30-0-6 /><section end=mg-mp-mg-tst-MTD-Scenarioset0-v30-0-6 /> | ||
| Regel 1.809: | Regel 1.809: | ||
|style="background-color: white;"|Man (code = 'M' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') | |style="background-color: white;"|Man (code = 'M' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') | ||
|}<section end=patient-mg-mp-mg-tst-MTD-Scenarioset0-v30-0-7 /><section begin=mbhs-mg-mp-mg-tst-MTD-Scenarioset0-v30-0-7 /> | |}<section end=patient-mg-mp-mg-tst-MTD-Scenarioset0-v30-0-7 /><section begin=mbhs-mg-mp-mg-tst-MTD-Scenarioset0-v30-0-7 /> | ||
| − | ==== Scenario 0.7 - MBH_300_QA1==== | + | ==== Scenario 0.7 - MBH_300_QA1-mgb==== |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatietoediening MBH_300_QA1_MTD | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatietoediening MBH_300_QA1_MTD-mgb |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
| Regel 1.819: | Regel 1.819: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
| − | |style="background-color: white;"|MBH_300_QA1_MTD (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.18629005.1) | + | |style="background-color: white;"|MBH_300_QA1_MTD-mgb (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.18629005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|RegistratieDatumTijd |
|style="background-color: white;"|T - 18 dagen om 10:04:22 uur | |style="background-color: white;"|T - 18 dagen om 10:04:22 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|ToedieningsDatumTijd |
|style="background-color: white;"|T - 18 dagen om 10:04:22 uur | |style="background-color: white;"|T - 18 dagen om 10:04:22 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|ToegediendeHoeveelheid |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
| Regel 1.856: | Regel 1.856: | ||
|style="background-color: white;"|IBUPROFEN TABLET 600MG (code = '42080' in codeSystem 'G-Standaard GPK') | |style="background-color: white;"|IBUPROFEN TABLET 600MG (code = '42080' in codeSystem 'G-Standaard GPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|RelatieMedicatieafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
| Regel 1.863: | Regel 1.863: | ||
|style="background-color: white;"|MBH_300_QA1_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |style="background-color: white;"|MBH_300_QA1_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|RelatieToedieningsafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
| Regel 1.871: | Regel 1.871: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
| − | |style="background-color: white;"|MBH_300_QA1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | + | |style="background-color: white;"|MBH_300_QA1-mgb (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
==== Bouwstenen ==== | ==== Bouwstenen ==== | ||
| Regel 1.885: | Regel 1.885: | ||
|rowspan="7"| | |rowspan="7"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|ZorgverlenerIdentificatienummer |
|style="background-color: white;"|222220000 (in identificerend systeem: UZI Personen) | |style="background-color: white;"|222220000 (in identificerend systeem: UZI Personen) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 1.905: | Regel 1.905: | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|ZorgaanbiederIdentificatienummer |
|style="background-color: white;"|11110000 (in identificerend systeem: URA) | |style="background-color: white;"|11110000 (in identificerend systeem: URA) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|OrganisatieNaam |
|style="background-color: white;"|Thuiszorg Om en Bij | |style="background-color: white;"|Thuiszorg Om en Bij | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|OrganisatieType |
|style="background-color: white;"|Thuiszorg (code = 'T2' in codeSystem '<span title="2.16.840.1.113883.2.4.15.1060">HL7 RoleCodeNL Care provider type (organizations)</span>') | |style="background-color: white;"|Thuiszorg (code = 'T2' in codeSystem '<span title="2.16.840.1.113883.2.4.15.1060">HL7 RoleCodeNL Care provider type (organizations)</span>') | ||
|}<section end=mbhs-mg-mp-mg-tst-MTD-Scenarioset0-v30-0-7 /><section end=mg-mp-mg-tst-MTD-Scenarioset0-v30-0-7 /> | |}<section end=mbhs-mg-mp-mg-tst-MTD-Scenarioset0-v30-0-7 /><section end=mg-mp-mg-tst-MTD-Scenarioset0-v30-0-7 /> | ||
| Regel 1.949: | Regel 1.949: | ||
|style="background-color: white;"|Man (code = 'M' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') | |style="background-color: white;"|Man (code = 'M' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') | ||
|}<section end=patient-mg-mp-mg-tst-MTD-Scenarioset2-v30-2-1 /><section begin=mbhs-mg-mp-mg-tst-MTD-Scenarioset2-v30-2-1 /> | |}<section end=patient-mg-mp-mg-tst-MTD-Scenarioset2-v30-2-1 /><section begin=mbhs-mg-mp-mg-tst-MTD-Scenarioset2-v30-2-1 /> | ||
| − | ==== Scenario 2.1 - MBH_300_toelichting==== | + | ==== Scenario 2.1 - MBH_300_toelichting-mgb==== |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatietoediening MBH_300_toelichting_MTD | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatietoediening MBH_300_toelichting_MTD-mgb |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
| Regel 1.959: | Regel 1.959: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
| − | |style="background-color: white;"|MBH_300_toelichting_MTD (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.18629005.1) | + | |style="background-color: white;"|MBH_300_toelichting_MTD-mgb (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.18629005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|RegistratieDatumTijd |
|style="background-color: white;"|T - 18 dagen om 10:33:47 uur | |style="background-color: white;"|T - 18 dagen om 10:33:47 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|ToedieningsDatumTijd |
|style="background-color: white;"|T - 18 dagen om 10:33:47 uur | |style="background-color: white;"|T - 18 dagen om 10:33:47 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|ToegediendeHoeveelheid |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
| Regel 1.999: | Regel 1.999: | ||
|style="background-color: white;"|In overleg met specialist | |style="background-color: white;"|In overleg met specialist | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|RelatieMedicatieafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
| Regel 2.006: | Regel 2.006: | ||
|style="background-color: white;"|MBH_300_toelichting_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |style="background-color: white;"|MBH_300_toelichting_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|RelatieToedieningsafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
| Regel 2.014: | Regel 2.014: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
| − | |style="background-color: white;"|MBH_300_toelichting (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | + | |style="background-color: white;"|MBH_300_toelichting-mgb (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
==== Bouwstenen ==== | ==== Bouwstenen ==== | ||
| Regel 2.028: | Regel 2.028: | ||
|rowspan="7"| | |rowspan="7"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|ZorgverlenerIdentificatienummer |
|style="background-color: white;"|222220000 (in identificerend systeem: UZI Personen) | |style="background-color: white;"|222220000 (in identificerend systeem: UZI Personen) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 2.048: | Regel 2.048: | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|ZorgaanbiederIdentificatienummer |
|style="background-color: white;"|11110000 (in identificerend systeem: URA) | |style="background-color: white;"|11110000 (in identificerend systeem: URA) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|OrganisatieNaam |
|style="background-color: white;"|Thuiszorg Om en Bij | |style="background-color: white;"|Thuiszorg Om en Bij | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|OrganisatieType |
|style="background-color: white;"|Thuiszorg (code = 'T2' in codeSystem '<span title="2.16.840.1.113883.2.4.15.1060">HL7 RoleCodeNL Care provider type (organizations)</span>') | |style="background-color: white;"|Thuiszorg (code = 'T2' in codeSystem '<span title="2.16.840.1.113883.2.4.15.1060">HL7 RoleCodeNL Care provider type (organizations)</span>') | ||
|}<section end=mbhs-mg-mp-mg-tst-MTD-Scenarioset2-v30-2-1 /><section end=mg-mp-mg-tst-MTD-Scenarioset2-v30-2-1 /> | |}<section end=mbhs-mg-mp-mg-tst-MTD-Scenarioset2-v30-2-1 /><section end=mg-mp-mg-tst-MTD-Scenarioset2-v30-2-1 /> | ||
| Regel 2.092: | Regel 2.092: | ||
|style="background-color: white;"|Man (code = 'M' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') | |style="background-color: white;"|Man (code = 'M' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') | ||
|}<section end=patient-mg-mp-mg-tst-MTD-Scenarioset2-v30-2-2 /><section begin=mbhs-mg-mp-mg-tst-MTD-Scenarioset2-v30-2-2 /> | |}<section end=patient-mg-mp-mg-tst-MTD-Scenarioset2-v30-2-2 /><section begin=mbhs-mg-mp-mg-tst-MTD-Scenarioset2-v30-2-2 /> | ||
| − | ==== Scenario 2.2 - MBH_300_Toedieningsweg==== | + | ==== Scenario 2.2 - MBH_300_Toedieningsweg-mgb==== |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatietoediening MBH_300_Toedieningsweg_MTD | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatietoediening MBH_300_Toedieningsweg_MTD-mgb |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
| Regel 2.102: | Regel 2.102: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
| − | |style="background-color: white;"|MBH_300_Toedieningsweg_MTD (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.18629005.1) | + | |style="background-color: white;"|MBH_300_Toedieningsweg_MTD-mgb (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.18629005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|RegistratieDatumTijd |
|style="background-color: white;"|T - 4 dagen om 11:26:44 uur | |style="background-color: white;"|T - 4 dagen om 11:26:44 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|ToedieningsDatumTijd |
|style="background-color: white;"|T - 4 dagen om 11:26 uur | |style="background-color: white;"|T - 4 dagen om 11:26 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|ToegediendeHoeveelheid |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
| Regel 2.139: | Regel 2.139: | ||
|style="background-color: white;"|DEXAMETHASON/FRAMYCETINE/GRAMICIDINE OORDR (code = '79804' in codeSystem 'G-Standaard GPK') | |style="background-color: white;"|DEXAMETHASON/FRAMYCETINE/GRAMICIDINE OORDR (code = '79804' in codeSystem 'G-Standaard GPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|RelatieMedicatieafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
| Regel 2.146: | Regel 2.146: | ||
|style="background-color: white;"|MBH_300_Toedieningsweg_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |style="background-color: white;"|MBH_300_Toedieningsweg_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|RelatieToedieningsafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
| Regel 2.154: | Regel 2.154: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
| − | |style="background-color: white;"|MBH_300_Toedieningsweg (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | + | |style="background-color: white;"|MBH_300_Toedieningsweg-mgb (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
==== Bouwstenen ==== | ==== Bouwstenen ==== | ||
| Regel 2.168: | Regel 2.168: | ||
|rowspan="7"| | |rowspan="7"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|ZorgverlenerIdentificatienummer |
|style="background-color: white;"|222220000 (in identificerend systeem: UZI Personen) | |style="background-color: white;"|222220000 (in identificerend systeem: UZI Personen) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 2.188: | Regel 2.188: | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|ZorgaanbiederIdentificatienummer |
|style="background-color: white;"|11110000 (in identificerend systeem: URA) | |style="background-color: white;"|11110000 (in identificerend systeem: URA) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|OrganisatieNaam |
|style="background-color: white;"|Thuiszorg Om en Bij | |style="background-color: white;"|Thuiszorg Om en Bij | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|OrganisatieType |
|style="background-color: white;"|Thuiszorg (code = 'T2' in codeSystem '<span title="2.16.840.1.113883.2.4.15.1060">HL7 RoleCodeNL Care provider type (organizations)</span>') | |style="background-color: white;"|Thuiszorg (code = 'T2' in codeSystem '<span title="2.16.840.1.113883.2.4.15.1060">HL7 RoleCodeNL Care provider type (organizations)</span>') | ||
|}<section end=mbhs-mg-mp-mg-tst-MTD-Scenarioset2-v30-2-2 /><section end=mg-mp-mg-tst-MTD-Scenarioset2-v30-2-2 /> | |}<section end=mbhs-mg-mp-mg-tst-MTD-Scenarioset2-v30-2-2 /><section end=mg-mp-mg-tst-MTD-Scenarioset2-v30-2-2 /> | ||
| Regel 2.232: | Regel 2.232: | ||
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') | |style="background-color: white;"|Vrouw (code = 'F' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') | ||
|}<section end=patient-mg-mp-mg-tst-MTD-Scenarioset3-v30-3-11 /><section begin=mbhs-mg-mp-mg-tst-MTD-Scenarioset3-v30-3-11 /> | |}<section end=patient-mg-mp-mg-tst-MTD-Scenarioset3-v30-3-11 /><section begin=mbhs-mg-mp-mg-tst-MTD-Scenarioset3-v30-3-11 /> | ||
| − | ==== Scenario 3.11 - MBH_300_MTDopschorten==== | + | ==== Scenario 3.11 - MBH_300_MTDopschorten-mgb==== |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatietoediening MBH_300_MTDopschorten_MTD1 | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatietoediening MBH_300_MTDopschorten_MTD1-mgb |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
| Regel 2.242: | Regel 2.242: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
| − | |style="background-color: white;"|MBH_300_MTDopschorten_MTD1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.18629005.1) | + | |style="background-color: white;"|MBH_300_MTDopschorten_MTD1-mgb (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.18629005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|RegistratieDatumTijd |
|style="background-color: white;"|T - 4 dagen om 08:38:45 uur | |style="background-color: white;"|T - 4 dagen om 08:38:45 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|ToedieningsDatumTijd |
|style="background-color: white;"|T - 4 dagen om 08:38:45 uur | |style="background-color: white;"|T - 4 dagen om 08:38:45 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|ToegediendeHoeveelheid |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
| Regel 2.270: | Regel 2.270: | ||
|style="background-color: white;"|Zie [[#JANTIEN_TOEDIEN|Zorgverlener: JANTIEN_TOEDIEN]] | |style="background-color: white;"|Zie [[#JANTIEN_TOEDIEN|Zorgverlener: JANTIEN_TOEDIEN]] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|MedicatietoedieningRedenVanAfwijken |
|style="background-color: white;"|niet in staat om medicatie te gebruiken (code = '408366001' in codeSystem '<span title="2.16.840.1.113883.6.96">SNOMED CT</span>') | |style="background-color: white;"|niet in staat om medicatie te gebruiken (code = '408366001' in codeSystem '<span title="2.16.840.1.113883.6.96">SNOMED CT</span>') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 2.282: | Regel 2.282: | ||
|style="background-color: white;"|PROPRANOLOL TABLET 80MG (code = '16322' in codeSystem 'G-Standaard GPK') | |style="background-color: white;"|PROPRANOLOL TABLET 80MG (code = '16322' in codeSystem 'G-Standaard GPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|RelatieMedicatieafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
| Regel 2.289: | Regel 2.289: | ||
|style="background-color: white;"|MBH_300_MTDopschorten_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |style="background-color: white;"|MBH_300_MTDopschorten_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|RelatieToedieningsafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
| Regel 2.297: | Regel 2.297: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
| − | |style="background-color: white;"|MBH_300_MTDopschorten (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | + | |style="background-color: white;"|MBH_300_MTDopschorten-mgb (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatietoediening MBH_300_MTDopschorten_MTD2 | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatietoediening MBH_300_MTDopschorten_MTD2-mgb |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
| Regel 2.307: | Regel 2.307: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
| − | |style="background-color: white;"|MBH_300_MTDopschorten_MTD2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.18629005.1) | + | |style="background-color: white;"|MBH_300_MTDopschorten_MTD2-mgb (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.18629005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|RegistratieDatumTijd |
|style="background-color: white;"|T - 4 dagen om 11:22:06 uur | |style="background-color: white;"|T - 4 dagen om 11:22:06 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|ToedieningsDatumTijd |
|style="background-color: white;"|T - 4 dagen om 11:22:06 uur | |style="background-color: white;"|T - 4 dagen om 11:22:06 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|ToegediendeHoeveelheid |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
| Regel 2.344: | Regel 2.344: | ||
|style="background-color: white;"|PROPRANOLOL TABLET 80MG (code = '16322' in codeSystem 'G-Standaard GPK') | |style="background-color: white;"|PROPRANOLOL TABLET 80MG (code = '16322' in codeSystem 'G-Standaard GPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|RelatieMedicatieafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
| Regel 2.351: | Regel 2.351: | ||
|style="background-color: white;"|MBH_300_MTDopschorten_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |style="background-color: white;"|MBH_300_MTDopschorten_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|RelatieToedieningsafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
| Regel 2.359: | Regel 2.359: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
| − | |style="background-color: white;"|MBH_300_MTDopschorten (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | + | |style="background-color: white;"|MBH_300_MTDopschorten-mgb (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
==== Bouwstenen ==== | ==== Bouwstenen ==== | ||
| Regel 2.373: | Regel 2.373: | ||
|rowspan="7"| | |rowspan="7"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|ZorgverlenerIdentificatienummer |
|style="background-color: white;"|222220000 (in identificerend systeem: UZI Personen) | |style="background-color: white;"|222220000 (in identificerend systeem: UZI Personen) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 2.393: | Regel 2.393: | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|ZorgaanbiederIdentificatienummer |
|style="background-color: white;"|11110000 (in identificerend systeem: URA) | |style="background-color: white;"|11110000 (in identificerend systeem: URA) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|OrganisatieNaam |
|style="background-color: white;"|Thuiszorg Om en Bij | |style="background-color: white;"|Thuiszorg Om en Bij | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|OrganisatieType |
|style="background-color: white;"|Thuiszorg (code = 'T2' in codeSystem '<span title="2.16.840.1.113883.2.4.15.1060">HL7 RoleCodeNL Care provider type (organizations)</span>') | |style="background-color: white;"|Thuiszorg (code = 'T2' in codeSystem '<span title="2.16.840.1.113883.2.4.15.1060">HL7 RoleCodeNL Care provider type (organizations)</span>') | ||
|}<section end=mbhs-mg-mp-mg-tst-MTD-Scenarioset3-v30-3-11 /><section end=mg-mp-mg-tst-MTD-Scenarioset3-v30-3-11 /> | |}<section end=mbhs-mg-mp-mg-tst-MTD-Scenarioset3-v30-3-11 /><section end=mg-mp-mg-tst-MTD-Scenarioset3-v30-3-11 /> | ||
| Regel 2.437: | Regel 2.437: | ||
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') | |style="background-color: white;"|Vrouw (code = 'F' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') | ||
|}<section end=patient-mg-mp-mg-tst-MTD-Scenarioset3-v30-3-12 /><section begin=mbhs-mg-mp-mg-tst-MTD-Scenarioset3-v30-3-12 /> | |}<section end=patient-mg-mp-mg-tst-MTD-Scenarioset3-v30-3-12 /><section begin=mbhs-mg-mp-mg-tst-MTD-Scenarioset3-v30-3-12 /> | ||
| − | ==== Scenario 3.12 - mbh_300_AfwijkendeToediening==== | + | ==== Scenario 3.12 - mbh_300_AfwijkendeToediening-mgb==== |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatietoediening mbh_300_AfwijkendeToediening_MTD_normaal | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatietoediening mbh_300_AfwijkendeToediening_MTD_normaal-mgb |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
| Regel 2.447: | Regel 2.447: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
| − | |style="background-color: white;"|mbh_300_AfwijkendeToediening_MTD_normaal (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.18629005.1) | + | |style="background-color: white;"|mbh_300_AfwijkendeToediening_MTD_normaal-mgb (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.18629005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|RegistratieDatumTijd |
|style="background-color: white;"|T - 1 dag om 11:00 uur | |style="background-color: white;"|T - 1 dag om 11:00 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|ToedieningsDatumTijd |
|style="background-color: white;"|T - 1 dag om 11:00 uur | |style="background-color: white;"|T - 1 dag om 11:00 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|ToegediendeHoeveelheid |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
| Regel 2.484: | Regel 2.484: | ||
|style="background-color: white;"|AMLODIPINE TABLET 5MG (code = '155616' in codeSystem 'G-Standaard GPK') | |style="background-color: white;"|AMLODIPINE TABLET 5MG (code = '155616' in codeSystem 'G-Standaard GPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|RelatieMedicatieafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
| Regel 2.491: | Regel 2.491: | ||
|style="background-color: white;"|MBH_300_AfwijkendeToediening_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |style="background-color: white;"|MBH_300_AfwijkendeToediening_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|RelatieToedieningsafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
| Regel 2.499: | Regel 2.499: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
| − | |style="background-color: white;"|mbh_300_AfwijkendeToediening (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | + | |style="background-color: white;"|mbh_300_AfwijkendeToediening-mgb (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatietoediening mbh_300_AfwijkendeToediening_MTD_afwijkendeQty | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatietoediening mbh_300_AfwijkendeToediening_MTD_afwijkendeQty-mgb |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
| Regel 2.509: | Regel 2.509: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
| − | |style="background-color: white;"|mbh_300_AfwijkendeToediening_MTD_afwijkendeQty (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.18629005.1) | + | |style="background-color: white;"|mbh_300_AfwijkendeToediening_MTD_afwijkendeQty-mgb (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.18629005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|RegistratieDatumTijd |
|style="background-color: white;"|T om 11:00 uur | |style="background-color: white;"|T om 11:00 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|ToedieningsDatumTijd |
|style="background-color: white;"|T om 11:00 uur | |style="background-color: white;"|T om 11:00 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|ToegediendeHoeveelheid |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
| Regel 2.537: | Regel 2.537: | ||
|style="background-color: white;"|Zie [[#JANTIEN_TOEDIEN|Zorgverlener: JANTIEN_TOEDIEN]] | |style="background-color: white;"|Zie [[#JANTIEN_TOEDIEN|Zorgverlener: JANTIEN_TOEDIEN]] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|MedicatietoedieningRedenVanAfwijken |
|style="background-color: white;"|Overig (code = 'OTH' in codeSystem '<span title="2.16.840.1.113883.5.1008">HL7 NullFlavor</span>'): Tensie meting uitgevoerd. Uitslag: laag-normaal. Daarom 1 stuks toegediend i.p.v. 2. | |style="background-color: white;"|Overig (code = 'OTH' in codeSystem '<span title="2.16.840.1.113883.5.1008">HL7 NullFlavor</span>'): Tensie meting uitgevoerd. Uitslag: laag-normaal. Daarom 1 stuks toegediend i.p.v. 2. | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 2.549: | Regel 2.549: | ||
|style="background-color: white;"|AMLODIPINE TABLET 5MG (code = '155616' in codeSystem 'G-Standaard GPK') | |style="background-color: white;"|AMLODIPINE TABLET 5MG (code = '155616' in codeSystem 'G-Standaard GPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|RelatieMedicatieafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
| Regel 2.556: | Regel 2.556: | ||
|style="background-color: white;"|MBH_300_AfwijkendeToediening_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |style="background-color: white;"|MBH_300_AfwijkendeToediening_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|RelatieToedieningsafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
| Regel 2.564: | Regel 2.564: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
| − | |style="background-color: white;"|mbh_300_AfwijkendeToediening (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | + | |style="background-color: white;"|mbh_300_AfwijkendeToediening-mgb (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
==== Bouwstenen ==== | ==== Bouwstenen ==== | ||
| Regel 2.578: | Regel 2.578: | ||
|rowspan="7"| | |rowspan="7"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|ZorgverlenerIdentificatienummer |
|style="background-color: white;"|222220000 (in identificerend systeem: UZI Personen) | |style="background-color: white;"|222220000 (in identificerend systeem: UZI Personen) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 2.598: | Regel 2.598: | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|ZorgaanbiederIdentificatienummer |
|style="background-color: white;"|11110000 (in identificerend systeem: URA) | |style="background-color: white;"|11110000 (in identificerend systeem: URA) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|OrganisatieNaam |
|style="background-color: white;"|Thuiszorg Om en Bij | |style="background-color: white;"|Thuiszorg Om en Bij | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|OrganisatieType |
|style="background-color: white;"|Thuiszorg (code = 'T2' in codeSystem '<span title="2.16.840.1.113883.2.4.15.1060">HL7 RoleCodeNL Care provider type (organizations)</span>') | |style="background-color: white;"|Thuiszorg (code = 'T2' in codeSystem '<span title="2.16.840.1.113883.2.4.15.1060">HL7 RoleCodeNL Care provider type (organizations)</span>') | ||
|}<section end=mbhs-mg-mp-mg-tst-MTD-Scenarioset3-v30-3-12 /><section end=mg-mp-mg-tst-MTD-Scenarioset3-v30-3-12 /> | |}<section end=mbhs-mg-mp-mg-tst-MTD-Scenarioset3-v30-3-12 /><section end=mg-mp-mg-tst-MTD-Scenarioset3-v30-3-12 /> | ||
| Regel 2.642: | Regel 2.642: | ||
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') | |style="background-color: white;"|Vrouw (code = 'F' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') | ||
|}<section end=patient-mg-mp-mg-tst-MTD-Scenarioset3-v30-3-13 /><section begin=mbhs-mg-mp-mg-tst-MTD-Scenarioset3-v30-3-13 /> | |}<section end=patient-mg-mp-mg-tst-MTD-Scenarioset3-v30-3-13 /><section begin=mbhs-mg-mp-mg-tst-MTD-Scenarioset3-v30-3-13 /> | ||
| − | ==== Scenario 3.13 - MBH_300_CorrectieToediening ==== | + | ==== Scenario 3.13 - MBH_300_CorrectieToediening -mgb==== |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatietoediening MBH_300_CorrectieToediening_MTD_normaal | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatietoediening MBH_300_CorrectieToediening_MTD_normaal-mgb |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
| Regel 2.652: | Regel 2.652: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
| − | |style="background-color: white;"|MBH_300_CorrectieToediening_MTD_normaal (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.18629005.1) | + | |style="background-color: white;"|MBH_300_CorrectieToediening_MTD_normaal-mgb (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.18629005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|RegistratieDatumTijd |
|style="background-color: white;"|T - 2 dagen om 13:45 uur | |style="background-color: white;"|T - 2 dagen om 13:45 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|ToedieningsDatumTijd |
|style="background-color: white;"|T - 2 dagen om 13:45 uur | |style="background-color: white;"|T - 2 dagen om 13:45 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|ToegediendeHoeveelheid |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
| Regel 2.689: | Regel 2.689: | ||
|style="background-color: white;"|TRIMETHOPRIM TABLET 300MG (code = '39136' in codeSystem 'G-Standaard GPK') | |style="background-color: white;"|TRIMETHOPRIM TABLET 300MG (code = '39136' in codeSystem 'G-Standaard GPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|RelatieMedicatieafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
| Regel 2.696: | Regel 2.696: | ||
|style="background-color: white;"|MBH_300_CorrectieToediening_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |style="background-color: white;"|MBH_300_CorrectieToediening_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|RelatieToedieningsafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
| Regel 2.704: | Regel 2.704: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
| − | |style="background-color: white;"|MBH_300_CorrectieToediening (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | + | |style="background-color: white;"|MBH_300_CorrectieToediening -mgb (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatietoediening MBH_300_CorrectieToediening_MTD_extraHoeveelheid | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatietoediening MBH_300_CorrectieToediening_MTD_extraHoeveelheid-mgb |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
| Regel 2.714: | Regel 2.714: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
| − | |style="background-color: white;"|MBH_300_CorrectieToediening_MTD_extraHoeveelheid (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.18629005.1) | + | |style="background-color: white;"|MBH_300_CorrectieToediening_MTD_extraHoeveelheid-mgb (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.18629005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|RegistratieDatumTijd |
|style="background-color: white;"|T - 2 dagen om 13:50 uur | |style="background-color: white;"|T - 2 dagen om 13:50 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|ToedieningsDatumTijd |
|style="background-color: white;"|T - 2 dagen om 13:45 uur | |style="background-color: white;"|T - 2 dagen om 13:45 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|ToegediendeHoeveelheid |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
| Regel 2.751: | Regel 2.751: | ||
|style="background-color: white;"|TRIMETHOPRIM TABLET 300MG (code = '39136' in codeSystem 'G-Standaard GPK') | |style="background-color: white;"|TRIMETHOPRIM TABLET 300MG (code = '39136' in codeSystem 'G-Standaard GPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|RelatieMedicatieafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
| Regel 2.758: | Regel 2.758: | ||
|style="background-color: white;"|MBH_300_CorrectieToediening_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |style="background-color: white;"|MBH_300_CorrectieToediening_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|RelatieToedieningsafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
| Regel 2.766: | Regel 2.766: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
| − | |style="background-color: white;"|MBH_300_CorrectieToediening (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | + | |style="background-color: white;"|MBH_300_CorrectieToediening -mgb (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
==== Bouwstenen ==== | ==== Bouwstenen ==== | ||
| Regel 2.780: | Regel 2.780: | ||
|rowspan="7"| | |rowspan="7"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|ZorgverlenerIdentificatienummer |
|style="background-color: white;"|222220000 (in identificerend systeem: UZI Personen) | |style="background-color: white;"|222220000 (in identificerend systeem: UZI Personen) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 2.800: | Regel 2.800: | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|ZorgaanbiederIdentificatienummer |
|style="background-color: white;"|11110000 (in identificerend systeem: URA) | |style="background-color: white;"|11110000 (in identificerend systeem: URA) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|OrganisatieNaam |
|style="background-color: white;"|Thuiszorg Om en Bij | |style="background-color: white;"|Thuiszorg Om en Bij | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|OrganisatieType |
|style="background-color: white;"|Thuiszorg (code = 'T2' in codeSystem '<span title="2.16.840.1.113883.2.4.15.1060">HL7 RoleCodeNL Care provider type (organizations)</span>') | |style="background-color: white;"|Thuiszorg (code = 'T2' in codeSystem '<span title="2.16.840.1.113883.2.4.15.1060">HL7 RoleCodeNL Care provider type (organizations)</span>') | ||
|}<section end=mbhs-mg-mp-mg-tst-MTD-Scenarioset3-v30-3-13 /><section end=mg-mp-mg-tst-MTD-Scenarioset3-v30-3-13 /> | |}<section end=mbhs-mg-mp-mg-tst-MTD-Scenarioset3-v30-3-13 /><section end=mg-mp-mg-tst-MTD-Scenarioset3-v30-3-13 /> | ||
| Regel 2.844: | Regel 2.844: | ||
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') | |style="background-color: white;"|Vrouw (code = 'F' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') | ||
|}<section end=patient-mg-mp-mg-tst-MTD-Scenarioset3-v30-3-14 /><section begin=mbhs-mg-mp-mg-tst-MTD-Scenarioset3-v30-3-14 /> | |}<section end=patient-mg-mp-mg-tst-MTD-Scenarioset3-v30-3-14 /><section begin=mbhs-mg-mp-mg-tst-MTD-Scenarioset3-v30-3-14 /> | ||
| − | ==== Scenario 3.14 - MBH_300_CorrectieOpToediening==== | + | ==== Scenario 3.14 - MBH_300_CorrectieOpToediening-mgb==== |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatietoediening MBH_300_CorrectieOpToediening_MTD_verkeerdeQty | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatietoediening MBH_300_CorrectieOpToediening_MTD_verkeerdeQty-mgb |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
| Regel 2.854: | Regel 2.854: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
| − | |style="background-color: white;"|MBH_300_CorrectieOpToediening_MTD_verkeerdeQty (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.18629005.1) | + | |style="background-color: white;"|MBH_300_CorrectieOpToediening_MTD_verkeerdeQty-mgb (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.18629005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|RegistratieDatumTijd |
|style="background-color: white;"|T - 3 dagen om 07:45 uur | |style="background-color: white;"|T - 3 dagen om 07:45 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|ToedieningsDatumTijd |
|style="background-color: white;"|T - 3 dagen om 07:45 uur | |style="background-color: white;"|T - 3 dagen om 07:45 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|ToegediendeHoeveelheid |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
| Regel 2.891: | Regel 2.891: | ||
|style="background-color: white;"|PANTOPRAZOL TABLET MSR 20MG (code = '106275' in codeSystem 'G-Standaard GPK') | |style="background-color: white;"|PANTOPRAZOL TABLET MSR 20MG (code = '106275' in codeSystem 'G-Standaard GPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|RelatieMedicatieafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
| Regel 2.898: | Regel 2.898: | ||
|style="background-color: white;"|MBH_300_CorrectieOpToediening_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |style="background-color: white;"|MBH_300_CorrectieOpToediening_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|RelatieToedieningsafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
| Regel 2.906: | Regel 2.906: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
| − | |style="background-color: white;"|MBH_300_CorrectieOpToediening (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | + | |style="background-color: white;"|MBH_300_CorrectieOpToediening-mgb (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatietoediening | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatietoediening MBH_300_CorrectieOpToediening_correctie_MTD-mgb |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
| Regel 2.916: | Regel 2.916: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_CorrectieOpToediening_correctie_MTD-mgb (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.18629005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|RegistratieDatumTijd |
|style="background-color: white;"|T - 3 dagen om 07:48 uur | |style="background-color: white;"|T - 3 dagen om 07:48 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|ToedieningsDatumTijd |
|style="background-color: white;"|T - 3 dagen om 07:48 uur | |style="background-color: white;"|T - 3 dagen om 07:48 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|ToegediendeHoeveelheid |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
| Regel 2.944: | Regel 2.944: | ||
|style="background-color: white;"|Zie [[#TANJA_DE_BAKKER|Zorgverlener: TANJA_DE_BAKKER]] | |style="background-color: white;"|Zie [[#TANJA_DE_BAKKER|Zorgverlener: TANJA_DE_BAKKER]] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|MedicatietoedieningRedenVanAfwijken |
|style="background-color: white;"|foutieve registratie van medicatie (code = '159691000146109' in codeSystem '<span title="2.16.840.1.113883.6.96">SNOMED CT</span>') | |style="background-color: white;"|foutieve registratie van medicatie (code = '159691000146109' in codeSystem '<span title="2.16.840.1.113883.6.96">SNOMED CT</span>') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 2.956: | Regel 2.956: | ||
|style="background-color: white;"|PANTOPRAZOL TABLET MSR 20MG (code = '106275' in codeSystem 'G-Standaard GPK') | |style="background-color: white;"|PANTOPRAZOL TABLET MSR 20MG (code = '106275' in codeSystem 'G-Standaard GPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|RelatieMedicatieafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
| Regel 2.963: | Regel 2.963: | ||
|style="background-color: white;"|MBH_300_CorrectieOpToediening_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |style="background-color: white;"|MBH_300_CorrectieOpToediening_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|RelatieToedieningsafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
| Regel 2.971: | Regel 2.971: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
| − | |style="background-color: white;"|MBH_300_CorrectieOpToediening (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | + | |style="background-color: white;"|MBH_300_CorrectieOpToediening-mgb (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatietoediening MBH_300_CorrectieOpToediening_CorrecteHoeveelheid_MTD | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatietoediening MBH_300_CorrectieOpToediening_CorrecteHoeveelheid_MTD-mgb |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
| Regel 2.981: | Regel 2.981: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
| − | |style="background-color: white;"|MBH_300_CorrectieOpToediening_CorrecteHoeveelheid_MTD (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.18629005.1) | + | |style="background-color: white;"|MBH_300_CorrectieOpToediening_CorrecteHoeveelheid_MTD-mgb (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.18629005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|RegistratieDatumTijd |
|style="background-color: white;"|T - 3 dagen om 07:49 uur | |style="background-color: white;"|T - 3 dagen om 07:49 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|ToedieningsDatumTijd |
|style="background-color: white;"|T - 3 dagen om 07:49 uur | |style="background-color: white;"|T - 3 dagen om 07:49 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|ToegediendeHoeveelheid |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
| Regel 3.021: | Regel 3.021: | ||
|style="background-color: white;"|Correctie op verkeerd geregistreerde hoeveelheid | |style="background-color: white;"|Correctie op verkeerd geregistreerde hoeveelheid | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|RelatieMedicatieafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
| Regel 3.028: | Regel 3.028: | ||
|style="background-color: white;"|MBH_300_CorrectieOpToediening_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |style="background-color: white;"|MBH_300_CorrectieOpToediening_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|RelatieToedieningsafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
| Regel 3.036: | Regel 3.036: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
| − | |style="background-color: white;"|MBH_300_CorrectieOpToediening (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | + | |style="background-color: white;"|MBH_300_CorrectieOpToediening-mgb (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
==== Bouwstenen ==== | ==== Bouwstenen ==== | ||
| Regel 3.050: | Regel 3.050: | ||
|rowspan="7"| | |rowspan="7"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|ZorgverlenerIdentificatienummer |
|style="background-color: white;"|222221111 (in identificerend systeem: UZI Personen) | |style="background-color: white;"|222221111 (in identificerend systeem: UZI Personen) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 3.070: | Regel 3.070: | ||
|rowspan="5"| | |rowspan="5"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|ZorgaanbiederIdentificatienummer |
|style="background-color: white;"|11112222 (in identificerend systeem: URA) | |style="background-color: white;"|11112222 (in identificerend systeem: URA) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|OrganisatieNaam |
|style="background-color: white;"|Trombosedienst Ons Dorp | |style="background-color: white;"|Trombosedienst Ons Dorp | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|AfdelingSpecialisme |
|style="background-color: white;"|Trombosediensten (code = '3400' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') | |style="background-color: white;"|Trombosediensten (code = '3400' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 3.117: | Regel 3.117: | ||
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') | |style="background-color: white;"|Vrouw (code = 'F' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') | ||
|}<section end=patient-mg-mp-mg-tst-MTD-Scenarioset6-v30-6-13 /><section begin=mbhs-mg-mp-mg-tst-MTD-Scenarioset6-v30-6-13 /> | |}<section end=patient-mg-mp-mg-tst-MTD-Scenarioset6-v30-6-13 /><section begin=mbhs-mg-mp-mg-tst-MTD-Scenarioset6-v30-6-13 /> | ||
| − | ==== Scenario 6.13 - MBH_300_toedieningssnelheid==== | + | ==== Scenario 6.13 - MBH_300_toedieningssnelheid-mgb==== |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatietoediening MBH_300_toedieningssnelheid_MTD | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatietoediening MBH_300_toedieningssnelheid_MTD-mgb |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
| Regel 3.127: | Regel 3.127: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
| − | |style="background-color: white;"|MBH_300_toedieningssnelheid_MTD (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.18629005.1) | + | |style="background-color: white;"|MBH_300_toedieningssnelheid_MTD-mgb (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.18629005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|RegistratieDatumTijd |
|style="background-color: white;"|T om 11:49:39 uur | |style="background-color: white;"|T om 11:49:39 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|ToedieningsDatumTijd |
|style="background-color: white;"|T om 11:49:39 uur | |style="background-color: white;"|T om 11:49:39 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="5"| | + | |colspan="5"|ToegediendeHoeveelheid |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
| Regel 3.152: | Regel 3.152: | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|nominaleWaarde |
|style="background-color: white;"|0.3 ml/h | |style="background-color: white;"|0.3 ml/h | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="5"| | + | |colspan="5"|PrikPlakLocatie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="5"| | |rowspan="5"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|AnatomischeLocatie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
| Regel 3.185: | Regel 3.185: | ||
|style="background-color: white;"|MORFINE INFVLST 5MG/ML CAS 100ML (code = '134538' in codeSystem 'G-Standaard GPK') | |style="background-color: white;"|MORFINE INFVLST 5MG/ML CAS 100ML (code = '134538' in codeSystem 'G-Standaard GPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="5"| | + | |colspan="5"|RelatieMedicatieafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
| Regel 3.192: | Regel 3.192: | ||
|style="background-color: white;"|MBH_300_toedieningssnelheid_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |style="background-color: white;"|MBH_300_toedieningssnelheid_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="5"| | + | |colspan="5"|RelatieToedieningsafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
| Regel 3.200: | Regel 3.200: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
| − | |style="background-color: white;"|MBH_300_toedieningssnelheid (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | + | |style="background-color: white;"|MBH_300_toedieningssnelheid-mgb (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
==== Bouwstenen ==== | ==== Bouwstenen ==== | ||
| Regel 3.214: | Regel 3.214: | ||
|rowspan="7"| | |rowspan="7"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|ZorgverlenerIdentificatienummer |
|style="background-color: white;"|000001111 (in identificerend systeem: UZI Personen) | |style="background-color: white;"|000001111 (in identificerend systeem: UZI Personen) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 3.234: | Regel 3.234: | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|ZorgaanbiederIdentificatienummer |
|style="background-color: white;"|00001111 (in identificerend systeem: URA) | |style="background-color: white;"|00001111 (in identificerend systeem: URA) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|OrganisatieNaam |
|style="background-color: white;"|Huisartsenpraktijk Pulver & Partners | |style="background-color: white;"|Huisartsenpraktijk Pulver & Partners | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 3.278: | Regel 3.278: | ||
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') | |style="background-color: white;"|Vrouw (code = 'F' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') | ||
|}<section end=patient-mg-mp-mg-tst-MTD-Scenarioset6-v30-6-14 /><section begin=mbhs-mg-mp-mg-tst-MTD-Scenarioset6-v30-6-14 /> | |}<section end=patient-mg-mp-mg-tst-MTD-Scenarioset6-v30-6-14 /><section begin=mbhs-mg-mp-mg-tst-MTD-Scenarioset6-v30-6-14 /> | ||
| − | ==== Scenario 6.14 - MBH_300_toedieningsduur==== | + | ==== Scenario 6.14 - MBH_300_toedieningsduur-mgb==== |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatietoediening MBH_300_toedieningsduur_MTD | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatietoediening MBH_300_toedieningsduur_MTD-mgb |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
| Regel 3.288: | Regel 3.288: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
| − | |style="background-color: white;"|MBH_300_toedieningsduur_MTD (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.18629005.1) | + | |style="background-color: white;"|MBH_300_toedieningsduur_MTD-mgb (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.18629005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|RegistratieDatumTijd |
|style="background-color: white;"|T + 8 dagen om 08:59:59 uur | |style="background-color: white;"|T + 8 dagen om 08:59:59 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|ToedieningsDatumTijd |
|style="background-color: white;"|T + 8 dagen om 08:59:59 uur | |style="background-color: white;"|T + 8 dagen om 08:59:59 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="5"| | + | |colspan="5"|ToegediendeHoeveelheid |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
| Regel 3.309: | Regel 3.309: | ||
|style="background-color: white;"|transdermaal (code = '58' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |style="background-color: white;"|transdermaal (code = '58' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="5"| | + | |colspan="5"|PrikPlakLocatie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|AnatomischeLocatie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
| Regel 3.336: | Regel 3.336: | ||
|style="background-color: white;"|NITROGLYCERINE PLEISTER 5MG/24UUR (DEPONIT T) (code = '196738' in codeSystem 'G-Standaard GPK') | |style="background-color: white;"|NITROGLYCERINE PLEISTER 5MG/24UUR (DEPONIT T) (code = '196738' in codeSystem 'G-Standaard GPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="5"| | + | |colspan="5"|RelatieMedicatieafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
| Regel 3.343: | Regel 3.343: | ||
|style="background-color: white;"|MBH_300_toedieningsduur_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |style="background-color: white;"|MBH_300_toedieningsduur_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="5"| | + | |colspan="5"|RelatieToedieningsafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
| Regel 3.351: | Regel 3.351: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
| − | |style="background-color: white;"|MBH_300_toedieningsduur (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | + | |style="background-color: white;"|MBH_300_toedieningsduur-mgb (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
==== Bouwstenen ==== | ==== Bouwstenen ==== | ||
| Regel 3.365: | Regel 3.365: | ||
|rowspan="7"| | |rowspan="7"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|ZorgverlenerIdentificatienummer |
|style="background-color: white;"|000001111 (in identificerend systeem: UZI Personen) | |style="background-color: white;"|000001111 (in identificerend systeem: UZI Personen) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 3.385: | Regel 3.385: | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|ZorgaanbiederIdentificatienummer |
|style="background-color: white;"|00001111 (in identificerend systeem: URA) | |style="background-color: white;"|00001111 (in identificerend systeem: URA) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|OrganisatieNaam |
|style="background-color: white;"|Huisartsenpraktijk Pulver & Partners | |style="background-color: white;"|Huisartsenpraktijk Pulver & Partners | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 3.432: | Regel 3.432: | ||
|style="background-color: white;"|Man (code = 'M' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') | |style="background-color: white;"|Man (code = 'M' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') | ||
|}<section end=patient-mg-mp-mg-tst-MTD-Scenarioset7-v30-7-1 /><section begin=mbhs-mg-mp-mg-tst-MTD-Scenarioset7-v30-7-1 /> | |}<section end=patient-mg-mp-mg-tst-MTD-Scenarioset7-v30-7-1 /><section begin=mbhs-mg-mp-mg-tst-MTD-Scenarioset7-v30-7-1 /> | ||
| − | ==== Scenario 7.1 - MBH_300_magistraalalleingredienten==== | + | ==== Scenario 7.1 - MBH_300_magistraalalleingredienten-mgb==== |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatietoediening MBH_300_magistraalalleingredienten_MTD | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatietoediening MBH_300_magistraalalleingredienten_MTD-mgb |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
| Regel 3.442: | Regel 3.442: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
| − | |style="background-color: white;"|MBH_300_magistraalalleingredienten_MTD (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.18629005.1) | + | |style="background-color: white;"|MBH_300_magistraalalleingredienten_MTD-mgb (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.18629005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|RegistratieDatumTijd |
|style="background-color: white;"|T - 1 dag om 14:00 uur | |style="background-color: white;"|T - 1 dag om 14:00 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|ToedieningsDatumTijd |
|style="background-color: white;"|T - 1 dag om 14:00 uur | |style="background-color: white;"|T - 1 dag om 14:00 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="5"| | + | |colspan="5"|ToegediendeHoeveelheid |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
| Regel 3.470: | Regel 3.470: | ||
|style="background-color: white;"|Zie [[#JANTIEN_TOEDIEN|Zorgverlener: JANTIEN_TOEDIEN]] | |style="background-color: white;"|Zie [[#JANTIEN_TOEDIEN|Zorgverlener: JANTIEN_TOEDIEN]] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="5"|Geneesmiddel - | + | |colspan="5"|Geneesmiddel - ProductSpecificatie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="11"| | |rowspan="11"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|ProductNaam |
|style="background-color: white;"|Ureum 10% in eucerine cum aqua 100gr | |style="background-color: white;"|Ureum 10% in eucerine cum aqua 100gr | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 3.484: | Regel 3.484: | ||
|rowspan="3"| | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="2"| | + | |colspan="2"|IngredientCode |
|style="background-color: white;"|UREUM ZALF 10% FAGRON (code = '1042467' in codeSystem 'G-Standaard HPK') | |style="background-color: white;"|UREUM ZALF 10% FAGRON (code = '1042467' in codeSystem 'G-Standaard HPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 3.494: | Regel 3.494: | ||
|rowspan="3"| | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="2"| | + | |colspan="2"|IngredientCode |
|style="background-color: white;"|EUCERINE MET WATER FAGRON (code = '1516981' in codeSystem 'G-Standaard HPK') | |style="background-color: white;"|EUCERINE MET WATER FAGRON (code = '1516981' in codeSystem 'G-Standaard HPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 3.500: | Regel 3.500: | ||
|style="background-color: white;"|90 gram per 100 gram | |style="background-color: white;"|90 gram per 100 gram | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="5"| | + | |colspan="5"|RelatieMedicatieafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
| Regel 3.507: | Regel 3.507: | ||
|style="background-color: white;"|MBH_300_magistraalalleingredienten_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |style="background-color: white;"|MBH_300_magistraalalleingredienten_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="5"| | + | |colspan="5"|RelatieToedieningsafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
| Regel 3.515: | Regel 3.515: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
| − | |style="background-color: white;"|MBH_300_magistraalalleingredienten (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | + | |style="background-color: white;"|MBH_300_magistraalalleingredienten-mgb (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
==== Bouwstenen ==== | ==== Bouwstenen ==== | ||
| Regel 3.529: | Regel 3.529: | ||
|rowspan="7"| | |rowspan="7"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|ZorgverlenerIdentificatienummer |
|style="background-color: white;"|222220000 (in identificerend systeem: UZI Personen) | |style="background-color: white;"|222220000 (in identificerend systeem: UZI Personen) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 3.549: | Regel 3.549: | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|ZorgaanbiederIdentificatienummer |
|style="background-color: white;"|11110000 (in identificerend systeem: URA) | |style="background-color: white;"|11110000 (in identificerend systeem: URA) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|OrganisatieNaam |
|style="background-color: white;"|Thuiszorg Om en Bij | |style="background-color: white;"|Thuiszorg Om en Bij | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|OrganisatieType |
|style="background-color: white;"|Thuiszorg (code = 'T2' in codeSystem '<span title="2.16.840.1.113883.2.4.15.1060">HL7 RoleCodeNL Care provider type (organizations)</span>') | |style="background-color: white;"|Thuiszorg (code = 'T2' in codeSystem '<span title="2.16.840.1.113883.2.4.15.1060">HL7 RoleCodeNL Care provider type (organizations)</span>') | ||
|}<section end=mbhs-mg-mp-mg-tst-MTD-Scenarioset7-v30-7-1 /><section end=mg-mp-mg-tst-MTD-Scenarioset7-v30-7-1 /> | |}<section end=mbhs-mg-mp-mg-tst-MTD-Scenarioset7-v30-7-1 /><section end=mg-mp-mg-tst-MTD-Scenarioset7-v30-7-1 /> | ||
| Regel 3.596: | Regel 3.596: | ||
|style="background-color: white;"|Man (code = 'M' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') | |style="background-color: white;"|Man (code = 'M' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') | ||
|}<section end=patient-mg-mp-mg-tst-MTD-Scenarioset7-v30-7-2 /><section begin=mbhs-mg-mp-mg-tst-MTD-Scenarioset7-v30-7-2 /> | |}<section end=patient-mg-mp-mg-tst-MTD-Scenarioset7-v30-7-2 /><section begin=mbhs-mg-mp-mg-tst-MTD-Scenarioset7-v30-7-2 /> | ||
| − | ==== Scenario 7.2 - MBH_300_magistraalactieveingredient==== | + | ==== Scenario 7.2 - MBH_300_magistraalactieveingredient-mgb==== |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatietoediening MBH_300_magistraalactieveingredient_MTD | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatietoediening MBH_300_magistraalactieveingredient_MTD-mgb |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
| Regel 3.606: | Regel 3.606: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
| − | |style="background-color: white;"|MBH_300_magistraalactieveingredient_MTD (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.18629005.1) | + | |style="background-color: white;"|MBH_300_magistraalactieveingredient_MTD-mgb (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.18629005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|RegistratieDatumTijd |
|style="background-color: white;"|T - 1 dag om 12:00 uur | |style="background-color: white;"|T - 1 dag om 12:00 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|ToedieningsDatumTijd |
|style="background-color: white;"|T - 1 dag om 12:00 uur | |style="background-color: white;"|T - 1 dag om 12:00 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="5"| | + | |colspan="5"|ToegediendeHoeveelheid |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
| Regel 3.634: | Regel 3.634: | ||
|style="background-color: white;"|Zie [[#JANTIEN_TOEDIEN|Zorgverlener: JANTIEN_TOEDIEN]] | |style="background-color: white;"|Zie [[#JANTIEN_TOEDIEN|Zorgverlener: JANTIEN_TOEDIEN]] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="5"|Geneesmiddel - | + | |colspan="5"|Geneesmiddel - ProductSpecificatie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="7"| | |rowspan="7"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|ProductNaam |
|style="background-color: white;"|Vaseline 20% in cetomacrogolcrème FNA | |style="background-color: white;"|Vaseline 20% in cetomacrogolcrème FNA | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 3.648: | Regel 3.648: | ||
|rowspan="3"| | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="2"| | + | |colspan="2"|IngredientCode |
|style="background-color: white;"|CETOMACROGOLCREME FNA (code = '457590' in codeSystem 'G-Standaard HPK') | |style="background-color: white;"|CETOMACROGOLCREME FNA (code = '457590' in codeSystem 'G-Standaard HPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 3.654: | Regel 3.654: | ||
|style="background-color: white;"|80 gram per 100 gram | |style="background-color: white;"|80 gram per 100 gram | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="5"| | + | |colspan="5"|RelatieMedicatieafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
| Regel 3.661: | Regel 3.661: | ||
|style="background-color: white;"|MBH_300_magistraalactieveingredient_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |style="background-color: white;"|MBH_300_magistraalactieveingredient_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="5"| | + | |colspan="5"|RelatieToedieningsafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
| Regel 3.669: | Regel 3.669: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
| − | |style="background-color: white;"|MBH_300_magistraalactieveingredient (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | + | |style="background-color: white;"|MBH_300_magistraalactieveingredient-mgb (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
==== Bouwstenen ==== | ==== Bouwstenen ==== | ||
| Regel 3.683: | Regel 3.683: | ||
|rowspan="7"| | |rowspan="7"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|ZorgverlenerIdentificatienummer |
|style="background-color: white;"|222220000 (in identificerend systeem: UZI Personen) | |style="background-color: white;"|222220000 (in identificerend systeem: UZI Personen) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 3.703: | Regel 3.703: | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|ZorgaanbiederIdentificatienummer |
|style="background-color: white;"|11110000 (in identificerend systeem: URA) | |style="background-color: white;"|11110000 (in identificerend systeem: URA) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|OrganisatieNaam |
|style="background-color: white;"|Thuiszorg Om en Bij | |style="background-color: white;"|Thuiszorg Om en Bij | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|OrganisatieType |
|style="background-color: white;"|Thuiszorg (code = 'T2' in codeSystem '<span title="2.16.840.1.113883.2.4.15.1060">HL7 RoleCodeNL Care provider type (organizations)</span>') | |style="background-color: white;"|Thuiszorg (code = 'T2' in codeSystem '<span title="2.16.840.1.113883.2.4.15.1060">HL7 RoleCodeNL Care provider type (organizations)</span>') | ||
|}<section end=mbhs-mg-mp-mg-tst-MTD-Scenarioset7-v30-7-2 /><section end=mg-mp-mg-tst-MTD-Scenarioset7-v30-7-2 /> | |}<section end=mbhs-mg-mp-mg-tst-MTD-Scenarioset7-v30-7-2 /><section end=mg-mp-mg-tst-MTD-Scenarioset7-v30-7-2 /> | ||
| Regel 3.750: | Regel 3.750: | ||
|style="background-color: white;"|Man (code = 'M' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') | |style="background-color: white;"|Man (code = 'M' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') | ||
|}<section end=patient-mg-mp-mg-tst-MTD-Scenarioset7-v30-7-3 /><section begin=mbhs-mg-mp-mg-tst-MTD-Scenarioset7-v30-7-3 /> | |}<section end=patient-mg-mp-mg-tst-MTD-Scenarioset7-v30-7-3 /><section begin=mbhs-mg-mp-mg-tst-MTD-Scenarioset7-v30-7-3 /> | ||
| − | ==== Scenario 7.3 - MBH_300_magistraal90miljoennr==== | + | ==== Scenario 7.3 - MBH_300_magistraal90miljoennr-mgb==== |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatietoediening MBH_300_magistraal90miljoennr_MTD | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatietoediening MBH_300_magistraal90miljoennr_MTD-mgb |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
| Regel 3.760: | Regel 3.760: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
| − | |style="background-color: white;"|MBH_300_magistraal90miljoennr_MTD (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.18629005.1) | + | |style="background-color: white;"|MBH_300_magistraal90miljoennr_MTD-mgb (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.18629005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|RegistratieDatumTijd |
|style="background-color: white;"|T - 2 dagen om 13:00 uur | |style="background-color: white;"|T - 2 dagen om 13:00 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|ToedieningsDatumTijd |
|style="background-color: white;"|T - 2 dagen om 13:00 uur | |style="background-color: white;"|T - 2 dagen om 13:00 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="5"| | + | |colspan="5"|ToegediendeHoeveelheid |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
| Regel 3.788: | Regel 3.788: | ||
|style="background-color: white;"|Zie [[#JANTIEN_TOEDIEN|Zorgverlener: JANTIEN_TOEDIEN]] | |style="background-color: white;"|Zie [[#JANTIEN_TOEDIEN|Zorgverlener: JANTIEN_TOEDIEN]] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="5"|Geneesmiddel - | + | |colspan="5"|Geneesmiddel - ProductSpecificatie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="8"| | |rowspan="8"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|ProductCode |
|style="background-color: white;"|Eigen artikel: ureumzalf (code = '90000001' in codeSystem '2.16.840.1.113883.2.4.3.11.999.77.90000000.1.1111') | |style="background-color: white;"|Eigen artikel: ureumzalf (code = '90000001' in codeSystem '2.16.840.1.113883.2.4.3.11.999.77.90000000.1.1111') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|ProductNaam |
|style="background-color: white;"|Ureum 10% in eucerine cum aqua 100gr | |style="background-color: white;"|Ureum 10% in eucerine cum aqua 100gr | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 3.805: | Regel 3.805: | ||
|rowspan="3"| | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="2"| | + | |colspan="2"|IngredientCode |
|style="background-color: white;"|UREUM ZALF 10% FAGRON (code = '1042467' in codeSystem 'G-Standaard HPK') | |style="background-color: white;"|UREUM ZALF 10% FAGRON (code = '1042467' in codeSystem 'G-Standaard HPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 3.811: | Regel 3.811: | ||
|style="background-color: white;"|10 gram per 100 gram | |style="background-color: white;"|10 gram per 100 gram | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="5"| | + | |colspan="5"|RelatieMedicatieafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
| Regel 3.818: | Regel 3.818: | ||
|style="background-color: white;"|MBH_300_magistraal90miljoennr_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |style="background-color: white;"|MBH_300_magistraal90miljoennr_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="5"| | + | |colspan="5"|RelatieToedieningsafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
| Regel 3.826: | Regel 3.826: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
| − | |style="background-color: white;"|MBH_300_magistraal90miljoennr (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | + | |style="background-color: white;"|MBH_300_magistraal90miljoennr-mgb (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
==== Bouwstenen ==== | ==== Bouwstenen ==== | ||
| Regel 3.840: | Regel 3.840: | ||
|rowspan="7"| | |rowspan="7"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|ZorgverlenerIdentificatienummer |
|style="background-color: white;"|222220000 (in identificerend systeem: UZI Personen) | |style="background-color: white;"|222220000 (in identificerend systeem: UZI Personen) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 3.860: | Regel 3.860: | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|ZorgaanbiederIdentificatienummer |
|style="background-color: white;"|11110000 (in identificerend systeem: URA) | |style="background-color: white;"|11110000 (in identificerend systeem: URA) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|OrganisatieNaam |
|style="background-color: white;"|Thuiszorg Om en Bij | |style="background-color: white;"|Thuiszorg Om en Bij | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|OrganisatieType |
|style="background-color: white;"|Thuiszorg (code = 'T2' in codeSystem '<span title="2.16.840.1.113883.2.4.15.1060">HL7 RoleCodeNL Care provider type (organizations)</span>') | |style="background-color: white;"|Thuiszorg (code = 'T2' in codeSystem '<span title="2.16.840.1.113883.2.4.15.1060">HL7 RoleCodeNL Care provider type (organizations)</span>') | ||
|}<section end=mbhs-mg-mp-mg-tst-MTD-Scenarioset7-v30-7-3 /><section end=mg-mp-mg-tst-MTD-Scenarioset7-v30-7-3 /> | |}<section end=mbhs-mg-mp-mg-tst-MTD-Scenarioset7-v30-7-3 /><section end=mg-mp-mg-tst-MTD-Scenarioset7-v30-7-3 /> | ||
| Regel 3.907: | Regel 3.907: | ||
|style="background-color: white;"|Man (code = 'M' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') | |style="background-color: white;"|Man (code = 'M' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') | ||
|}<section end=patient-mg-mp-mg-tst-MTD-Scenarioset7-v30-7-4 /><section begin=mbhs-mg-mp-mg-tst-MTD-Scenarioset7-v30-7-4 /> | |}<section end=patient-mg-mp-mg-tst-MTD-Scenarioset7-v30-7-4 /><section begin=mbhs-mg-mp-mg-tst-MTD-Scenarioset7-v30-7-4 /> | ||
| − | ==== Scenario 7.4 - MBH_300_vrijetekstproduct==== | + | ==== Scenario 7.4 - MBH_300_vrijetekstproduct-mgb==== |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatietoediening MBH_300_vrijetekstproduct_MTD | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatietoediening MBH_300_vrijetekstproduct_MTD-mgb |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
| Regel 3.917: | Regel 3.917: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
| − | |style="background-color: white;"|MBH_300_vrijetekstproduct_MTD (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.18629005.1) | + | |style="background-color: white;"|MBH_300_vrijetekstproduct_MTD-mgb (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.18629005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|RegistratieDatumTijd |
|style="background-color: white;"|T - 1 dag om 19:35 uur | |style="background-color: white;"|T - 1 dag om 19:35 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|ToedieningsDatumTijd |
|style="background-color: white;"|T - 1 dag om 19:25 uur | |style="background-color: white;"|T - 1 dag om 19:25 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|ToegediendeHoeveelheid |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
| Regel 3.945: | Regel 3.945: | ||
|style="background-color: white;"|Zie [[#PETER_VAN_PULVER|Zorgverlener: PETER_VAN_PULVER]] | |style="background-color: white;"|Zie [[#PETER_VAN_PULVER|Zorgverlener: PETER_VAN_PULVER]] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"|Geneesmiddel - | + | |colspan="4"|Geneesmiddel - ProductSpecificatie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="2"| | + | |colspan="2"|ProductNaam |
|style="background-color: white;"|Jemperli 500 mg/ 10 mL | |style="background-color: white;"|Jemperli 500 mg/ 10 mL | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 3.955: | Regel 3.955: | ||
|style="background-color: white;"|Titel: Jemperli (Dostarlimab-gxly) 500 mg/10 mL | |style="background-color: white;"|Titel: Jemperli (Dostarlimab-gxly) 500 mg/10 mL | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|RelatieMedicatieafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
| Regel 3.962: | Regel 3.962: | ||
|style="background-color: white;"|MBH_300_vrijetekstproduct_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |style="background-color: white;"|MBH_300_vrijetekstproduct_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|RelatieToedieningsafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
| Regel 3.970: | Regel 3.970: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
| − | |style="background-color: white;"|MBH_300_vrijetekstproduct (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | + | |style="background-color: white;"|MBH_300_vrijetekstproduct-mgb (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
==== Bouwstenen ==== | ==== Bouwstenen ==== | ||
| Regel 3.984: | Regel 3.984: | ||
|rowspan="7"| | |rowspan="7"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|ZorgverlenerIdentificatienummer |
|style="background-color: white;"|000001111 (in identificerend systeem: UZI Personen) | |style="background-color: white;"|000001111 (in identificerend systeem: UZI Personen) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 4.004: | Regel 4.004: | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|ZorgaanbiederIdentificatienummer |
|style="background-color: white;"|00001111 (in identificerend systeem: URA) | |style="background-color: white;"|00001111 (in identificerend systeem: URA) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|OrganisatieNaam |
|style="background-color: white;"|Huisartsenpraktijk Pulver & Partners | |style="background-color: white;"|Huisartsenpraktijk Pulver & Partners | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 4.048: | Regel 4.048: | ||
|style="background-color: white;"|Man (code = 'M' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') | |style="background-color: white;"|Man (code = 'M' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') | ||
|}<section end=patient-mg-mp-mg-tst-MTD-Scenarioset10-v30-10-1 /><section begin=mbhs-mg-mp-mg-tst-MTD-Scenarioset10-v30-10-1 /> | |}<section end=patient-mg-mp-mg-tst-MTD-Scenarioset10-v30-10-1 /><section begin=mbhs-mg-mp-mg-tst-MTD-Scenarioset10-v30-10-1 /> | ||
| − | ==== Scenario 10.1 - MBH_300_ZINRvoorschrijven==== | + | ==== Scenario 10.1 - MBH_300_ZINRvoorschrijven-mgb==== |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatietoediening MBH_300_ZINRvoorschrijven_MTD | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatietoediening MBH_300_ZINRvoorschrijven_MTD-mgb |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
| Regel 4.058: | Regel 4.058: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
| − | |style="background-color: white;"|MBH_300_ZINRvoorschrijven_MTD (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.18629005.1) | + | |style="background-color: white;"|MBH_300_ZINRvoorschrijven_MTD-mgb (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.18629005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|RegistratieDatumTijd |
|style="background-color: white;"|T om 15:36 uur | |style="background-color: white;"|T om 15:36 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|ToedieningsDatumTijd |
|style="background-color: white;"|T om 15:36 uur | |style="background-color: white;"|T om 15:36 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|ToegediendeHoeveelheid |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
| Regel 4.098: | Regel 4.098: | ||
|style="background-color: white;"|INDAPAMIDE 2,5MG TABLET (code = '83593' in codeSystem 'G-Standaard GPK') | |style="background-color: white;"|INDAPAMIDE 2,5MG TABLET (code = '83593' in codeSystem 'G-Standaard GPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|RelatieMedicatieafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
| Regel 4.105: | Regel 4.105: | ||
|style="background-color: white;"|MBH_300_ZINRvoorschrijven_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |style="background-color: white;"|MBH_300_ZINRvoorschrijven_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|RelatieToedieningsafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
| Regel 4.113: | Regel 4.113: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
| − | |style="background-color: white;"|MBH_300_ZINRvoorschrijven (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | + | |style="background-color: white;"|MBH_300_ZINRvoorschrijven-mgb (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
==== Bouwstenen ==== | ==== Bouwstenen ==== | ||
| Regel 4.127: | Regel 4.127: | ||
|rowspan="7"| | |rowspan="7"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|ZorgverlenerIdentificatienummer |
|style="background-color: white;"|222220000 (in identificerend systeem: UZI Personen) | |style="background-color: white;"|222220000 (in identificerend systeem: UZI Personen) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 4.147: | Regel 4.147: | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|ZorgaanbiederIdentificatienummer |
|style="background-color: white;"|11110000 (in identificerend systeem: URA) | |style="background-color: white;"|11110000 (in identificerend systeem: URA) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|OrganisatieNaam |
|style="background-color: white;"|Thuiszorg Om en Bij | |style="background-color: white;"|Thuiszorg Om en Bij | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|OrganisatieType |
|style="background-color: white;"|Thuiszorg (code = 'T2' in codeSystem '<span title="2.16.840.1.113883.2.4.15.1060">HL7 RoleCodeNL Care provider type (organizations)</span>') | |style="background-color: white;"|Thuiszorg (code = 'T2' in codeSystem '<span title="2.16.840.1.113883.2.4.15.1060">HL7 RoleCodeNL Care provider type (organizations)</span>') | ||
|}<section end=mbhs-mg-mp-mg-tst-MTD-Scenarioset10-v30-10-1 /><section end=mg-mp-mg-tst-MTD-Scenarioset10-v30-10-1 /> | |}<section end=mbhs-mg-mp-mg-tst-MTD-Scenarioset10-v30-10-1 /><section end=mg-mp-mg-tst-MTD-Scenarioset10-v30-10-1 /> | ||
| Regel 4.194: | Regel 4.194: | ||
|style="background-color: white;"|Man (code = 'M' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') | |style="background-color: white;"|Man (code = 'M' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') | ||
|}<section end=patient-mg-mp-mg-tst-MTD-Scenarioset11-v30-11-1 /><section begin=mbhs-mg-mp-mg-tst-MTD-Scenarioset11-v30-11-1 /> | |}<section end=patient-mg-mp-mg-tst-MTD-Scenarioset11-v30-11-1 /><section begin=mbhs-mg-mp-mg-tst-MTD-Scenarioset11-v30-11-1 /> | ||
| − | ==== Scenario 11.1 - MBH_300_wdsmtd1==== | + | ==== Scenario 11.1 - MBH_300_wdsmtd1-mgb==== |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatietoediening MBH_300_wdsmtd1_MTD | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatietoediening MBH_300_wdsmtd1_MTD-mgb |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
| Regel 4.204: | Regel 4.204: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
| − | |style="background-color: white;"|MBH_300_wdsmtd1_MTD (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.18629005.1) | + | |style="background-color: white;"|MBH_300_wdsmtd1_MTD-mgb (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.18629005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|RegistratieDatumTijd |
|style="background-color: white;"|T - 20 dagen om 20:30 uur | |style="background-color: white;"|T - 20 dagen om 20:30 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|ToedieningsDatumTijd |
|style="background-color: white;"|T - 20 dagen om 20:30 uur | |style="background-color: white;"|T - 20 dagen om 20:30 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|ToegediendeHoeveelheid |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
| Regel 4.241: | Regel 4.241: | ||
|style="background-color: white;"|ACENOCOUMAROL TABLET 1MG (code = '20303' in codeSystem 'G-Standaard GPK') | |style="background-color: white;"|ACENOCOUMAROL TABLET 1MG (code = '20303' in codeSystem 'G-Standaard GPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|RelatieMedicatieafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
| Regel 4.248: | Regel 4.248: | ||
|style="background-color: white;"|MBH_300_wdsmtd1_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |style="background-color: white;"|MBH_300_wdsmtd1_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|RelatieToedieningsafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
| Regel 4.255: | Regel 4.255: | ||
|style="background-color: white;"|MBH_300_wdsmtd1_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |style="background-color: white;"|MBH_300_wdsmtd1_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|RelatieWisselendDoseerschema |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
| Regel 4.263: | Regel 4.263: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
| − | |style="background-color: white;"|MBH_300_wdsmtd1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | + | |style="background-color: white;"|MBH_300_wdsmtd1-mgb (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
==== Bouwstenen ==== | ==== Bouwstenen ==== | ||
| Regel 4.277: | Regel 4.277: | ||
|rowspan="7"| | |rowspan="7"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|ZorgverlenerIdentificatienummer |
|style="background-color: white;"|000001111 (in identificerend systeem: UZI Personen) | |style="background-color: white;"|000001111 (in identificerend systeem: UZI Personen) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 4.297: | Regel 4.297: | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|ZorgaanbiederIdentificatienummer |
|style="background-color: white;"|00001111 (in identificerend systeem: URA) | |style="background-color: white;"|00001111 (in identificerend systeem: URA) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|OrganisatieNaam |
|style="background-color: white;"|Huisartsenpraktijk Pulver & Partners | |style="background-color: white;"|Huisartsenpraktijk Pulver & Partners | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 4.341: | Regel 4.341: | ||
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') | |style="background-color: white;"|Vrouw (code = 'F' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') | ||
|}<section end=patient-mg-mp-mg-tst-MTD-Scenarioset13-v30-13-4 /><section begin=mbhs-mg-mp-mg-tst-MTD-Scenarioset13-v30-13-4 /> | |}<section end=patient-mg-mp-mg-tst-MTD-Scenarioset13-v30-13-4 /><section begin=mbhs-mg-mp-mg-tst-MTD-Scenarioset13-v30-13-4 /> | ||
| − | ==== Scenario 13.4 - MBH_300_contactepisode==== | + | ==== Scenario 13.4 - MBH_300_contactepisode-mgb==== |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatietoediening MBH_300_contactepisode_MTD1 | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatietoediening MBH_300_contactepisode_MTD1-mgb |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
| Regel 4.351: | Regel 4.351: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
| − | |style="background-color: white;"|MBH_300_contactepisode_MTD1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.18629005.1) | + | |style="background-color: white;"|MBH_300_contactepisode_MTD1-mgb (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.18629005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|RegistratieDatumTijd |
|style="background-color: white;"|T - 20 dagen om 20:30 uur | |style="background-color: white;"|T - 20 dagen om 20:30 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|ToedieningsDatumTijd |
|style="background-color: white;"|T - 20 dagen om 20:30 uur | |style="background-color: white;"|T - 20 dagen om 20:30 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|ToegediendeHoeveelheid |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
| Regel 4.388: | Regel 4.388: | ||
|style="background-color: white;"|ACENOCOUMAROL TABLET 1MG (code = '20303' in codeSystem 'G-Standaard GPK') | |style="background-color: white;"|ACENOCOUMAROL TABLET 1MG (code = '20303' in codeSystem 'G-Standaard GPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|RelatieMedicatieafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
| Regel 4.395: | Regel 4.395: | ||
|style="background-color: white;"|MBH_300_contactepisode_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |style="background-color: white;"|MBH_300_contactepisode_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|RelatieWisselendDoseerschema |
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
| Regel 4.409: | Regel 4.402: | ||
|style="background-color: white;"|MBH_300_QA1_WDS1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.632.1) | |style="background-color: white;"|MBH_300_QA1_WDS1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.632.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|RelatieContact |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
| Regel 4.416: | Regel 4.409: | ||
|style="background-color: white;"|MBH_300_contactepisode_CONTACT2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.66.2709) | |style="background-color: white;"|MBH_300_contactepisode_CONTACT2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.66.2709) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|RelatieZorgepisode |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
| Regel 4.424: | Regel 4.417: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
| − | |style="background-color: white;"|MBH_300_contactepisode (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | + | |style="background-color: white;"|MBH_300_contactepisode-mgb (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
==== Bouwstenen ==== | ==== Bouwstenen ==== | ||
| Regel 4.438: | Regel 4.431: | ||
|rowspan="7"| | |rowspan="7"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|ZorgverlenerIdentificatienummer |
|style="background-color: white;"|000001111 (in identificerend systeem: UZI Personen) | |style="background-color: white;"|000001111 (in identificerend systeem: UZI Personen) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 4.458: | Regel 4.451: | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|ZorgaanbiederIdentificatienummer |
|style="background-color: white;"|00001111 (in identificerend systeem: URA) | |style="background-color: white;"|00001111 (in identificerend systeem: URA) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|OrganisatieNaam |
|style="background-color: white;"|Huisartsenpraktijk Pulver & Partners | |style="background-color: white;"|Huisartsenpraktijk Pulver & Partners | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 4.502: | Regel 4.495: | ||
|style="background-color: white;"|Man (code = 'M' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') | |style="background-color: white;"|Man (code = 'M' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') | ||
|}<section end=patient-mg-mp-mg-tst-MTD-Scenarioset16-v30-16-1 /><section begin=mbhs-mg-mp-mg-tst-MTD-Scenarioset16-v30-16-1 /> | |}<section end=patient-mg-mp-mg-tst-MTD-Scenarioset16-v30-16-1 /><section begin=mbhs-mg-mp-mg-tst-MTD-Scenarioset16-v30-16-1 /> | ||
| − | ==== Scenario 16.1 - MBH_300_redenvanafwijken==== | + | ==== Scenario 16.1 - MBH_300_redenvanafwijken-mgb==== |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatietoediening MBH_300_redenvanafwijken_MTD | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatietoediening MBH_300_redenvanafwijken_MTD-mgb |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
| Regel 4.512: | Regel 4.505: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
| − | |style="background-color: white;"|MBH_300_redenvanafwijken_MTD (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.18629005.1) | + | |style="background-color: white;"|MBH_300_redenvanafwijken_MTD-mgb (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.18629005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|RegistratieDatumTijd |
|style="background-color: white;"|T - 28 dagen om 13:04:22 uur | |style="background-color: white;"|T - 28 dagen om 13:04:22 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|ToedieningsDatumTijd |
|style="background-color: white;"|T - 28 dagen om 13:04:22 uur | |style="background-color: white;"|T - 28 dagen om 13:04:22 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|ToegediendeHoeveelheid |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
| Regel 4.540: | Regel 4.533: | ||
|style="background-color: white;"|Zie [[#JANTIEN_TOEDIEN|Zorgverlener: JANTIEN_TOEDIEN]] | |style="background-color: white;"|Zie [[#JANTIEN_TOEDIEN|Zorgverlener: JANTIEN_TOEDIEN]] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|MedicatietoedieningRedenVanAfwijken |
|style="background-color: white;"|niet in staat om medicatie te gebruiken (code = '408366001' in codeSystem '<span title="2.16.840.1.113883.6.96">SNOMED CT</span>') | |style="background-color: white;"|niet in staat om medicatie te gebruiken (code = '408366001' in codeSystem '<span title="2.16.840.1.113883.6.96">SNOMED CT</span>') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 4.552: | Regel 4.545: | ||
|style="background-color: white;"|OXAZEPAM TABLET 10MG (code = '1023' in codeSystem 'G-Standaard GPK') | |style="background-color: white;"|OXAZEPAM TABLET 10MG (code = '1023' in codeSystem 'G-Standaard GPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|RelatieMedicatieafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
| Regel 4.559: | Regel 4.552: | ||
|style="background-color: white;"|MBH_300_redenvanafwijken_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |style="background-color: white;"|MBH_300_redenvanafwijken_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|RelatieToedieningsafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
| Regel 4.567: | Regel 4.560: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
| − | |style="background-color: white;"|MBH_300_redenvanafwijken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | + | |style="background-color: white;"|MBH_300_redenvanafwijken-mgb (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
==== Bouwstenen ==== | ==== Bouwstenen ==== | ||
| Regel 4.581: | Regel 4.574: | ||
|rowspan="7"| | |rowspan="7"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|ZorgverlenerIdentificatienummer |
|style="background-color: white;"|222220000 (in identificerend systeem: UZI Personen) | |style="background-color: white;"|222220000 (in identificerend systeem: UZI Personen) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 4.601: | Regel 4.594: | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|ZorgaanbiederIdentificatienummer |
|style="background-color: white;"|11110000 (in identificerend systeem: URA) | |style="background-color: white;"|11110000 (in identificerend systeem: URA) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|OrganisatieNaam |
|style="background-color: white;"|Thuiszorg Om en Bij | |style="background-color: white;"|Thuiszorg Om en Bij | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|OrganisatieType |
|style="background-color: white;"|Thuiszorg (code = 'T2' in codeSystem '<span title="2.16.840.1.113883.2.4.15.1060">HL7 RoleCodeNL Care provider type (organizations)</span>') | |style="background-color: white;"|Thuiszorg (code = 'T2' in codeSystem '<span title="2.16.840.1.113883.2.4.15.1060">HL7 RoleCodeNL Care provider type (organizations)</span>') | ||
|}<section end=mbhs-mg-mp-mg-tst-MTD-Scenarioset16-v30-16-1 /><section end=mg-mp-mg-tst-MTD-Scenarioset16-v30-16-1 /> | |}<section end=mbhs-mg-mp-mg-tst-MTD-Scenarioset16-v30-16-1 /><section end=mg-mp-mg-tst-MTD-Scenarioset16-v30-16-1 /> | ||
| Regel 4.645: | Regel 4.638: | ||
|style="background-color: white;"|Man (code = 'M' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') | |style="background-color: white;"|Man (code = 'M' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') | ||
|}<section end=patient-mg-mp-mg-tst-MTD-Scenarioset16-v30-16-2 /><section begin=mbhs-mg-mp-mg-tst-MTD-Scenarioset16-v30-16-2 /> | |}<section end=patient-mg-mp-mg-tst-MTD-Scenarioset16-v30-16-2 /><section begin=mbhs-mg-mp-mg-tst-MTD-Scenarioset16-v30-16-2 /> | ||
| − | ==== Scenario 16.2 - MBH_300_adhoctoediening==== | + | ==== Scenario 16.2 - MBH_300_adhoctoediening-mgb==== |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatietoediening MBH_300_adhoctoediening_MTD | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatietoediening MBH_300_adhoctoediening_MTD-mgb |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
| Regel 4.655: | Regel 4.648: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
| − | |style="background-color: white;"|MBH_300_adhoctoediening_MTD (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.18629005.1) | + | |style="background-color: white;"|MBH_300_adhoctoediening_MTD-mgb (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.18629005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|RegistratieDatumTijd |
|style="background-color: white;"|T - 5 dagen om 13:05:33 uur | |style="background-color: white;"|T - 5 dagen om 13:05:33 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|ToedieningsDatumTijd |
|style="background-color: white;"|T - 5 dagen om 13:05:33 uur | |style="background-color: white;"|T - 5 dagen om 13:05:33 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|ToegediendeHoeveelheid |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
| Regel 4.693: | Regel 4.686: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
| − | |style="background-color: white;"|MBH_300_adhoctoediening (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | + | |style="background-color: white;"|MBH_300_adhoctoediening-mgb (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
==== Bouwstenen ==== | ==== Bouwstenen ==== | ||
| Regel 4.707: | Regel 4.700: | ||
|rowspan="7"| | |rowspan="7"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|ZorgverlenerIdentificatienummer |
|style="background-color: white;"|222220000 (in identificerend systeem: UZI Personen) | |style="background-color: white;"|222220000 (in identificerend systeem: UZI Personen) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 4.727: | Regel 4.720: | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|ZorgaanbiederIdentificatienummer |
|style="background-color: white;"|11110000 (in identificerend systeem: URA) | |style="background-color: white;"|11110000 (in identificerend systeem: URA) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|OrganisatieNaam |
|style="background-color: white;"|Thuiszorg Om en Bij | |style="background-color: white;"|Thuiszorg Om en Bij | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|OrganisatieType |
|style="background-color: white;"|Thuiszorg (code = 'T2' in codeSystem '<span title="2.16.840.1.113883.2.4.15.1060">HL7 RoleCodeNL Care provider type (organizations)</span>') | |style="background-color: white;"|Thuiszorg (code = 'T2' in codeSystem '<span title="2.16.840.1.113883.2.4.15.1060">HL7 RoleCodeNL Care provider type (organizations)</span>') | ||
|}<section end=mbhs-mg-mp-mg-tst-MTD-Scenarioset16-v30-16-2 /><section end=mg-mp-mg-tst-MTD-Scenarioset16-v30-16-2 /> | |}<section end=mbhs-mg-mp-mg-tst-MTD-Scenarioset16-v30-16-2 /><section end=mg-mp-mg-tst-MTD-Scenarioset16-v30-16-2 /> | ||
| Regel 4.771: | Regel 4.764: | ||
|style="background-color: white;"|Man (code = 'M' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') | |style="background-color: white;"|Man (code = 'M' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') | ||
|}<section end=patient-mg-mp-mg-tst-MTD-Scenarioset16-v30-16-3 /><section begin=mbhs-mg-mp-mg-tst-MTD-Scenarioset16-v30-16-3 /> | |}<section end=patient-mg-mp-mg-tst-MTD-Scenarioset16-v30-16-3 /><section begin=mbhs-mg-mp-mg-tst-MTD-Scenarioset16-v30-16-3 /> | ||
| − | ==== Scenario 16.3 - MBH_300_afwijkendeToediener==== | + | ==== Scenario 16.3 - MBH_300_afwijkendeToediener-mgb==== |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatietoediening MBH_300_afwijkendeToediener_MTD_Patient | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatietoediening MBH_300_afwijkendeToediener_MTD_Patient-mgb |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
| Regel 4.781: | Regel 4.774: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
| − | |style="background-color: white;"|MBH_300_afwijkendeToediener_MTD_Patient (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.18629005.1) | + | |style="background-color: white;"|MBH_300_afwijkendeToediener_MTD_Patient-mgb (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.18629005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|RegistratieDatumTijd |
|style="background-color: white;"|T - 2 dagen om 20:00 uur | |style="background-color: white;"|T - 2 dagen om 20:00 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|ToedieningsDatumTijd |
|style="background-color: white;"|T - 2 dagen om 20:00 uur | |style="background-color: white;"|T - 2 dagen om 20:00 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="5"| | + | |colspan="5"|ToegediendeHoeveelheid |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
| Regel 4.806: | Regel 4.799: | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|Patiënt |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="2"| | + | |colspan="2"|ToedienerIsPatient |
|style="background-color: white;"|Ja | |style="background-color: white;"|Ja | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 4.822: | Regel 4.815: | ||
|style="background-color: white;"|MIRTAZAPINE TABLET 15MG (code = '93521' in codeSystem 'G-Standaard GPK') | |style="background-color: white;"|MIRTAZAPINE TABLET 15MG (code = '93521' in codeSystem 'G-Standaard GPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="5"| | + | |colspan="5"|RelatieMedicatieafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
| Regel 4.829: | Regel 4.822: | ||
|style="background-color: white;"|MBH_300_afwijkendeToediener_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |style="background-color: white;"|MBH_300_afwijkendeToediener_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="5"| | + | |colspan="5"|RelatieToedieningsafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
| Regel 4.837: | Regel 4.830: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
| − | |style="background-color: white;"|MBH_300_afwijkendeToediener (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | + | |style="background-color: white;"|MBH_300_afwijkendeToediener-mgb (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
|}<section end=mbhs-mg-mp-mg-tst-MTD-Scenarioset16-v30-16-3 /><section end=mg-mp-mg-tst-MTD-Scenarioset16-v30-16-3 /> | |}<section end=mbhs-mg-mp-mg-tst-MTD-Scenarioset16-v30-16-3 /><section end=mg-mp-mg-tst-MTD-Scenarioset16-v30-16-3 /> | ||
== TEST Medicatiegegevens MTD Scenarioset 16== | == TEST Medicatiegegevens MTD Scenarioset 16== | ||
| Regel 4.882: | Regel 4.867: | ||
|style="background-color: white;"|Man (code = 'M' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') | |style="background-color: white;"|Man (code = 'M' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') | ||
|}<section end=patient-mg-mp-mg-tst-MTD-Scenarioset16-v30-16-4 /><section begin=mbhs-mg-mp-mg-tst-MTD-Scenarioset16-v30-16-4 /> | |}<section end=patient-mg-mp-mg-tst-MTD-Scenarioset16-v30-16-4 /><section begin=mbhs-mg-mp-mg-tst-MTD-Scenarioset16-v30-16-4 /> | ||
| − | ==== Scenario 16.4 - MBH_300_afwijkendeToediener==== | + | ==== Scenario 16.4 - MBH_300_afwijkendeToediener-mgb==== |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatietoediening MBH_300_afwijkendeToediener_MTD_Mantelzorger | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatietoediening MBH_300_afwijkendeToediener_MTD_Mantelzorger-mgb |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
| Regel 4.892: | Regel 4.877: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
| − | |style="background-color: white;"|MBH_300_afwijkendeToediener_MTD_Mantelzorger (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.18629005.1) | + | |style="background-color: white;"|MBH_300_afwijkendeToediener_MTD_Mantelzorger-mgb (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.18629005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|RegistratieDatumTijd |
|style="background-color: white;"|T - 1 dag om 20:00 uur | |style="background-color: white;"|T - 1 dag om 20:00 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|ToedieningsDatumTijd |
|style="background-color: white;"|T - 1 dag om 20:00 uur | |style="background-color: white;"|T - 1 dag om 20:00 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="5"| | + | |colspan="5"|ToegediendeHoeveelheid |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
| Regel 4.933: | Regel 4.918: | ||
|style="background-color: white;"|MIRTAZAPINE TABLET 15MG (code = '93521' in codeSystem 'G-Standaard GPK') | |style="background-color: white;"|MIRTAZAPINE TABLET 15MG (code = '93521' in codeSystem 'G-Standaard GPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="5"| | + | |colspan="5"|RelatieMedicatieafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
| Regel 4.940: | Regel 4.925: | ||
|style="background-color: white;"|MBH_300_afwijkendeToediener_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |style="background-color: white;"|MBH_300_afwijkendeToediener_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="5"| | + | |colspan="5"|RelatieToedieningsafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
| Regel 4.948: | Regel 4.933: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
| − | |style="background-color: white;"|MBH_300_afwijkendeToediener (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | + | |style="background-color: white;"|MBH_300_afwijkendeToediener-mgb (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
==== Bouwstenen ==== | ==== Bouwstenen ==== | ||
| Regel 5.003: | Regel 4.988: | ||
|style="background-color: white;"|Man (code = 'M' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') | |style="background-color: white;"|Man (code = 'M' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') | ||
|}<section end=patient-mg-mp-mg-tst-MTD-Scenarioset16-v30-16-5 /><section begin=mbhs-mg-mp-mg-tst-MTD-Scenarioset16-v30-16-5 /> | |}<section end=patient-mg-mp-mg-tst-MTD-Scenarioset16-v30-16-5 /><section begin=mbhs-mg-mp-mg-tst-MTD-Scenarioset16-v30-16-5 /> | ||
| − | ==== Scenario 16.5 - MBH_300_toedieningRelatieMA==== | + | ==== Scenario 16.5 - MBH_300_toedieningRelatieMA-mgb==== |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatietoediening MBH_300_toedieningRelatieMA_MTD | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatietoediening MBH_300_toedieningRelatieMA_MTD-mgb |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
| Regel 5.013: | Regel 4.998: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
| − | |style="background-color: white;"|MBH_300_toedieningRelatieMA_MTD (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.18629005.1) | + | |style="background-color: white;"|MBH_300_toedieningRelatieMA_MTD-mgb (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.18629005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|RegistratieDatumTijd |
|style="background-color: white;"|T - 2 dagen om 09:10 uur | |style="background-color: white;"|T - 2 dagen om 09:10 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|ToedieningsDatumTijd |
|style="background-color: white;"|T - 2 dagen om 09:10 uur | |style="background-color: white;"|T - 2 dagen om 09:10 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|ToegediendeHoeveelheid |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
| Regel 5.050: | Regel 5.035: | ||
|style="background-color: white;"|MECLOZINE TABLET 12,5MG (code = '1309' in codeSystem 'G-Standaard GPK') | |style="background-color: white;"|MECLOZINE TABLET 12,5MG (code = '1309' in codeSystem 'G-Standaard GPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|RelatieMedicatieafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
| Regel 5.058: | Regel 5.043: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
| − | |style="background-color: white;"|MBH_300_toedieningRelatieMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | + | |style="background-color: white;"|MBH_300_toedieningRelatieMA-mgb (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
==== Bouwstenen ==== | ==== Bouwstenen ==== | ||
| Regel 5.072: | Regel 5.057: | ||
|rowspan="7"| | |rowspan="7"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|ZorgverlenerIdentificatienummer |
|style="background-color: white;"|000001115 (in identificerend systeem: UZI Personen) | |style="background-color: white;"|000001115 (in identificerend systeem: UZI Personen) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 5.092: | Regel 5.077: | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|ZorgaanbiederIdentificatienummer |
|style="background-color: white;"|00005111 (in identificerend systeem: URA) | |style="background-color: white;"|00005111 (in identificerend systeem: URA) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|OrganisatieNaam |
|style="background-color: white;"|Huisartsenpraktijk Itis | |style="background-color: white;"|Huisartsenpraktijk Itis | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
Versie van 3 feb 2026 om 13:28
Inhoud
- 1 Addenda voor inhoudelijke gegevens
- 1.1 Overzicht van scenario's voor sturend/beschikbaarstellend systeem
- 1.2 Overzicht van scenario's voor ontvangend/raadplegend systeem
- 1.3 TEST Medicatiegegevens MTD Scenarioset 0 (filterqueries)
- 1.4 TEST Medicatiegegevens MTD Scenarioset 0 (filterqueries)
- 1.5 TEST Medicatiegegevens MTD Scenarioset 0 (filterqueries)
- 1.6 TEST Medicatiegegevens MTD Scenarioset 0 (filterqueries)
- 1.7 TEST Medicatiegegevens MTD Scenarioset 0 (filterqueries)
- 1.8 TEST Medicatiegegevens MTD Scenarioset 0 (filterqueries)
- 1.9 TEST Medicatiegegevens MTD Scenarioset 0 (filterqueries)
- 1.10 TEST Medicatiegegevens MTD Scenarioset 2
- 1.11 TEST Medicatiegegevens MTD Scenarioset 2
- 1.12 TEST Medicatiegegevens MTD Scenarioset 3
- 1.13 TEST Medicatiegegevens MTD Scenarioset 3
- 1.14 TEST Medicatiegegevens MTD Scenarioset 3
- 1.15 TEST Medicatiegegevens MTD Scenarioset 3
- 1.16 TEST Medicatiegegevens MTD Scenarioset 6
- 1.17 TEST Medicatiegegevens MTD Scenarioset 6
- 1.18 TEST Medicatiegegevens MTD Scenarioset 7
- 1.19 TEST Medicatiegegevens MTD Scenarioset 7
- 1.20 TEST Medicatiegegevens MTD Scenarioset 7
- 1.21 TEST Medicatiegegevens MTD Scenarioset 7
- 1.22 TEST Medicatiegegevens MTD Scenarioset 10
- 1.23 TEST Medicatiegegevens MTD Scenarioset 11
- 1.24 TEST Medicatiegegevens MTD Scenarioset 13
- 1.25 TEST Medicatiegegevens MTD Scenarioset 16
- 1.26 TEST Medicatiegegevens MTD Scenarioset 16
- 1.27 TEST Medicatiegegevens MTD Scenarioset 16
- 1.28 TEST Medicatiegegevens MTD Scenarioset 16
- 1.29 TEST Medicatiegegevens MTD Scenarioset 16
1 Addenda voor inhoudelijke gegevens
1.1 Overzicht van scenario's voor sturend/beschikbaarstellend systeem
1.1.1 Scenarioset 0
Onderstaand scenario 0.1 bevat in het antwoord alle bouwstenen voor de patiënt. De daaropvolgende scenario's passen steeds een filter toe, waardoor het antwoord een subset van de bouwstenen uit scenario 0.1 bevat. Bij inhoudelijke gegevens staat om die reden alleen scenario 0.1 opgenomen. Deze omvat immers alle bouwstenen van alle subscenario's.
In de tabel staat bij elk scenario benoemd hoeveel van alle bouwstenen deze bevat (maar niet welke).
| Scenario | Screenshots? | Beschrijving |
| 0.1 | Alle medicatietoedieningen van de patiënt, zonder aanvullend filtercriterium (Antwoord: bericht met 6 medicatietoedieningen) | |
| 0.2 | Specifieke medicatietoedieningen met identificaties als filter (in kwalificatiesimulator het id van "MBH_300_QA1_MTD" invoeren) (Antwoord: bericht met 1 medicatietoediening) | |
| 0.3 optioneel | Medicatietoedieningen met een filter op productcode (HPK 202681) (Antwoord: bericht met 1 Medicatietoediening) | |
| 0.4 | Medicatietoedieningen met een filter op gebruiksperiode – ingangsdatum (alles vanaf T-21) (Antwoord: bericht met 3 medicatietoedieningen) | |
| 0.5 | Medicatietoedieningen met een filter op gebruiksperiode – einddatum (alles voor T-22) (Antwoord: bericht met 3 Medicatietoedieningen) | |
| 0.6 | Medicatietoedieningen met een filter op gebruiksperiode – ingangsdatum én einddatum (alles vanaf T-21 tot en met T-7) (Antwoord: bericht met 2 Medicatietoedieningen) | |
| 0.7 | Medicatietoedieningen met een specifieke medicamenteuze behandeling als filter (in kwalificatiesimulator het id van "MBH_300_QA1" invoeren) (Antwoord: bericht met 1 Medicatietoedieningen) |
1.1.2 Scenarioset 2
| Scenario | Screenshots? | Beschrijving | MBH id | MTD id |
| 2.1 | Medicatie toediening met gevulde toelichting | MBH_300_toelichting-mgb | MBH_300_toelichting_MTD-mgb | |
| 2.2 | Medicatie toediening met een afwijkende toedieningsweg | MBH_300_Toedieningsweg-mgb | MBH_300_Toedieningsweg_MTD-mgb |
1.1.3 Scenarioset 3
| Scenario | Screenshots? | Beschrijving | MBH id | MTD id |
| 3.11 | Een MTD wordt opgeschort en vervolgens later toegediend | MBH_300_MTDopschorten-mgb | MBH_300_MTDopschorten_MTD1-mgb MBH_300_MTDopschorten_MTD2-mgb | |
| 3.12 | Een MTD wijkt af van de MA/TA met de toegediende hoeveelheid | mbh_300_AfwijkendeToediening-mgb | mbh_300_AfwijkendeToediening_MTD_normaal-mgb mbh_300_AfwijkendeToediening_MTD_afwijkendeQty-mgb | |
| 3.13 | Een extra MTD voor de juiste hoeveelheid | MBH_300_CorrectieToediening -mgb | MBH_300_CorrectieToediening_MTD_normaal-mgb MBH_300_CorrectieToediening_MTD_extraHoeveelheid-mgb | |
| 3.14 | MTD correctie met negatieve hoeveelheid | MBH_300_CorrectieOpToediening-mgb | MBH_300_CorrectieOpToediening_MTD_verkeerdeQty-mgb MBH_300_CorrectieOpToediening_correctie_MTD-mgb MBH_300_CorrectieOpToediening_CorrecteHoeveelheid_MTD-mgb |
1.1.4 Scenarioset 6
| Scenario | Screenshots? | Beschrijving | MBH id | MTD id |
| 6.13 | Toedieningssnelheid en prikplaklocatie met lateraliteit | MBH_300_toedieningssnelheid-mgb | MBH_300_toedieningssnelheid_MTD-mgb | |
| 6.14 | Prikplaklocatie zonder lateraliteit | MBH_300_toedieningsduur-mgb | MBH_300_toedieningsduur_MTD-mgb |
1.1.5 Scenarioset 7
| Scenario | Screenshots? | Beschrijving | MBH id | MTD id |
| 7.1 | Maak screenshot(s) waarop zichtbaar is dat er ingrediënten ingevoerd/gekozen kunnen worden | Alle ingrediënten | MBH_300_magistraalalleingredienten-mgb | MBH_300_magistraalalleingredienten_MTD-mgb |
| 7.2 | Maak screenshot(s) waarop zichtbaar is dat er een ingrediënt ingevoerd/gekozen kan worden | Actief ingrediënt | MBH_300_magistraalactieveingredient-mgb | MBH_300_magistraalactieveingredient_MTD-mgb |
| 7.3 | Maak screenshot(s) waarop zichtbaar is dat het eigen artikel gekozen wordt | 90 miljoen nummer | MBH_300_magistraal90miljoennr-mgb | MBH_300_magistraal90miljoennr_MTD-mgb |
| 7.4 | Maak screenshot(s) waarop zichtbaar is dat het vrije tekst product gekozen wordt | Vrije tekst product | MBH_300_vrijetekstproduct-mgb | MBH_300_vrijetekstproduct_MTD-mgb |
1.1.6 Scenarioset 10
| Scenario | Screenshots? | Beschrijving | MBH id | MTD id |
| 10.1 | ZI-nr geneesmiddel | MBH_300_ZINRvoorschrijven-mgb | MBH_300_ZINRvoorschrijven_MTD-mgb |
1.1.7 Scenarioset 11
| Scenario | Screenshots? | Beschrijving | MBH id | MTD id |
| 11.1 | Toediening met relatie naar WDS | MBH_300_wdsmtd1-mgb | MBH_300_wdsmtd1_MTD-mgb |
1.1.8 Scenarioset 13
| Scenario | Screenshots? | Beschrijving | MBH id | MTD id |
| 13.4 | Contact Episode | MBH_300_contactepisode-mgb | MBH_300_contactepisode_MTD1-mgb |
1.1.9 Scenarioset 16
| Scenario | Screenshots? | Beschrijving | MBH id | MTD id |
| 16.1 | Medicatietoediening met reden van afwijken | MBH_300_redenvanafwijken-mgb | MBH_300_redenvanafwijken_MTD-mgb | |
| 16.2 | Ad-hoc medicatietoediening (zonder relatie naar afspraak bouwsteen) | MBH_300_adhoctoediening-mgb | MBH_300_adhoctoediening_MTD-mgb | |
| 16.3 | Medicatietoediening met patiënt als toediener | MBH_300_afwijkendeToediener-mgb | MBH_300_afwijkendeToediener_MTD_Patient-mgb | |
| 16.4 | Medicatietoediening met mantelzorger als toediener | MBH_300_afwijkendeToediener-mgb | MBH_300_afwijkendeToediener_MTD_Mantelzorger-mgb | |
| 16.5 | Medicatietoediening met relatieMA | MBH_300_toedieningRelatieMA-mgb | MBH_300_toedieningRelatieMA_MTD-mgb |
1.2 Overzicht van scenario's voor ontvangend/raadplegend systeem
1.2.1 Scenarioset 0
Onderstaand scenario 0.1 bevat in het antwoord alle bouwstenen voor de patiënt. De daaropvolgende scenario's passen steeds een filter toe, waardoor het antwoord een subset van de bouwstenen uit scenario 0.1 bevat. Bij inhoudelijke gegevens staat om die reden alleen scenario 0.1 opgenomen. Deze omvat immers alle bouwstenen van alle subscenario's.
In de tabel staat bij elk scenario benoemd hoeveel van alle bouwstenen deze bevat (maar niet welke).
| Scenario | Beschrijving |
| 0.1 | Alle medicatietoedieningen van de patiënt, zonder aanvullend filtercriterium (Antwoord: bericht met 6 medicatietoedieningen) |
| 0.2 | Specifieke medicatietoedieningen met identificaties als filter (in kwalificatiesimulator het id van "MBH_300_QA1_MTD" invoeren) (Antwoord: bericht met 1 medicatietoediening) |
| 0.3 | Medicatietoedieningen met een filter op productcode (HPK 202681) (Antwoord: bericht met 1 Medicatietoediening) |
| 0.4 | Medicatietoedieningen met een filter op gebruiksperiode – ingangsdatum (alles vanaf T-21) (Antwoord: bericht met 3 medicatietoedieningen) |
| 0.5 | Medicatietoedieningen met een filter op gebruiksperiode – einddatum (alles voor T-22) (Antwoord: bericht met 3 Medicatietoedieningen) |
| 0.6 | Medicatietoedieningen met een filter op gebruiksperiode – ingangsdatum én einddatum (alles vanaf T-21 tot en met T-7) (Antwoord: bericht met 2 Medicatietoedieningen) |
| 0.7 | Medicatietoedieningen met een specifieke medicamenteuze behandeling als filter (in kwalificatiesimulator het id van "MBH_300_QA1" invoeren) (Antwoord: bericht met 1 Medicatietoedieningen) |
1.2.2 Scenarioset 2
| Scenario | Beschrijving | MBH id | MTD id |
| 2.1 | Medicatie toediening met gevulde toelichting | MBH_300_toelichting-mgb | MBH_300_toelichting_MTD-mgb |
| 2.2 | Medicatie toediening met een afwijkende toedieningsweg | MBH_300_Toedieningsweg-mgb | MBH_300_Toedieningsweg_MTD-mgb |
1.2.3 Scenarioset 3
| Scenario | Beschrijving | MBH id | MTD id |
| 3.11 | Een MTD wordt opgeschort en vervolgens later toegediend | MBH_300_MTDopschorten-mgb | MBH_300_MTDopschorten_MTD1-mgb MBH_300_MTDopschorten_MTD2-mgb |
| 3.12 | Een MTD wijkt af van de MA/TA met de toegediende hoeveelheid | mbh_300_AfwijkendeToediening-mgb | mbh_300_AfwijkendeToediening_MTD_normaal-mgb mbh_300_AfwijkendeToediening_MTD_afwijkendeQty-mgb |
| 3.13 | Een extra MTD voor de juiste hoeveelheid | MBH_300_CorrectieToediening -mgb | MBH_300_CorrectieToediening_MTD_normaal-mgb MBH_300_CorrectieToediening_MTD_extraHoeveelheid-mgb |
| 3.14 | MTD correctie met negatieve hoeveelheid | MBH_300_CorrectieOpToediening-mgb | MBH_300_CorrectieOpToediening_MTD_verkeerdeQty-mgb MBH_300_CorrectieOpToediening_correctie_MTD-mgb MBH_300_CorrectieOpToediening_CorrecteHoeveelheid_MTD-mgb |
1.2.4 Scenarioset 6
| Scenario | Beschrijving | MBH id | MTD id |
| 6.13 | Toedieningssnelheid en prikplaklocatie met lateraliteit | MBH_300_toedieningssnelheid-mgb | MBH_300_toedieningssnelheid_MTD-mgb |
| 6.14 | Prikplaklocatie zonder lateraliteit | MBH_300_toedieningsduur-mgb | MBH_300_toedieningsduur_MTD-mgb |
1.2.5 Scenarioset 7
| Scenario | Beschrijving | MBH id | MTD id |
| 7.1 | Alle ingrediënten | MBH_300_magistraalalleingredienten-mgb | MBH_300_magistraalalleingredienten_MTD-mgb |
| 7.2 | Actief ingrediënt | MBH_300_magistraalactieveingredient-mgb | MBH_300_magistraalactieveingredient_MTD-mgb |
| 7.3 | 90 miljoen nummer | MBH_300_magistraal90miljoennr-mgb | MBH_300_magistraal90miljoennr_MTD-mgb |
| 7.4 | Vrije tekst product | MBH_300_vrijetekstproduct-mgb | MBH_300_vrijetekstproduct_MTD-mgb |
1.2.6 Scenarioset 10
| Scenario | Beschrijving | MBH id | MTD id |
| 10.1 | ZI-nr geneesmiddel | MBH_300_ZINRvoorschrijven-mgb | MBH_300_ZINRvoorschrijven_MTD-mgb |
1.2.7 Scenarioset 11
| Scenario | Beschrijving | MBH id | MTD id |
| 11.1 | Toediening met relatie naar WDS | MBH_300_wdsmtd1-mgb | MBH_300_wdsmtd1_MTD-mgb |
1.2.8 Scenarioset 13
| Scenario | Beschrijving | MBH id | MTD id |
| 13.4 | Contact Episode | MBH_300_contactepisode-mgb | MBH_300_contactepisode_MTD1-mgb |
1.2.9 Scenarioset 16
| Scenario | Beschrijving | MBH id | MTD id |
| 16.1 | Medicatietoediening met reden van afwijken | MBH_300_redenvanafwijken-mgb | MBH_300_redenvanafwijken_MTD-mgb |
| 16.2 | Ad-hoc medicatietoediening (zonder relatie naar afspraak bouwsteen) | MBH_300_adhoctoediening-mgb | MBH_300_adhoctoediening_MTD-mgb |
| 16.3 | Medicatietoediening met patiënt als toediener | MBH_300_afwijkendeToediener-mgb | MBH_300_afwijkendeToediener_MTD_Patient-mgb |
| 16.4 | Medicatietoediening met mantelzorger als toediener | MBH_300_afwijkendeToediener-mgb | MBH_300_afwijkendeToediener_MTD_Mantelzorger-mgb |
| 16.5 | Medicatietoediening met relatieMA | MBH_300_toedieningRelatieMA-mgb | MBH_300_toedieningRelatieMA_MTD-mgb |
1.3 TEST Medicatiegegevens MTD Scenarioset 0 (filterqueries)
| Patiënt | ||||
| Gegevenselement | Waarde | |||
| Naamgegevens | ||||
| Initialen | R. | |||
| Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik') | |||
| Geslachtsnaam | ||||
| Voorvoegsels | van | |||
| Achternaam | XXX_Sonnenberg | |||
| Adresgegevens | krommeweg 1001 A 1234QQ Ons Dorp 157 Nederland 3 Woon-/verblijfadres | |||
| Identificatienummer | 999901084 [BSN] | |||
| Geboortedatum | 20 nov 1985 | |||
| Geslacht | Man (code = 'M' in codeSystem 'HL7 AdministrativeGender') | |||
1.3.1 Scenario 0.1 - MBH_300_QA1-mgb
| Medicatietoediening MBH_300_QA1_MTD-mgb | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_QA1_MTD-mgb (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.18629005.1) | ||
| RegistratieDatumTijd | T - 18 dagen om 10:04:22 uur | ||
| ToedieningsDatumTijd | T - 18 dagen om 10:04:22 uur | ||
| ToegediendeHoeveelheid | |||
| Aantal | 1 | ||
| Eenheid | stuk (code = '245' in codeSystem 'G-Standaard thesaurus basiseenheden') | ||
| Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
| Toediener | |||
| Zorgverlener | Zie Zorgverlener: JANTIEN_TOEDIEN | ||
| Geneesmiddel - primaire code | IBUPROFEN PCH TABLET 600MG (code = '641898' in codeSystem 'G-Standaard HPK') | ||
| Geneesmiddel - generiekere code | IBUPROFEN TABLET 600MG (code = '17469' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | IBUPROFEN TABLET 600MG (code = '42080' in codeSystem 'G-Standaard GPK') | ||
| RelatieMedicatieafspraak | |||
| Identificatie | MBH_300_QA1_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| RelatieToedieningsafspraak | |||
| Identificatie | MBH_300_QA1_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
| MBH identificatie | MBH_300_QA1-mgb (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
1.3.2 Scenario 0.1 - MBH_300_QA2-mgb
| Medicatietoediening MBH_300_QA2_MTD-mgb | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_QA2_MTD-mgb (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.18629005.1) | ||
| RegistratieDatumTijd | T - 99 dagen om 13:10:40 uur | ||
| ToedieningsDatumTijd | T - 99 dagen om 13:10:40 uur | ||
| ToegediendeHoeveelheid | |||
| Aantal | 5 | ||
| Eenheid | milliliter (code = '233' in codeSystem 'G-Standaard thesaurus basiseenheden') | ||
| Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
| Toediener | |||
| Zorgverlener | Zie Zorgverlener: JANTIEN_TOEDIEN | ||
| MedicatietoedieningRedenVanAfwijken | onvoldoende medicatie op voorraad (code = '705046008' in codeSystem 'SNOMED CT') | ||
| Geneesmiddel - primaire code | XPRAEP SIROOP 2MG/ML (code = '101079' in codeSystem 'G-Standaard HPK') | ||
| Geneesmiddel - generiekere code | SENNOSIDEN A+B 2MG/ML (code = '3379' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | SENNOSIDEN A+B 2MG/ML (code = '10960' in codeSystem 'G-Standaard GPK') | ||
| RelatieMedicatieafspraak | |||
| Identificatie | MBH_300_QA2_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| RelatieToedieningsafspraak | |||
| Identificatie | MBH_300_QA2_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
| MBH identificatie | MBH_300_QA2-mgb (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
1.3.3 Scenario 0.1 - MBH_300_QA3-mgb
| Medicatietoediening MBH_300_QA3_MTD-mgb | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_QA3_MTD-mgb (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.18629005.1) | ||
| RegistratieDatumTijd | T - 45 dagen om 11:26:44 uur | ||
| ToedieningsDatumTijd | T - 45 dagen om 11:26:44 uur | ||
| ToegediendeHoeveelheid | |||
| Aantal | 50 | ||
| Eenheid | milliliter (code = '233' in codeSystem 'G-Standaard thesaurus basiseenheden') | ||
| Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
| Toediener | |||
| Zorgverlener | Zie Zorgverlener: JANTIEN_TOEDIEN | ||
| Geneesmiddel - primaire code | NUTRIDRINK BANAANSMAAK (code = '690090' in codeSystem 'G-Standaard HPK') | ||
| Geneesmiddel - generiekere code | VLOEIBARE VOEDING MET O.A. VITAMINE K (code = '88749' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | VLOEIBARE VOEDING MET O.A. VITAMINE K (code = '130575' in codeSystem 'G-Standaard GPK') | ||
| RelatieMedicatieafspraak | |||
| Identificatie | MBH_300_QA3_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| RelatieToedieningsafspraak | |||
| Identificatie | MBH_300_QA3_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
| MBH identificatie | MBH_300_QA3-mgb (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
1.3.4 Scenario 0.1 - MBH_300_QA4-mgb
| Medicatietoediening MBH_300_QA4_MTD-mgb | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_QA4_MTD-mgb (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.18629005.1) | ||
| RegistratieDatumTijd | T - 9 dagen om 17:01:01 uur | ||
| ToedieningsDatumTijd | T - 9 dagen om 17:01:01 uur | ||
| ToegediendeHoeveelheid | |||
| Aantal | 1 | ||
| Eenheid | stuk (code = '245' in codeSystem 'G-Standaard thesaurus basiseenheden') | ||
| Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
| Toediener | |||
| Zorgverlener | Zie Zorgverlener: JANTIEN_TOEDIEN | ||
| Geneesmiddel - primaire code | ASPIRINE TABLET 100MG (code = '202681' in codeSystem 'G-Standaard HPK') | ||
| Geneesmiddel - generiekere code | ACETYLSALICYLZUUR TABLET 100MG (code = '3956' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | ACETYLSALICYLZUUR TABLET 100MG (code = '12548' in codeSystem 'G-Standaard GPK') | ||
| RelatieMedicatieafspraak | |||
| Identificatie | MBH_300_QA4_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| RelatieToedieningsafspraak | |||
| Identificatie | MBH_300_QA4_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
| MBH identificatie | MBH_300_QA4-mgb (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
1.3.5 Scenario 0.1 - MBH_300_QA5-mgb
| Medicatietoediening MBH_300_QA5_MTD-mgb | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_QA5_MTD-mgb (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.18629005.1) | ||
| RegistratieDatumTijd | T - 49 dagen om 13:54:35 uur | ||
| ToedieningsDatumTijd | T - 49 dagen om 13:54:35 uur | ||
| ToegediendeHoeveelheid | |||
| Aantal | 2 | ||
| Eenheid | stuk (code = '245' in codeSystem 'G-Standaard thesaurus basiseenheden') | ||
| Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
| Toediener | |||
| Zorgverlener | Zie Zorgverlener: JANTIEN_TOEDIEN | ||
| Geneesmiddel - primaire code | PARACETAMOL SANDOZ TABLET 500MG (code = '665800' in codeSystem 'G-Standaard HPK') | ||
| Geneesmiddel - generiekere code | PARACETAMOL 500MG TABLET (code = '67903' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | PARACETAMOL 500MG TABLET (code = '2194' in codeSystem 'G-Standaard GPK') | ||
| RelatieMedicatieafspraak | |||
| Identificatie | MBH_300_QA5_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| RelatieToedieningsafspraak | |||
| Identificatie | MBH_300_QA5_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
| MBH identificatie | MBH_300_QA5-mgb (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
1.3.6 Scenario 0.1 - MBH_300_QA6-mgb
| Medicatietoediening MBH_300_QA6_MTD-mgb | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_QA6_MTD-mgb (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.18629005.1) | ||
| RegistratieDatumTijd | T - 4 dagen om 08:08:08 uur | ||
| ToedieningsDatumTijd | T - 4 dagen om 08:08:08 uur | ||
| ToegediendeHoeveelheid | |||
| Aantal | 1 | ||
| Eenheid | stuk (code = '245' in codeSystem 'G-Standaard thesaurus basiseenheden') | ||
| Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
| Toediener | |||
| Zorgverlener | Zie Zorgverlener: JANTIEN_TOEDIEN | ||
| Geneesmiddel - primaire code | OXAZEPAM ACTAVIS TABLET 10MG (code = '613401' in codeSystem 'G-Standaard HPK') | ||
| Geneesmiddel - generiekere code | OXAZEPAM TABLET 10MG (code = '353' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | OXAZEPAM TABLET 10MG (code = '1023' in codeSystem 'G-Standaard GPK') | ||
| RelatieMedicatieafspraak | |||
| Identificatie | MBH_300_QA6_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| RelatieToedieningsafspraak | |||
| Identificatie | MBH_300_QA6_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
| MBH identificatie | MBH_300_QA6-mgb (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
1.3.7 Bouwstenen
| Bouwstenen | ||||
| Gegevenselement | Waarde | |||
| Zorgverlener JANTIEN_TOEDIEN | ||||
| ZorgverlenerIdentificatienummer | 222220000 (in identificerend systeem: UZI Personen) | |||
| Naamgegevens | Jantien Toedien | |||
| Specialisme | Verpleegkundigen, niet nader gespecificeerd (code = '9100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') | |||
| Zorgaanbieder | ||||
| Zorgaanbieder | Zie Zorgaanbieder: THUISZORG_OM_EN_BIJ | |||
| Zorgaanbieder THUISZORG_OM_EN_BIJ | ||||
| ZorgaanbiederIdentificatienummer | 11110000 (in identificerend systeem: URA) | |||
| OrganisatieNaam | Thuiszorg Om en Bij | |||
| OrganisatieType | Thuiszorg (code = 'T2' in codeSystem 'HL7 RoleCodeNL Care provider type (organizations)') | |||
1.4 TEST Medicatiegegevens MTD Scenarioset 0 (filterqueries)
| Patiënt | ||||
| Gegevenselement | Waarde | |||
| Naamgegevens | ||||
| Initialen | R. | |||
| Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik') | |||
| Geslachtsnaam | ||||
| Voorvoegsels | van | |||
| Achternaam | XXX_Sonnenberg | |||
| Adresgegevens | krommeweg 1001 A 1234QQ Ons Dorp 157 Nederland 3 Woon-/verblijfadres | |||
| Identificatienummer | 999901084 [BSN] | |||
| Geboortedatum | 20 nov 1985 | |||
| Geslacht | Man (code = 'M' in codeSystem 'HL7 AdministrativeGender') | |||
1.4.1 Scenario 0.2 - MBH_300_QA1-mgb
| Medicatietoediening MBH_300_QA1_MTD-mgb | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_QA1_MTD-mgb (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.18629005.1) | ||
| RegistratieDatumTijd | T - 18 dagen om 10:04:22 uur | ||
| ToedieningsDatumTijd | T - 18 dagen om 10:04:22 uur | ||
| ToegediendeHoeveelheid | |||
| Aantal | 1 | ||
| Eenheid | stuk (code = '245' in codeSystem 'G-Standaard thesaurus basiseenheden') | ||
| Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
| Toediener | |||
| Zorgverlener | Zie Zorgverlener: JANTIEN_TOEDIEN | ||
| Geneesmiddel - primaire code | IBUPROFEN PCH TABLET 600MG (code = '641898' in codeSystem 'G-Standaard HPK') | ||
| Geneesmiddel - generiekere code | IBUPROFEN TABLET 600MG (code = '17469' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | IBUPROFEN TABLET 600MG (code = '42080' in codeSystem 'G-Standaard GPK') | ||
| RelatieMedicatieafspraak | |||
| Identificatie | MBH_300_QA1_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| RelatieToedieningsafspraak | |||
| Identificatie | MBH_300_QA1_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
| MBH identificatie | MBH_300_QA1-mgb (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
1.4.2 Bouwstenen
| Bouwstenen | ||||
| Gegevenselement | Waarde | |||
| Zorgverlener JANTIEN_TOEDIEN | ||||
| ZorgverlenerIdentificatienummer | 222220000 (in identificerend systeem: UZI Personen) | |||
| Naamgegevens | Jantien Toedien | |||
| Specialisme | Verpleegkundigen, niet nader gespecificeerd (code = '9100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') | |||
| Zorgaanbieder | ||||
| Zorgaanbieder | Zie Zorgaanbieder: THUISZORG_OM_EN_BIJ | |||
| Zorgaanbieder THUISZORG_OM_EN_BIJ | ||||
| ZorgaanbiederIdentificatienummer | 11110000 (in identificerend systeem: URA) | |||
| OrganisatieNaam | Thuiszorg Om en Bij | |||
| OrganisatieType | Thuiszorg (code = 'T2' in codeSystem 'HL7 RoleCodeNL Care provider type (organizations)') | |||
1.5 TEST Medicatiegegevens MTD Scenarioset 0 (filterqueries)
| Patiënt | ||||
| Gegevenselement | Waarde | |||
| Naamgegevens | ||||
| Initialen | R. | |||
| Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik') | |||
| Geslachtsnaam | ||||
| Voorvoegsels | van | |||
| Achternaam | XXX_Sonnenberg | |||
| Adresgegevens | krommeweg 1001 A 1234QQ Ons Dorp 157 Nederland 3 Woon-/verblijfadres | |||
| Identificatienummer | 999901084 [BSN] | |||
| Geboortedatum | 20 nov 1985 | |||
| Geslacht | Man (code = 'M' in codeSystem 'HL7 AdministrativeGender') | |||
1.5.1 Scenario 0.3 - MBH_300_QA4-mgb
| Medicatietoediening MBH_300_QA4_MTD-mgb | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_QA4_MTD-mgb (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.18629005.1) | ||
| RegistratieDatumTijd | T - 9 dagen om 17:01:01 uur | ||
| ToedieningsDatumTijd | T - 9 dagen om 17:01:01 uur | ||
| ToegediendeHoeveelheid | |||
| Aantal | 1 | ||
| Eenheid | stuk (code = '245' in codeSystem 'G-Standaard thesaurus basiseenheden') | ||
| Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
| Toediener | |||
| Zorgverlener | Zie Zorgverlener: JANTIEN_TOEDIEN | ||
| Geneesmiddel - primaire code | ASPIRINE TABLET 100MG (code = '202681' in codeSystem 'G-Standaard HPK') | ||
| Geneesmiddel - generiekere code | ACETYLSALICYLZUUR TABLET 100MG (code = '3956' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | ACETYLSALICYLZUUR TABLET 100MG (code = '12548' in codeSystem 'G-Standaard GPK') | ||
| RelatieMedicatieafspraak | |||
| Identificatie | MBH_300_QA4_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| RelatieToedieningsafspraak | |||
| Identificatie | MBH_300_QA4_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
| MBH identificatie | MBH_300_QA4-mgb (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
1.5.2 Bouwstenen
| Bouwstenen | ||||
| Gegevenselement | Waarde | |||
| Zorgverlener JANTIEN_TOEDIEN | ||||
| ZorgverlenerIdentificatienummer | 222220000 (in identificerend systeem: UZI Personen) | |||
| Naamgegevens | Jantien Toedien | |||
| Specialisme | Verpleegkundigen, niet nader gespecificeerd (code = '9100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') | |||
| Zorgaanbieder | ||||
| Zorgaanbieder | Zie Zorgaanbieder: THUISZORG_OM_EN_BIJ | |||
| Zorgaanbieder THUISZORG_OM_EN_BIJ | ||||
| ZorgaanbiederIdentificatienummer | 11110000 (in identificerend systeem: URA) | |||
| OrganisatieNaam | Thuiszorg Om en Bij | |||
| OrganisatieType | Thuiszorg (code = 'T2' in codeSystem 'HL7 RoleCodeNL Care provider type (organizations)') | |||
1.6 TEST Medicatiegegevens MTD Scenarioset 0 (filterqueries)
| Patiënt | ||||
| Gegevenselement | Waarde | |||
| Naamgegevens | ||||
| Initialen | R. | |||
| Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik') | |||
| Geslachtsnaam | ||||
| Voorvoegsels | van | |||
| Achternaam | XXX_Sonnenberg | |||
| Adresgegevens | krommeweg 1001 A 1234QQ Ons Dorp 157 Nederland 3 Woon-/verblijfadres | |||
| Identificatienummer | 999901084 [BSN] | |||
| Geboortedatum | 20 nov 1985 | |||
| Geslacht | Man (code = 'M' in codeSystem 'HL7 AdministrativeGender') | |||
1.6.1 Scenario 0.4 - MBH_300_QA1-mgb
| Medicatietoediening MBH_300_QA1_MTD-mgb | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_QA1_MTD-mgb (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.18629005.1) | ||
| RegistratieDatumTijd | T - 18 dagen om 10:04:22 uur | ||
| ToedieningsDatumTijd | T - 18 dagen om 10:04:22 uur | ||
| ToegediendeHoeveelheid | |||
| Aantal | 1 | ||
| Eenheid | stuk (code = '245' in codeSystem 'G-Standaard thesaurus basiseenheden') | ||
| Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
| Toediener | |||
| Zorgverlener | Zie Zorgverlener: JANTIEN_TOEDIEN | ||
| Geneesmiddel - primaire code | IBUPROFEN PCH TABLET 600MG (code = '641898' in codeSystem 'G-Standaard HPK') | ||
| Geneesmiddel - generiekere code | IBUPROFEN TABLET 600MG (code = '17469' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | IBUPROFEN TABLET 600MG (code = '42080' in codeSystem 'G-Standaard GPK') | ||
| RelatieMedicatieafspraak | |||
| Identificatie | MBH_300_QA1_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| RelatieToedieningsafspraak | |||
| Identificatie | MBH_300_QA1_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
| MBH identificatie | MBH_300_QA1-mgb (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
1.6.2 Scenario 0.4 - MBH_300_QA4-mgb
| Medicatietoediening MBH_300_QA4_MTD-mgb | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_QA4_MTD-mgb (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.18629005.1) | ||
| RegistratieDatumTijd | T - 9 dagen om 17:01:01 uur | ||
| ToedieningsDatumTijd | T - 9 dagen om 17:01:01 uur | ||
| ToegediendeHoeveelheid | |||
| Aantal | 1 | ||
| Eenheid | stuk (code = '245' in codeSystem 'G-Standaard thesaurus basiseenheden') | ||
| Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
| Toediener | |||
| Zorgverlener | Zie Zorgverlener: JANTIEN_TOEDIEN | ||
| Geneesmiddel - primaire code | ASPIRINE TABLET 100MG (code = '202681' in codeSystem 'G-Standaard HPK') | ||
| Geneesmiddel - generiekere code | ACETYLSALICYLZUUR TABLET 100MG (code = '3956' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | ACETYLSALICYLZUUR TABLET 100MG (code = '12548' in codeSystem 'G-Standaard GPK') | ||
| RelatieMedicatieafspraak | |||
| Identificatie | MBH_300_QA4_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| RelatieToedieningsafspraak | |||
| Identificatie | MBH_300_QA4_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
| MBH identificatie | MBH_300_QA4-mgb (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
1.6.3 Scenario 0.4 - MBH_300_QA6-mgb
| Medicatietoediening MBH_300_QA6_MTD-mgb | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_QA6_MTD-mgb (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.18629005.1) | ||
| RegistratieDatumTijd | T - 4 dagen om 08:08:08 uur | ||
| ToedieningsDatumTijd | T - 4 dagen om 08:08:08 uur | ||
| ToegediendeHoeveelheid | |||
| Aantal | 1 | ||
| Eenheid | stuk (code = '245' in codeSystem 'G-Standaard thesaurus basiseenheden') | ||
| Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
| Toediener | |||
| Zorgverlener | Zie Zorgverlener: JANTIEN_TOEDIEN | ||
| Geneesmiddel - primaire code | OXAZEPAM ACTAVIS TABLET 10MG (code = '613401' in codeSystem 'G-Standaard HPK') | ||
| Geneesmiddel - generiekere code | OXAZEPAM TABLET 10MG (code = '353' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | OXAZEPAM TABLET 10MG (code = '1023' in codeSystem 'G-Standaard GPK') | ||
| RelatieMedicatieafspraak | |||
| Identificatie | MBH_300_QA6_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| RelatieToedieningsafspraak | |||
| Identificatie | MBH_300_QA6_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
| MBH identificatie | MBH_300_QA6-mgb (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
1.6.4 Bouwstenen
| Bouwstenen | ||||
| Gegevenselement | Waarde | |||
| Zorgverlener JANTIEN_TOEDIEN | ||||
| ZorgverlenerIdentificatienummer | 222220000 (in identificerend systeem: UZI Personen) | |||
| Naamgegevens | Jantien Toedien | |||
| Specialisme | Verpleegkundigen, niet nader gespecificeerd (code = '9100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') | |||
| Zorgaanbieder | ||||
| Zorgaanbieder | Zie Zorgaanbieder: THUISZORG_OM_EN_BIJ | |||
| Zorgaanbieder THUISZORG_OM_EN_BIJ | ||||
| ZorgaanbiederIdentificatienummer | 11110000 (in identificerend systeem: URA) | |||
| OrganisatieNaam | Thuiszorg Om en Bij | |||
| OrganisatieType | Thuiszorg (code = 'T2' in codeSystem 'HL7 RoleCodeNL Care provider type (organizations)') | |||
1.7 TEST Medicatiegegevens MTD Scenarioset 0 (filterqueries)
| Patiënt | ||||
| Gegevenselement | Waarde | |||
| Naamgegevens | ||||
| Initialen | R. | |||
| Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik') | |||
| Geslachtsnaam | ||||
| Voorvoegsels | van | |||
| Achternaam | XXX_Sonnenberg | |||
| Adresgegevens | krommeweg 1001 A 1234QQ Ons Dorp 157 Nederland 3 Woon-/verblijfadres | |||
| Identificatienummer | 999901084 [BSN] | |||
| Geboortedatum | 20 nov 1985 | |||
| Geslacht | Man (code = 'M' in codeSystem 'HL7 AdministrativeGender') | |||
1.7.1 Scenario 0.5 - MBH_300_QA2-mgb
| Medicatietoediening MBH_300_QA2_MTD-mgb | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_QA2_MTD-mgb (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.18629005.1) | ||
| RegistratieDatumTijd | T - 99 dagen om 13:10:40 uur | ||
| ToedieningsDatumTijd | T - 99 dagen om 13:10:40 uur | ||
| ToegediendeHoeveelheid | |||
| Aantal | 5 | ||
| Eenheid | milliliter (code = '233' in codeSystem 'G-Standaard thesaurus basiseenheden') | ||
| Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
| Toediener | |||
| Zorgverlener | Zie Zorgverlener: JANTIEN_TOEDIEN | ||
| MedicatietoedieningRedenVanAfwijken | onvoldoende medicatie op voorraad (code = '705046008' in codeSystem 'SNOMED CT') | ||
| Geneesmiddel - primaire code | XPRAEP SIROOP 2MG/ML (code = '101079' in codeSystem 'G-Standaard HPK') | ||
| Geneesmiddel - generiekere code | SENNOSIDEN A+B 2MG/ML (code = '3379' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | SENNOSIDEN A+B 2MG/ML (code = '10960' in codeSystem 'G-Standaard GPK') | ||
| RelatieMedicatieafspraak | |||
| Identificatie | MBH_300_QA2_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| RelatieToedieningsafspraak | |||
| Identificatie | MBH_300_QA2_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
| MBH identificatie | MBH_300_QA2-mgb (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
1.7.2 Scenario 0.5 - MBH_300_QA3-mgb
| Medicatietoediening MBH_300_QA3_MTD-mgb | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_QA3_MTD-mgb (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.18629005.1) | ||
| RegistratieDatumTijd | T - 45 dagen om 11:26:44 uur | ||
| ToedieningsDatumTijd | T - 45 dagen om 11:26:44 uur | ||
| ToegediendeHoeveelheid | |||
| Aantal | 50 | ||
| Eenheid | milliliter (code = '233' in codeSystem 'G-Standaard thesaurus basiseenheden') | ||
| Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
| Toediener | |||
| Zorgverlener | Zie Zorgverlener: JANTIEN_TOEDIEN | ||
| Geneesmiddel - primaire code | NUTRIDRINK BANAANSMAAK (code = '690090' in codeSystem 'G-Standaard HPK') | ||
| Geneesmiddel - generiekere code | VLOEIBARE VOEDING MET O.A. VITAMINE K (code = '88749' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | VLOEIBARE VOEDING MET O.A. VITAMINE K (code = '130575' in codeSystem 'G-Standaard GPK') | ||
| RelatieMedicatieafspraak | |||
| Identificatie | MBH_300_QA3_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| RelatieToedieningsafspraak | |||
| Identificatie | MBH_300_QA3_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
| MBH identificatie | MBH_300_QA3-mgb (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
1.7.3 Scenario 0.5 - MBH_300_QA5-mgb
| Medicatietoediening MBH_300_QA5_MTD-mgb | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_QA5_MTD-mgb (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.18629005.1) | ||
| RegistratieDatumTijd | T - 49 dagen om 13:54:35 uur | ||
| ToedieningsDatumTijd | T - 49 dagen om 13:54:35 uur | ||
| ToegediendeHoeveelheid | |||
| Aantal | 2 | ||
| Eenheid | stuk (code = '245' in codeSystem 'G-Standaard thesaurus basiseenheden') | ||
| Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
| Toediener | |||
| Zorgverlener | Zie Zorgverlener: JANTIEN_TOEDIEN | ||
| Geneesmiddel - primaire code | PARACETAMOL SANDOZ TABLET 500MG (code = '665800' in codeSystem 'G-Standaard HPK') | ||
| Geneesmiddel - generiekere code | PARACETAMOL 500MG TABLET (code = '67903' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | PARACETAMOL 500MG TABLET (code = '2194' in codeSystem 'G-Standaard GPK') | ||
| RelatieMedicatieafspraak | |||
| Identificatie | MBH_300_QA5_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| RelatieToedieningsafspraak | |||
| Identificatie | MBH_300_QA5_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
| MBH identificatie | MBH_300_QA5-mgb (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
1.7.4 Bouwstenen
| Bouwstenen | ||||
| Gegevenselement | Waarde | |||
| Zorgverlener JANTIEN_TOEDIEN | ||||
| ZorgverlenerIdentificatienummer | 222220000 (in identificerend systeem: UZI Personen) | |||
| Naamgegevens | Jantien Toedien | |||
| Specialisme | Verpleegkundigen, niet nader gespecificeerd (code = '9100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') | |||
| Zorgaanbieder | ||||
| Zorgaanbieder | Zie Zorgaanbieder: THUISZORG_OM_EN_BIJ | |||
| Zorgaanbieder THUISZORG_OM_EN_BIJ | ||||
| ZorgaanbiederIdentificatienummer | 11110000 (in identificerend systeem: URA) | |||
| OrganisatieNaam | Thuiszorg Om en Bij | |||
| OrganisatieType | Thuiszorg (code = 'T2' in codeSystem 'HL7 RoleCodeNL Care provider type (organizations)') | |||
1.8 TEST Medicatiegegevens MTD Scenarioset 0 (filterqueries)
| Patiënt | ||||
| Gegevenselement | Waarde | |||
| Naamgegevens | ||||
| Initialen | R. | |||
| Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik') | |||
| Geslachtsnaam | ||||
| Voorvoegsels | van | |||
| Achternaam | XXX_Sonnenberg | |||
| Adresgegevens | krommeweg 1001 A 1234QQ Ons Dorp 157 Nederland 3 Woon-/verblijfadres | |||
| Identificatienummer | 999901084 [BSN] | |||
| Geboortedatum | 20 nov 1985 | |||
| Geslacht | Man (code = 'M' in codeSystem 'HL7 AdministrativeGender') | |||
1.8.1 Scenario 0.6 - MBH_300_QA1-mgb
| Medicatietoediening MBH_300_QA1_MTD-mgb | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_QA1_MTD-mgb (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.18629005.1) | ||
| RegistratieDatumTijd | T - 18 dagen om 10:04:22 uur | ||
| ToedieningsDatumTijd | T - 18 dagen om 10:04:22 uur | ||
| ToegediendeHoeveelheid | |||
| Aantal | 1 | ||
| Eenheid | stuk (code = '245' in codeSystem 'G-Standaard thesaurus basiseenheden') | ||
| Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
| Toediener | |||
| Zorgverlener | Zie Zorgverlener: JANTIEN_TOEDIEN | ||
| Geneesmiddel - primaire code | IBUPROFEN PCH TABLET 600MG (code = '641898' in codeSystem 'G-Standaard HPK') | ||
| Geneesmiddel - generiekere code | IBUPROFEN TABLET 600MG (code = '17469' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | IBUPROFEN TABLET 600MG (code = '42080' in codeSystem 'G-Standaard GPK') | ||
| RelatieMedicatieafspraak | |||
| Identificatie | MBH_300_QA1_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| RelatieToedieningsafspraak | |||
| Identificatie | MBH_300_QA1_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
| MBH identificatie | MBH_300_QA1-mgb (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
1.8.2 Scenario 0.6 - MBH_300_QA4-mgb
| Medicatietoediening MBH_300_QA4_MTD-mgb | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_QA4_MTD-mgb (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.18629005.1) | ||
| RegistratieDatumTijd | T - 9 dagen om 17:01:01 uur | ||
| ToedieningsDatumTijd | T - 9 dagen om 17:01:01 uur | ||
| ToegediendeHoeveelheid | |||
| Aantal | 1 | ||
| Eenheid | stuk (code = '245' in codeSystem 'G-Standaard thesaurus basiseenheden') | ||
| Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
| Toediener | |||
| Zorgverlener | Zie Zorgverlener: JANTIEN_TOEDIEN | ||
| Geneesmiddel - primaire code | ASPIRINE TABLET 100MG (code = '202681' in codeSystem 'G-Standaard HPK') | ||
| Geneesmiddel - generiekere code | ACETYLSALICYLZUUR TABLET 100MG (code = '3956' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | ACETYLSALICYLZUUR TABLET 100MG (code = '12548' in codeSystem 'G-Standaard GPK') | ||
| RelatieMedicatieafspraak | |||
| Identificatie | MBH_300_QA4_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| RelatieToedieningsafspraak | |||
| Identificatie | MBH_300_QA4_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
| MBH identificatie | MBH_300_QA4-mgb (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
1.8.3 Bouwstenen
| Bouwstenen | ||||
| Gegevenselement | Waarde | |||
| Zorgverlener JANTIEN_TOEDIEN | ||||
| ZorgverlenerIdentificatienummer | 222220000 (in identificerend systeem: UZI Personen) | |||
| Naamgegevens | Jantien Toedien | |||
| Specialisme | Verpleegkundigen, niet nader gespecificeerd (code = '9100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') | |||
| Zorgaanbieder | ||||
| Zorgaanbieder | Zie Zorgaanbieder: THUISZORG_OM_EN_BIJ | |||
| Zorgaanbieder THUISZORG_OM_EN_BIJ | ||||
| ZorgaanbiederIdentificatienummer | 11110000 (in identificerend systeem: URA) | |||
| OrganisatieNaam | Thuiszorg Om en Bij | |||
| OrganisatieType | Thuiszorg (code = 'T2' in codeSystem 'HL7 RoleCodeNL Care provider type (organizations)') | |||
1.9 TEST Medicatiegegevens MTD Scenarioset 0 (filterqueries)
| Patiënt | ||||
| Gegevenselement | Waarde | |||
| Naamgegevens | ||||
| Initialen | R. | |||
| Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik') | |||
| Geslachtsnaam | ||||
| Voorvoegsels | van | |||
| Achternaam | XXX_Sonnenberg | |||
| Adresgegevens | krommeweg 1001 A 1234QQ Ons Dorp 157 Nederland 3 Woon-/verblijfadres | |||
| Identificatienummer | 999901084 [BSN] | |||
| Geboortedatum | 20 nov 1985 | |||
| Geslacht | Man (code = 'M' in codeSystem 'HL7 AdministrativeGender') | |||
1.9.1 Scenario 0.7 - MBH_300_QA1-mgb
| Medicatietoediening MBH_300_QA1_MTD-mgb | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_QA1_MTD-mgb (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.18629005.1) | ||
| RegistratieDatumTijd | T - 18 dagen om 10:04:22 uur | ||
| ToedieningsDatumTijd | T - 18 dagen om 10:04:22 uur | ||
| ToegediendeHoeveelheid | |||
| Aantal | 1 | ||
| Eenheid | stuk (code = '245' in codeSystem 'G-Standaard thesaurus basiseenheden') | ||
| Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
| Toediener | |||
| Zorgverlener | Zie Zorgverlener: JANTIEN_TOEDIEN | ||
| Geneesmiddel - primaire code | IBUPROFEN PCH TABLET 600MG (code = '641898' in codeSystem 'G-Standaard HPK') | ||
| Geneesmiddel - generiekere code | IBUPROFEN TABLET 600MG (code = '17469' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | IBUPROFEN TABLET 600MG (code = '42080' in codeSystem 'G-Standaard GPK') | ||
| RelatieMedicatieafspraak | |||
| Identificatie | MBH_300_QA1_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| RelatieToedieningsafspraak | |||
| Identificatie | MBH_300_QA1_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
| MBH identificatie | MBH_300_QA1-mgb (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
1.9.2 Bouwstenen
| Bouwstenen | ||||
| Gegevenselement | Waarde | |||
| Zorgverlener JANTIEN_TOEDIEN | ||||
| ZorgverlenerIdentificatienummer | 222220000 (in identificerend systeem: UZI Personen) | |||
| Naamgegevens | Jantien Toedien | |||
| Specialisme | Verpleegkundigen, niet nader gespecificeerd (code = '9100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') | |||
| Zorgaanbieder | ||||
| Zorgaanbieder | Zie Zorgaanbieder: THUISZORG_OM_EN_BIJ | |||
| Zorgaanbieder THUISZORG_OM_EN_BIJ | ||||
| ZorgaanbiederIdentificatienummer | 11110000 (in identificerend systeem: URA) | |||
| OrganisatieNaam | Thuiszorg Om en Bij | |||
| OrganisatieType | Thuiszorg (code = 'T2' in codeSystem 'HL7 RoleCodeNL Care provider type (organizations)') | |||
1.10 TEST Medicatiegegevens MTD Scenarioset 2
| Patiënt | ||||
| Gegevenselement | Waarde | |||
| Naamgegevens | ||||
| Initialen | D. | |||
| Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik') | |||
| Geslachtsnaam | ||||
| Achternaam | XXX_Dixhoorn | |||
| Identificatienummer | 999900481 [BSN] | |||
| Geboortedatum | 22 okt 1963 | |||
| Geslacht | Man (code = 'M' in codeSystem 'HL7 AdministrativeGender') | |||
1.10.1 Scenario 2.1 - MBH_300_toelichting-mgb
| Medicatietoediening MBH_300_toelichting_MTD-mgb | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_toelichting_MTD-mgb (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.18629005.1) | ||
| RegistratieDatumTijd | T - 18 dagen om 10:33:47 uur | ||
| ToedieningsDatumTijd | T - 18 dagen om 10:33:47 uur | ||
| ToegediendeHoeveelheid | |||
| Aantal | 1 | ||
| Eenheid | stuk (code = '245' in codeSystem 'G-Standaard thesaurus basiseenheden') | ||
| Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
| Toediener | |||
| Zorgverlener | Zie Zorgverlener: JANTIEN_TOEDIEN | ||
| Geneesmiddel - primaire code | FUROSEMIDE SANDOZ TABLET 40MG (code = '598860' in codeSystem 'G-Standaard HPK') | ||
| Geneesmiddel - generiekere code | FUROSEMIDE 40MG TABLET (code = '5967' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | FUROSEMIDE 40MG TABLET (code = '16810' in codeSystem 'G-Standaard GPK') | ||
| Toelichting | In overleg met specialist | ||
| RelatieMedicatieafspraak | |||
| Identificatie | MBH_300_toelichting_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| RelatieToedieningsafspraak | |||
| Identificatie | MBH_300_toelichting_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
| MBH identificatie | MBH_300_toelichting-mgb (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
1.10.2 Bouwstenen
| Bouwstenen | ||||
| Gegevenselement | Waarde | |||
| Zorgverlener JANTIEN_TOEDIEN | ||||
| ZorgverlenerIdentificatienummer | 222220000 (in identificerend systeem: UZI Personen) | |||
| Naamgegevens | Jantien Toedien | |||
| Specialisme | Verpleegkundigen, niet nader gespecificeerd (code = '9100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') | |||
| Zorgaanbieder | ||||
| Zorgaanbieder | Zie Zorgaanbieder: THUISZORG_OM_EN_BIJ | |||
| Zorgaanbieder THUISZORG_OM_EN_BIJ | ||||
| ZorgaanbiederIdentificatienummer | 11110000 (in identificerend systeem: URA) | |||
| OrganisatieNaam | Thuiszorg Om en Bij | |||
| OrganisatieType | Thuiszorg (code = 'T2' in codeSystem 'HL7 RoleCodeNL Care provider type (organizations)') | |||
1.11 TEST Medicatiegegevens MTD Scenarioset 2
| Patiënt | ||||
| Gegevenselement | Waarde | |||
| Naamgegevens | ||||
| Initialen | D. | |||
| Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik') | |||
| Geslachtsnaam | ||||
| Achternaam | XXX_Dixhoorn | |||
| Identificatienummer | 999900481 [BSN] | |||
| Geboortedatum | 22 okt 1963 | |||
| Geslacht | Man (code = 'M' in codeSystem 'HL7 AdministrativeGender') | |||
1.11.1 Scenario 2.2 - MBH_300_Toedieningsweg-mgb
| Medicatietoediening MBH_300_Toedieningsweg_MTD-mgb | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_Toedieningsweg_MTD-mgb (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.18629005.1) | ||
| RegistratieDatumTijd | T - 4 dagen om 11:26:44 uur | ||
| ToedieningsDatumTijd | T - 4 dagen om 11:26 uur | ||
| ToegediendeHoeveelheid | |||
| Aantal | 1 | ||
| Eenheid | Druppel (code = '303' in codeSystem 'G-Standaard thesaurus basiseenheden') | ||
| Toedieningsweg | Oculair (code = '7' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
| Toediener | |||
| Zorgverlener | Zie Zorgverlener: JANTIEN_TOEDIEN | ||
| Geneesmiddel - primaire code | SOFRADEX OORDRUPPELS (code = '644781' in codeSystem 'G-Standaard HPK') | ||
| Geneesmiddel - generiekere code | DEXAMETHASON/FRAMYCETINE/GRAMICIDINE OORDR (code = '80691' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | DEXAMETHASON/FRAMYCETINE/GRAMICIDINE OORDR (code = '79804' in codeSystem 'G-Standaard GPK') | ||
| RelatieMedicatieafspraak | |||
| Identificatie | MBH_300_Toedieningsweg_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| RelatieToedieningsafspraak | |||
| Identificatie | MBH_300_Toedieningsweg_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
| MBH identificatie | MBH_300_Toedieningsweg-mgb (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
1.11.2 Bouwstenen
| Bouwstenen | ||||
| Gegevenselement | Waarde | |||
| Zorgverlener JANTIEN_TOEDIEN | ||||
| ZorgverlenerIdentificatienummer | 222220000 (in identificerend systeem: UZI Personen) | |||
| Naamgegevens | Jantien Toedien | |||
| Specialisme | Verpleegkundigen, niet nader gespecificeerd (code = '9100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') | |||
| Zorgaanbieder | ||||
| Zorgaanbieder | Zie Zorgaanbieder: THUISZORG_OM_EN_BIJ | |||
| Zorgaanbieder THUISZORG_OM_EN_BIJ | ||||
| ZorgaanbiederIdentificatienummer | 11110000 (in identificerend systeem: URA) | |||
| OrganisatieNaam | Thuiszorg Om en Bij | |||
| OrganisatieType | Thuiszorg (code = 'T2' in codeSystem 'HL7 RoleCodeNL Care provider type (organizations)') | |||
1.12 TEST Medicatiegegevens MTD Scenarioset 3
| Patiënt | ||||
| Gegevenselement | Waarde | |||
| Naamgegevens | ||||
| Initialen | C. | |||
| Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik') | |||
| Geslachtsnaam | ||||
| Achternaam | XXX_Dongen | |||
| Identificatienummer | 999900493 [BSN] | |||
| Geboortedatum | 23 okt 1963 | |||
| Geslacht | Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender') | |||
1.12.1 Scenario 3.11 - MBH_300_MTDopschorten-mgb
| Medicatietoediening MBH_300_MTDopschorten_MTD1-mgb | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_MTDopschorten_MTD1-mgb (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.18629005.1) | ||
| RegistratieDatumTijd | T - 4 dagen om 08:38:45 uur | ||
| ToedieningsDatumTijd | T - 4 dagen om 08:38:45 uur | ||
| ToegediendeHoeveelheid | |||
| Aantal | 0 | ||
| Eenheid | stuk (code = '245' in codeSystem 'G-Standaard thesaurus basiseenheden') | ||
| Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
| Toediener | |||
| Zorgverlener | Zie Zorgverlener: JANTIEN_TOEDIEN | ||
| MedicatietoedieningRedenVanAfwijken | niet in staat om medicatie te gebruiken (code = '408366001' in codeSystem 'SNOMED CT') | ||
| Geneesmiddel - primaire code | PROPRANOLOL HCL SANDOZ TABLET 80MG (code = '603678' in codeSystem 'G-Standaard HPK') | ||
| Geneesmiddel - generiekere code | PROPRANOLOL TABLET 80MG (code = '5738' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | PROPRANOLOL TABLET 80MG (code = '16322' in codeSystem 'G-Standaard GPK') | ||
| RelatieMedicatieafspraak | |||
| Identificatie | MBH_300_MTDopschorten_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| RelatieToedieningsafspraak | |||
| Identificatie | MBH_300_MTDopschorten_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
| MBH identificatie | MBH_300_MTDopschorten-mgb (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
| Medicatietoediening MBH_300_MTDopschorten_MTD2-mgb | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_MTDopschorten_MTD2-mgb (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.18629005.1) | ||
| RegistratieDatumTijd | T - 4 dagen om 11:22:06 uur | ||
| ToedieningsDatumTijd | T - 4 dagen om 11:22:06 uur | ||
| ToegediendeHoeveelheid | |||
| Aantal | 1 | ||
| Eenheid | stuk (code = '245' in codeSystem 'G-Standaard thesaurus basiseenheden') | ||
| Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
| Toediener | |||
| Zorgverlener | Zie Zorgverlener: JANTIEN_TOEDIEN | ||
| Geneesmiddel - primaire code | PROPRANOLOL HCL SANDOZ TABLET 80MG (code = '603678' in codeSystem 'G-Standaard HPK') | ||
| Geneesmiddel - generiekere code | PROPRANOLOL TABLET 80MG (code = '5738' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | PROPRANOLOL TABLET 80MG (code = '16322' in codeSystem 'G-Standaard GPK') | ||
| RelatieMedicatieafspraak | |||
| Identificatie | MBH_300_MTDopschorten_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| RelatieToedieningsafspraak | |||
| Identificatie | MBH_300_MTDopschorten_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
| MBH identificatie | MBH_300_MTDopschorten-mgb (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
1.12.2 Bouwstenen
| Bouwstenen | ||||
| Gegevenselement | Waarde | |||
| Zorgverlener JANTIEN_TOEDIEN | ||||
| ZorgverlenerIdentificatienummer | 222220000 (in identificerend systeem: UZI Personen) | |||
| Naamgegevens | Jantien Toedien | |||
| Specialisme | Verpleegkundigen, niet nader gespecificeerd (code = '9100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') | |||
| Zorgaanbieder | ||||
| Zorgaanbieder | Zie Zorgaanbieder: THUISZORG_OM_EN_BIJ | |||
| Zorgaanbieder THUISZORG_OM_EN_BIJ | ||||
| ZorgaanbiederIdentificatienummer | 11110000 (in identificerend systeem: URA) | |||
| OrganisatieNaam | Thuiszorg Om en Bij | |||
| OrganisatieType | Thuiszorg (code = 'T2' in codeSystem 'HL7 RoleCodeNL Care provider type (organizations)') | |||
1.13 TEST Medicatiegegevens MTD Scenarioset 3
| Patiënt | ||||
| Gegevenselement | Waarde | |||
| Naamgegevens | ||||
| Initialen | C. | |||
| Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik') | |||
| Geslachtsnaam | ||||
| Achternaam | XXX_Dongen | |||
| Identificatienummer | 999900493 [BSN] | |||
| Geboortedatum | 23 okt 1963 | |||
| Geslacht | Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender') | |||
1.13.1 Scenario 3.12 - mbh_300_AfwijkendeToediening-mgb
| Medicatietoediening mbh_300_AfwijkendeToediening_MTD_normaal-mgb | |||
| Gegevenselement | Waarde | ||
| Identificatie | mbh_300_AfwijkendeToediening_MTD_normaal-mgb (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.18629005.1) | ||
| RegistratieDatumTijd | T - 1 dag om 11:00 uur | ||
| ToedieningsDatumTijd | T - 1 dag om 11:00 uur | ||
| ToegediendeHoeveelheid | |||
| Aantal | 2 | ||
| Eenheid | stuks (code = '245' in codeSystem 'G-Standaard thesaurus basiseenheden') | ||
| Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
| Toediener | |||
| Zorgverlener | Zie Zorgverlener: JANTIEN_TOEDIEN | ||
| Geneesmiddel - primaire code | AMLODIPINE PCH TABLET 5MG (ALS BESILAAT) (code = '2202182' in codeSystem 'G-Standaard HPK') | ||
| Geneesmiddel - generiekere code | AMLODIPINE TABLET 5MG (code = '123315' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | AMLODIPINE TABLET 5MG (code = '155616' in codeSystem 'G-Standaard GPK') | ||
| RelatieMedicatieafspraak | |||
| Identificatie | MBH_300_AfwijkendeToediening_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| RelatieToedieningsafspraak | |||
| Identificatie | MBH_300_AfwijkendeToediening_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
| MBH identificatie | mbh_300_AfwijkendeToediening-mgb (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
| Medicatietoediening mbh_300_AfwijkendeToediening_MTD_afwijkendeQty-mgb | |||
| Gegevenselement | Waarde | ||
| Identificatie | mbh_300_AfwijkendeToediening_MTD_afwijkendeQty-mgb (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.18629005.1) | ||
| RegistratieDatumTijd | T om 11:00 uur | ||
| ToedieningsDatumTijd | T om 11:00 uur | ||
| ToegediendeHoeveelheid | |||
| Aantal | 1 | ||
| Eenheid | stuks (code = '245' in codeSystem 'G-Standaard thesaurus basiseenheden') | ||
| Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
| Toediener | |||
| Zorgverlener | Zie Zorgverlener: JANTIEN_TOEDIEN | ||
| MedicatietoedieningRedenVanAfwijken | Overig (code = 'OTH' in codeSystem 'HL7 NullFlavor'): Tensie meting uitgevoerd. Uitslag: laag-normaal. Daarom 1 stuks toegediend i.p.v. 2. | ||
| Geneesmiddel - primaire code | AMLODIPINE PCH TABLET 5MG (ALS BESILAAT) (code = '2202182' in codeSystem 'G-Standaard HPK') | ||
| Geneesmiddel - generiekere code | AMLODIPINE TABLET 5MG (code = '123315' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | AMLODIPINE TABLET 5MG (code = '155616' in codeSystem 'G-Standaard GPK') | ||
| RelatieMedicatieafspraak | |||
| Identificatie | MBH_300_AfwijkendeToediening_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| RelatieToedieningsafspraak | |||
| Identificatie | MBH_300_AfwijkendeToediening_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
| MBH identificatie | mbh_300_AfwijkendeToediening-mgb (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
1.13.2 Bouwstenen
| Bouwstenen | ||||
| Gegevenselement | Waarde | |||
| Zorgverlener JANTIEN_TOEDIEN | ||||
| ZorgverlenerIdentificatienummer | 222220000 (in identificerend systeem: UZI Personen) | |||
| Naamgegevens | Jantien Toedien | |||
| Specialisme | Verpleegkundigen, niet nader gespecificeerd (code = '9100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') | |||
| Zorgaanbieder | ||||
| Zorgaanbieder | Zie Zorgaanbieder: THUISZORG_OM_EN_BIJ | |||
| Zorgaanbieder THUISZORG_OM_EN_BIJ | ||||
| ZorgaanbiederIdentificatienummer | 11110000 (in identificerend systeem: URA) | |||
| OrganisatieNaam | Thuiszorg Om en Bij | |||
| OrganisatieType | Thuiszorg (code = 'T2' in codeSystem 'HL7 RoleCodeNL Care provider type (organizations)') | |||
1.14 TEST Medicatiegegevens MTD Scenarioset 3
| Patiënt | ||||
| Gegevenselement | Waarde | |||
| Naamgegevens | ||||
| Initialen | C. | |||
| Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik') | |||
| Geslachtsnaam | ||||
| Achternaam | XXX_Dongen | |||
| Identificatienummer | 999900493 [BSN] | |||
| Geboortedatum | 23 okt 1963 | |||
| Geslacht | Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender') | |||
1.14.1 Scenario 3.13 - MBH_300_CorrectieToediening -mgb
| Medicatietoediening MBH_300_CorrectieToediening_MTD_normaal-mgb | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_CorrectieToediening_MTD_normaal-mgb (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.18629005.1) | ||
| RegistratieDatumTijd | T - 2 dagen om 13:45 uur | ||
| ToedieningsDatumTijd | T - 2 dagen om 13:45 uur | ||
| ToegediendeHoeveelheid | |||
| Aantal | 1 | ||
| Eenheid | stuks (code = '245' in codeSystem 'G-Standaard thesaurus basiseenheden') | ||
| Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
| Toediener | |||
| Zorgverlener | Zie Zorgverlener: JANTIEN_TOEDIEN | ||
| Geneesmiddel - primaire code | TRIMETHOPRIM CF TABLET 300MG (code = '1089838' in codeSystem 'G-Standaard HPK') | ||
| Geneesmiddel - generiekere code | TRIMETHOPRIM TABLET (code = '16020' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | TRIMETHOPRIM TABLET 300MG (code = '39136' in codeSystem 'G-Standaard GPK') | ||
| RelatieMedicatieafspraak | |||
| Identificatie | MBH_300_CorrectieToediening_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| RelatieToedieningsafspraak | |||
| Identificatie | MBH_300_CorrectieToediening_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
| MBH identificatie | MBH_300_CorrectieToediening -mgb (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
| Medicatietoediening MBH_300_CorrectieToediening_MTD_extraHoeveelheid-mgb | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_CorrectieToediening_MTD_extraHoeveelheid-mgb (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.18629005.1) | ||
| RegistratieDatumTijd | T - 2 dagen om 13:50 uur | ||
| ToedieningsDatumTijd | T - 2 dagen om 13:45 uur | ||
| ToegediendeHoeveelheid | |||
| Aantal | 2 | ||
| Eenheid | stuks (code = '245' in codeSystem 'G-Standaard thesaurus basiseenheden') | ||
| Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
| Toediener | |||
| Zorgverlener | Zie Zorgverlener: JANTIEN_TOEDIEN | ||
| Geneesmiddel - primaire code | TRIMETHOPRIM CF TABLET 300MG (code = '1089838' in codeSystem 'G-Standaard HPK') | ||
| Geneesmiddel - generiekere code | TRIMETHOPRIM TABLET (code = '16020' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | TRIMETHOPRIM TABLET 300MG (code = '39136' in codeSystem 'G-Standaard GPK') | ||
| RelatieMedicatieafspraak | |||
| Identificatie | MBH_300_CorrectieToediening_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| RelatieToedieningsafspraak | |||
| Identificatie | MBH_300_CorrectieToediening_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
| MBH identificatie | MBH_300_CorrectieToediening -mgb (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
1.14.2 Bouwstenen
| Bouwstenen | ||||
| Gegevenselement | Waarde | |||
| Zorgverlener JANTIEN_TOEDIEN | ||||
| ZorgverlenerIdentificatienummer | 222220000 (in identificerend systeem: UZI Personen) | |||
| Naamgegevens | Jantien Toedien | |||
| Specialisme | Verpleegkundigen, niet nader gespecificeerd (code = '9100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') | |||
| Zorgaanbieder | ||||
| Zorgaanbieder | Zie Zorgaanbieder: THUISZORG_OM_EN_BIJ | |||
| Zorgaanbieder THUISZORG_OM_EN_BIJ | ||||
| ZorgaanbiederIdentificatienummer | 11110000 (in identificerend systeem: URA) | |||
| OrganisatieNaam | Thuiszorg Om en Bij | |||
| OrganisatieType | Thuiszorg (code = 'T2' in codeSystem 'HL7 RoleCodeNL Care provider type (organizations)') | |||
1.15 TEST Medicatiegegevens MTD Scenarioset 3
| Patiënt | ||||
| Gegevenselement | Waarde | |||
| Naamgegevens | ||||
| Initialen | C. | |||
| Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik') | |||
| Geslachtsnaam | ||||
| Achternaam | XXX_Dongen | |||
| Identificatienummer | 999900493 [BSN] | |||
| Geboortedatum | 23 okt 1963 | |||
| Geslacht | Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender') | |||
1.15.1 Scenario 3.14 - MBH_300_CorrectieOpToediening-mgb
| Medicatietoediening MBH_300_CorrectieOpToediening_MTD_verkeerdeQty-mgb | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_CorrectieOpToediening_MTD_verkeerdeQty-mgb (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.18629005.1) | ||
| RegistratieDatumTijd | T - 3 dagen om 07:45 uur | ||
| ToedieningsDatumTijd | T - 3 dagen om 07:45 uur | ||
| ToegediendeHoeveelheid | |||
| Aantal | 1 | ||
| Eenheid | Stuk (code = '245' in codeSystem 'G-Standaard thesaurus basiseenheden') | ||
| Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
| Toediener | |||
| Zorgverlener | Zie Zorgverlener: TANJA_DE_BAKKER | ||
| Geneesmiddel - primaire code | PANTOZOL TABLET MSR 20MG (code = '1163094' in codeSystem 'G-Standaard HPK') | ||
| Geneesmiddel - generiekere code | PANTOPRAZOL TABLET MSR 20MG (code = '52272' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | PANTOPRAZOL TABLET MSR 20MG (code = '106275' in codeSystem 'G-Standaard GPK') | ||
| RelatieMedicatieafspraak | |||
| Identificatie | MBH_300_CorrectieOpToediening_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| RelatieToedieningsafspraak | |||
| Identificatie | MBH_300_CorrectieOpToediening_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
| MBH identificatie | MBH_300_CorrectieOpToediening-mgb (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
| Medicatietoediening MBH_300_CorrectieOpToediening_correctie_MTD-mgb | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_CorrectieOpToediening_correctie_MTD-mgb (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.18629005.1) | ||
| RegistratieDatumTijd | T - 3 dagen om 07:48 uur | ||
| ToedieningsDatumTijd | T - 3 dagen om 07:48 uur | ||
| ToegediendeHoeveelheid | |||
| Aantal | -1 | ||
| Eenheid | Stuk (code = '245' in codeSystem 'G-Standaard thesaurus basiseenheden') | ||
| Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
| Toediener | |||
| Zorgverlener | Zie Zorgverlener: TANJA_DE_BAKKER | ||
| MedicatietoedieningRedenVanAfwijken | foutieve registratie van medicatie (code = '159691000146109' in codeSystem 'SNOMED CT') | ||
| Geneesmiddel - primaire code | PANTOZOL TABLET MSR 20MG (code = '1163094' in codeSystem 'G-Standaard HPK') | ||
| Geneesmiddel - generiekere code | PANTOPRAZOL TABLET MSR 20MG (code = '52272' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | PANTOPRAZOL TABLET MSR 20MG (code = '106275' in codeSystem 'G-Standaard GPK') | ||
| RelatieMedicatieafspraak | |||
| Identificatie | MBH_300_CorrectieOpToediening_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| RelatieToedieningsafspraak | |||
| Identificatie | MBH_300_CorrectieOpToediening_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
| MBH identificatie | MBH_300_CorrectieOpToediening-mgb (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
| Medicatietoediening MBH_300_CorrectieOpToediening_CorrecteHoeveelheid_MTD-mgb | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_CorrectieOpToediening_CorrecteHoeveelheid_MTD-mgb (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.18629005.1) | ||
| RegistratieDatumTijd | T - 3 dagen om 07:49 uur | ||
| ToedieningsDatumTijd | T - 3 dagen om 07:49 uur | ||
| ToegediendeHoeveelheid | |||
| Aantal | 2 | ||
| Eenheid | Stuks (code = '245' in codeSystem 'G-Standaard thesaurus basiseenheden') | ||
| Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
| Toediener | |||
| Zorgverlener | Zie Zorgverlener: TANJA_DE_BAKKER | ||
| Geneesmiddel - primaire code | PANTOZOL TABLET MSR 20MG (code = '1163094' in codeSystem 'G-Standaard HPK') | ||
| Geneesmiddel - generiekere code | PANTOPRAZOL TABLET MSR 20MG (code = '52272' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | PANTOPRAZOL TABLET MSR 20MG (code = '106275' in codeSystem 'G-Standaard GPK') | ||
| Toelichting | Correctie op verkeerd geregistreerde hoeveelheid | ||
| RelatieMedicatieafspraak | |||
| Identificatie | MBH_300_CorrectieOpToediening_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| RelatieToedieningsafspraak | |||
| Identificatie | MBH_300_CorrectieOpToediening_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
| MBH identificatie | MBH_300_CorrectieOpToediening-mgb (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
1.15.2 Bouwstenen
| Bouwstenen | ||||
| Gegevenselement | Waarde | |||
| Zorgverlener TANJA_DE_BAKKER | ||||
| ZorgverlenerIdentificatienummer | 222221111 (in identificerend systeem: UZI Personen) | |||
| Naamgegevens | Tanja de Bakker | |||
| Specialisme | Trombosediensten (code = '3400' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') | |||
| Zorgaanbieder | ||||
| Zorgaanbieder | Zie Zorgaanbieder: TROMBOSEDIENST_ONS_DORP | |||
| Zorgaanbieder TROMBOSEDIENST_ONS_DORP | ||||
| ZorgaanbiederIdentificatienummer | 11112222 (in identificerend systeem: URA) | |||
| OrganisatieNaam | Trombosedienst Ons Dorp | |||
| AfdelingSpecialisme | Trombosediensten (code = '3400' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') | |||
| Adresgegevens | Werkadres: Kerkstraat 28 d 1332GH Ons Dorp | |||
1.16 TEST Medicatiegegevens MTD Scenarioset 6
| Patiënt | ||||
| Gegevenselement | Waarde | |||
| Naamgegevens | ||||
| Initialen | M | |||
| Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik') | |||
| Geslachtsnaam | ||||
| Achternaam | XXX_Rambaldo | |||
| Identificatienummer | 999900936 [BSN] | |||
| Geboortedatum | 7 nov 1985 | |||
| Geslacht | Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender') | |||
1.16.1 Scenario 6.13 - MBH_300_toedieningssnelheid-mgb
| Medicatietoediening MBH_300_toedieningssnelheid_MTD-mgb | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_toedieningssnelheid_MTD-mgb (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.18629005.1) | |||
| RegistratieDatumTijd | T om 11:49:39 uur | |||
| ToedieningsDatumTijd | T om 11:49:39 uur | |||
| ToegediendeHoeveelheid | ||||
| Aantal | 100 | |||
| Eenheid | milliliter (code = '233' in codeSystem 'G-Standaard thesaurus basiseenheden') | |||
| Toedieningsweg | intraveneus (code = '5' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
| Toedieningssnelheid | ||||
| nominaleWaarde | 0.3 ml/h | |||
| PrikPlakLocatie | ||||
| AnatomischeLocatie | ||||
| Locatie | structuur van huid van anterieur oppervlak van bovenarm (code = '45981001' in codeSystem 'SNOMED CT') | |||
| Lateraliteit | links (code = '7771000' in codeSystem 'SNOMED CT') | |||
| Toediener | ||||
| Zorgverlener | Zie Zorgverlener: PETER_VAN_PULVER | |||
| Geneesmiddel - primaire code | MORFINE HCL 3WATER INFVLST 5MG/ML CASS 100ML AHZ (code = '2554771' in codeSystem 'G-Standaard HPK') | |||
| Geneesmiddel - generiekere code | MORFINE INFVLST 5MG/ML CAS 100ML (code = '94692' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | MORFINE INFVLST 5MG/ML CAS 100ML (code = '134538' in codeSystem 'G-Standaard GPK') | |||
| RelatieMedicatieafspraak | ||||
| Identificatie | MBH_300_toedieningssnelheid_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
| RelatieToedieningsafspraak | ||||
| Identificatie | MBH_300_toedieningssnelheid_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
| MBH identificatie | MBH_300_toedieningssnelheid-mgb (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
1.16.2 Bouwstenen
| Bouwstenen | ||||
| Gegevenselement | Waarde | |||
| Zorgverlener PETER_VAN_PULVER | ||||
| ZorgverlenerIdentificatienummer | 000001111 (in identificerend systeem: UZI Personen) | |||
| Naamgegevens | Peter van Pulver | |||
| Specialisme | Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') | |||
| Zorgaanbieder | ||||
| Zorgaanbieder | Zie Zorgaanbieder: HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS | |||
| Zorgaanbieder HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS | ||||
| ZorgaanbiederIdentificatienummer | 00001111 (in identificerend systeem: URA) | |||
| OrganisatieNaam | Huisartsenpraktijk Pulver & Partners | |||
| Adresgegevens | Werkadres: Dorpsstraat 1 1234AA Ons Dorp | |||
1.17 TEST Medicatiegegevens MTD Scenarioset 6
| Patiënt | ||||
| Gegevenselement | Waarde | |||
| Naamgegevens | ||||
| Initialen | M | |||
| Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik') | |||
| Geslachtsnaam | ||||
| Achternaam | XXX_Rambaldo | |||
| Identificatienummer | 999900936 [BSN] | |||
| Geboortedatum | 7 nov 1985 | |||
| Geslacht | Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender') | |||
1.17.1 Scenario 6.14 - MBH_300_toedieningsduur-mgb
| Medicatietoediening MBH_300_toedieningsduur_MTD-mgb | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_toedieningsduur_MTD-mgb (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.18629005.1) | |||
| RegistratieDatumTijd | T + 8 dagen om 08:59:59 uur | |||
| ToedieningsDatumTijd | T + 8 dagen om 08:59:59 uur | |||
| ToegediendeHoeveelheid | ||||
| Aantal | 1 | |||
| Eenheid | stuk (code = '245' in codeSystem 'G-Standaard thesaurus basiseenheden') | |||
| Toedieningsweg | transdermaal (code = '58' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
| PrikPlakLocatie | ||||
| AnatomischeLocatie | ||||
| Locatie | structuur van huid van rechter bovenkwadrant van voorzijde van thorax (code = '160561000146104' in codeSystem 'SNOMED CT') | |||
| Toediener | ||||
| Zorgverlener | Zie Zorgverlener: PETER_VAN_PULVER | |||
| Geneesmiddel - primaire code | DEPONIT T 5 PLEISTER TRANSDERMAAL 18,7MG (code = '1013602' in codeSystem 'G-Standaard HPK') | |||
| Geneesmiddel - generiekere code | NITROGLYCERINE PLEISTER 5MG/24UUR (DEPONIT T) (code = '228427' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | NITROGLYCERINE PLEISTER 5MG/24UUR (DEPONIT T) (code = '196738' in codeSystem 'G-Standaard GPK') | |||
| RelatieMedicatieafspraak | ||||
| Identificatie | MBH_300_toedieningsduur_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
| RelatieToedieningsafspraak | ||||
| Identificatie | MBH_300_toedieningsduur_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
| MBH identificatie | MBH_300_toedieningsduur-mgb (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
1.17.2 Bouwstenen
| Bouwstenen | ||||
| Gegevenselement | Waarde | |||
| Zorgverlener PETER_VAN_PULVER | ||||
| ZorgverlenerIdentificatienummer | 000001111 (in identificerend systeem: UZI Personen) | |||
| Naamgegevens | Peter van Pulver | |||
| Specialisme | Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') | |||
| Zorgaanbieder | ||||
| Zorgaanbieder | Zie Zorgaanbieder: HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS | |||
| Zorgaanbieder HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS | ||||
| ZorgaanbiederIdentificatienummer | 00001111 (in identificerend systeem: URA) | |||
| OrganisatieNaam | Huisartsenpraktijk Pulver & Partners | |||
| Adresgegevens | Werkadres: Dorpsstraat 1 1234AA Ons Dorp | |||
1.18 TEST Medicatiegegevens MTD Scenarioset 7
| Patiënt | ||||
| Gegevenselement | Waarde | |||
| Naamgegevens | ||||
| Initialen | M. | |||
| Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik') | |||
| Geslachtsnaam | ||||
| Voorvoegsels | van de | |||
| Achternaam | XXX_Rambaran Mishre | |||
| Identificatienummer | 999900948 [BSN] | |||
| Geboortedatum | 8 nov 1985 | |||
| Geslacht | Man (code = 'M' in codeSystem 'HL7 AdministrativeGender') | |||
1.18.1 Scenario 7.1 - MBH_300_magistraalalleingredienten-mgb
| Medicatietoediening MBH_300_magistraalalleingredienten_MTD-mgb | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_magistraalalleingredienten_MTD-mgb (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.18629005.1) | |||
| RegistratieDatumTijd | T - 1 dag om 14:00 uur | |||
| ToedieningsDatumTijd | T - 1 dag om 14:00 uur | |||
| ToegediendeHoeveelheid | ||||
| Aantal | 1 | |||
| Eenheid | gram (code = '215' in codeSystem 'G-Standaard thesaurus basiseenheden') | |||
| Toedieningsweg | cutaan (code = '53' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
| Toediener | ||||
| Zorgverlener | Zie Zorgverlener: JANTIEN_TOEDIEN | |||
| Geneesmiddel - ProductSpecificatie | ||||
| ProductNaam | Ureum 10% in eucerine cum aqua 100gr | |||
| Omschrijving | Titel: Ureum 10% in eucerine cum aqua 100gr Regel: UREUM 10gr Regel: EUCERINE MET WATER FAGRON ad 100gr | |||
| Ingredient | ||||
| IngredientCode | UREUM ZALF 10% FAGRON (code = '1042467' in codeSystem 'G-Standaard HPK') | |||
| Sterkte | 10 gram per 100 gram | |||
| Ingredient | ||||
| IngredientCode | EUCERINE MET WATER FAGRON (code = '1516981' in codeSystem 'G-Standaard HPK') | |||
| Sterkte | 90 gram per 100 gram | |||
| RelatieMedicatieafspraak | ||||
| Identificatie | MBH_300_magistraalalleingredienten_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
| RelatieToedieningsafspraak | ||||
| Identificatie | MBH_300_magistraalalleingredienten_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
| MBH identificatie | MBH_300_magistraalalleingredienten-mgb (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
1.18.2 Bouwstenen
| Bouwstenen | ||||
| Gegevenselement | Waarde | |||
| Zorgverlener JANTIEN_TOEDIEN | ||||
| ZorgverlenerIdentificatienummer | 222220000 (in identificerend systeem: UZI Personen) | |||
| Naamgegevens | Jantien Toedien | |||
| Specialisme | Verpleegkundigen, niet nader gespecificeerd (code = '9100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') | |||
| Zorgaanbieder | ||||
| Zorgaanbieder | Zie Zorgaanbieder: THUISZORG_OM_EN_BIJ | |||
| Zorgaanbieder THUISZORG_OM_EN_BIJ | ||||
| ZorgaanbiederIdentificatienummer | 11110000 (in identificerend systeem: URA) | |||
| OrganisatieNaam | Thuiszorg Om en Bij | |||
| OrganisatieType | Thuiszorg (code = 'T2' in codeSystem 'HL7 RoleCodeNL Care provider type (organizations)') | |||
1.19 TEST Medicatiegegevens MTD Scenarioset 7
| Patiënt | ||||
| Gegevenselement | Waarde | |||
| Naamgegevens | ||||
| Initialen | M. | |||
| Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik') | |||
| Geslachtsnaam | ||||
| Voorvoegsels | van de | |||
| Achternaam | XXX_Rambaran Mishre | |||
| Identificatienummer | 999900948 [BSN] | |||
| Geboortedatum | 8 nov 1985 | |||
| Geslacht | Man (code = 'M' in codeSystem 'HL7 AdministrativeGender') | |||
1.19.1 Scenario 7.2 - MBH_300_magistraalactieveingredient-mgb
| Medicatietoediening MBH_300_magistraalactieveingredient_MTD-mgb | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_magistraalactieveingredient_MTD-mgb (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.18629005.1) | |||
| RegistratieDatumTijd | T - 1 dag om 12:00 uur | |||
| ToedieningsDatumTijd | T - 1 dag om 12:00 uur | |||
| ToegediendeHoeveelheid | ||||
| Aantal | 1 | |||
| Eenheid | gram (code = '215' in codeSystem 'G-Standaard thesaurus basiseenheden') | |||
| Toedieningsweg | cutaan (code = '53' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
| Toediener | ||||
| Zorgverlener | Zie Zorgverlener: JANTIEN_TOEDIEN | |||
| Geneesmiddel - ProductSpecificatie | ||||
| ProductNaam | Vaseline 20% in cetomacrogolcrème FNA | |||
| Omschrijving | Titel: Vaseline 20% in cetomacrogolcrème FNA Regel 1: cetomacrogolcreme 80 gr | |||
| Ingredient | ||||
| IngredientCode | CETOMACROGOLCREME FNA (code = '457590' in codeSystem 'G-Standaard HPK') | |||
| Sterkte | 80 gram per 100 gram | |||
| RelatieMedicatieafspraak | ||||
| Identificatie | MBH_300_magistraalactieveingredient_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
| RelatieToedieningsafspraak | ||||
| Identificatie | MBH_300_magistraalactieveingredient_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
| MBH identificatie | MBH_300_magistraalactieveingredient-mgb (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
1.19.2 Bouwstenen
| Bouwstenen | ||||
| Gegevenselement | Waarde | |||
| Zorgverlener JANTIEN_TOEDIEN | ||||
| ZorgverlenerIdentificatienummer | 222220000 (in identificerend systeem: UZI Personen) | |||
| Naamgegevens | Jantien Toedien | |||
| Specialisme | Verpleegkundigen, niet nader gespecificeerd (code = '9100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') | |||
| Zorgaanbieder | ||||
| Zorgaanbieder | Zie Zorgaanbieder: THUISZORG_OM_EN_BIJ | |||
| Zorgaanbieder THUISZORG_OM_EN_BIJ | ||||
| ZorgaanbiederIdentificatienummer | 11110000 (in identificerend systeem: URA) | |||
| OrganisatieNaam | Thuiszorg Om en Bij | |||
| OrganisatieType | Thuiszorg (code = 'T2' in codeSystem 'HL7 RoleCodeNL Care provider type (organizations)') | |||
1.20 TEST Medicatiegegevens MTD Scenarioset 7
| Patiënt | ||||
| Gegevenselement | Waarde | |||
| Naamgegevens | ||||
| Initialen | M. | |||
| Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik') | |||
| Geslachtsnaam | ||||
| Voorvoegsels | van de | |||
| Achternaam | XXX_Rambaran Mishre | |||
| Identificatienummer | 999900948 [BSN] | |||
| Geboortedatum | 8 nov 1985 | |||
| Geslacht | Man (code = 'M' in codeSystem 'HL7 AdministrativeGender') | |||
1.20.1 Scenario 7.3 - MBH_300_magistraal90miljoennr-mgb
| Medicatietoediening MBH_300_magistraal90miljoennr_MTD-mgb | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_magistraal90miljoennr_MTD-mgb (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.18629005.1) | |||
| RegistratieDatumTijd | T - 2 dagen om 13:00 uur | |||
| ToedieningsDatumTijd | T - 2 dagen om 13:00 uur | |||
| ToegediendeHoeveelheid | ||||
| Aantal | 1 | |||
| Eenheid | gram (code = '215' in codeSystem 'G-Standaard thesaurus basiseenheden') | |||
| Toedieningsweg | cutaan (code = '53' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
| Toediener | ||||
| Zorgverlener | Zie Zorgverlener: JANTIEN_TOEDIEN | |||
| Geneesmiddel - ProductSpecificatie | ||||
| ProductCode | Eigen artikel: ureumzalf (code = '90000001' in codeSystem '2.16.840.1.113883.2.4.3.11.999.77.90000000.1.1111') | |||
| ProductNaam | Ureum 10% in eucerine cum aqua 100gr | |||
| Omschrijving | Titel: Ureum 10% in eucerine cum aqua 100gr Regel: UREUM 10gr Regel: EUCERINE MET WATER FAGRON ad 100gr | |||
| Ingredient | ||||
| IngredientCode | UREUM ZALF 10% FAGRON (code = '1042467' in codeSystem 'G-Standaard HPK') | |||
| Sterkte | 10 gram per 100 gram | |||
| RelatieMedicatieafspraak | ||||
| Identificatie | MBH_300_magistraal90miljoennr_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
| RelatieToedieningsafspraak | ||||
| Identificatie | MBH_300_magistraal90miljoennr_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
| MBH identificatie | MBH_300_magistraal90miljoennr-mgb (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
1.20.2 Bouwstenen
| Bouwstenen | ||||
| Gegevenselement | Waarde | |||
| Zorgverlener JANTIEN_TOEDIEN | ||||
| ZorgverlenerIdentificatienummer | 222220000 (in identificerend systeem: UZI Personen) | |||
| Naamgegevens | Jantien Toedien | |||
| Specialisme | Verpleegkundigen, niet nader gespecificeerd (code = '9100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') | |||
| Zorgaanbieder | ||||
| Zorgaanbieder | Zie Zorgaanbieder: THUISZORG_OM_EN_BIJ | |||
| Zorgaanbieder THUISZORG_OM_EN_BIJ | ||||
| ZorgaanbiederIdentificatienummer | 11110000 (in identificerend systeem: URA) | |||
| OrganisatieNaam | Thuiszorg Om en Bij | |||
| OrganisatieType | Thuiszorg (code = 'T2' in codeSystem 'HL7 RoleCodeNL Care provider type (organizations)') | |||
1.21 TEST Medicatiegegevens MTD Scenarioset 7
| Patiënt | ||||
| Gegevenselement | Waarde | |||
| Naamgegevens | ||||
| Initialen | M. | |||
| Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik') | |||
| Geslachtsnaam | ||||
| Voorvoegsels | van de | |||
| Achternaam | XXX_Rambaran Mishre | |||
| Identificatienummer | 999900948 [BSN] | |||
| Geboortedatum | 8 nov 1985 | |||
| Geslacht | Man (code = 'M' in codeSystem 'HL7 AdministrativeGender') | |||
1.21.1 Scenario 7.4 - MBH_300_vrijetekstproduct-mgb
| Medicatietoediening MBH_300_vrijetekstproduct_MTD-mgb | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_vrijetekstproduct_MTD-mgb (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.18629005.1) | ||
| RegistratieDatumTijd | T - 1 dag om 19:35 uur | ||
| ToedieningsDatumTijd | T - 1 dag om 19:25 uur | ||
| ToegediendeHoeveelheid | |||
| Aantal | 1 | ||
| Eenheid | stuks (code = '245' in codeSystem 'G-Standaard thesaurus basiseenheden') | ||
| Toedieningsweg | Intraveneus (code = '5' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
| Toediener | |||
| Zorgverlener | Zie Zorgverlener: PETER_VAN_PULVER | ||
| Geneesmiddel - ProductSpecificatie | |||
| ProductNaam | Jemperli 500 mg/ 10 mL | ||
| Omschrijving | Titel: Jemperli (Dostarlimab-gxly) 500 mg/10 mL | ||
| RelatieMedicatieafspraak | |||
| Identificatie | MBH_300_vrijetekstproduct_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| RelatieToedieningsafspraak | |||
| Identificatie | MBH_300_vrijetekstproduct_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
| MBH identificatie | MBH_300_vrijetekstproduct-mgb (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
1.21.2 Bouwstenen
| Bouwstenen | ||||
| Gegevenselement | Waarde | |||
| Zorgverlener PETER_VAN_PULVER | ||||
| ZorgverlenerIdentificatienummer | 000001111 (in identificerend systeem: UZI Personen) | |||
| Naamgegevens | Peter van Pulver | |||
| Specialisme | Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') | |||
| Zorgaanbieder | ||||
| Zorgaanbieder | Zie Zorgaanbieder: HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS | |||
| Zorgaanbieder HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS | ||||
| ZorgaanbiederIdentificatienummer | 00001111 (in identificerend systeem: URA) | |||
| OrganisatieNaam | Huisartsenpraktijk Pulver & Partners | |||
| Adresgegevens | Werkadres: Dorpsstraat 1 1234AA Ons Dorp | |||
1.22 TEST Medicatiegegevens MTD Scenarioset 10
| Patiënt | ||||
| Gegevenselement | Waarde | |||
| Naamgegevens | ||||
| Initialen | J. | |||
| Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik') | |||
| Geslachtsnaam | ||||
| Achternaam | XXX_Bree | |||
| Identificatienummer | 999901588 [BSN] | |||
| Geboortedatum | 1 jul 2010 | |||
| Geslacht | Man (code = 'M' in codeSystem 'HL7 AdministrativeGender') | |||
1.22.1 Scenario 10.1 - MBH_300_ZINRvoorschrijven-mgb
| Medicatietoediening MBH_300_ZINRvoorschrijven_MTD-mgb | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_ZINRvoorschrijven_MTD-mgb (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.18629005.1) | ||
| RegistratieDatumTijd | T om 15:36 uur | ||
| ToedieningsDatumTijd | T om 15:36 uur | ||
| ToegediendeHoeveelheid | |||
| Aantal | 1 | ||
| Eenheid | stuk (code = '245' in codeSystem 'G-Standaard thesaurus basiseenheden') | ||
| Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
| Toediener | |||
| Zorgverlener | Zie Zorgverlener: JANTIEN_TOEDIEN | ||
| Geneesmiddel - primaire code | INDAPAMIDE CF TABLET OMHULD 2,5MG (code = '16255429' in codeSystem 'G-Standaard ZI-nr') | ||
| Geneesmiddel - generiekere code | INDAPAMIDE CF TABLET OMHULD 2,5MG (code = '2593866' in codeSystem 'G-Standaard HPK') | ||
| Geneesmiddel - generiekere code | INDAPAMIDE 2,5MG TABLET (code = '2941' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | INDAPAMIDE 2,5MG TABLET (code = '83593' in codeSystem 'G-Standaard GPK') | ||
| RelatieMedicatieafspraak | |||
| Identificatie | MBH_300_ZINRvoorschrijven_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| RelatieToedieningsafspraak | |||
| Identificatie | MBH_300_ZINRvoorschrijven_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
| MBH identificatie | MBH_300_ZINRvoorschrijven-mgb (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
1.22.2 Bouwstenen
| Bouwstenen | ||||
| Gegevenselement | Waarde | |||
| Zorgverlener JANTIEN_TOEDIEN | ||||
| ZorgverlenerIdentificatienummer | 222220000 (in identificerend systeem: UZI Personen) | |||
| Naamgegevens | Jantien Toedien | |||
| Specialisme | Verpleegkundigen, niet nader gespecificeerd (code = '9100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') | |||
| Zorgaanbieder | ||||
| Zorgaanbieder | Zie Zorgaanbieder: THUISZORG_OM_EN_BIJ | |||
| Zorgaanbieder THUISZORG_OM_EN_BIJ | ||||
| ZorgaanbiederIdentificatienummer | 11110000 (in identificerend systeem: URA) | |||
| OrganisatieNaam | Thuiszorg Om en Bij | |||
| OrganisatieType | Thuiszorg (code = 'T2' in codeSystem 'HL7 RoleCodeNL Care provider type (organizations)') | |||
1.23 TEST Medicatiegegevens MTD Scenarioset 11
| Patiënt | ||||
| Gegevenselement | Waarde | |||
| Naamgegevens | ||||
| Initialen | M. | |||
| Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik') | |||
| Geslachtsnaam | ||||
| Voorvoegsels | van de | |||
| Achternaam | XXX_Roelofs | |||
| Identificatienummer | 999900973 [BSN] | |||
| Geboortedatum | 10 nov 1985 | |||
| Geslacht | Man (code = 'M' in codeSystem 'HL7 AdministrativeGender') | |||
1.23.1 Scenario 11.1 - MBH_300_wdsmtd1-mgb
| Medicatietoediening MBH_300_wdsmtd1_MTD-mgb | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_wdsmtd1_MTD-mgb (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.18629005.1) | ||
| RegistratieDatumTijd | T - 20 dagen om 20:30 uur | ||
| ToedieningsDatumTijd | T - 20 dagen om 20:30 uur | ||
| ToegediendeHoeveelheid | |||
| Aantal | 2 | ||
| Eenheid | stuks (code = '245' in codeSystem 'G-Standaard thesaurus basiseenheden') | ||
| Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
| Toediener | |||
| Zorgverlener | Zie Zorgverlener: PETER_VAN_PULVER | ||
| Geneesmiddel - primaire code | ACENOCOUMAROL CF TABLET 1MG (code = '856126' in codeSystem 'G-Standaard HPK') | ||
| Geneesmiddel - generiekere code | ACENOCOUMAROL TABLET 1MG (code = '7323' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | ACENOCOUMAROL TABLET 1MG (code = '20303' in codeSystem 'G-Standaard GPK') | ||
| RelatieMedicatieafspraak | |||
| Identificatie | MBH_300_wdsmtd1_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| RelatieToedieningsafspraak | |||
| Identificatie | MBH_300_wdsmtd1_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
| RelatieWisselendDoseerschema | |||
| Identificatie | MBH_300_wdsmtd1_WDS_opstartschema (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.632.1) | ||
| MBH identificatie | MBH_300_wdsmtd1-mgb (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
1.23.2 Bouwstenen
| Bouwstenen | ||||
| Gegevenselement | Waarde | |||
| Zorgverlener PETER_VAN_PULVER | ||||
| ZorgverlenerIdentificatienummer | 000001111 (in identificerend systeem: UZI Personen) | |||
| Naamgegevens | Peter van Pulver | |||
| Specialisme | Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') | |||
| Zorgaanbieder | ||||
| Zorgaanbieder | Zie Zorgaanbieder: HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS | |||
| Zorgaanbieder HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS | ||||
| ZorgaanbiederIdentificatienummer | 00001111 (in identificerend systeem: URA) | |||
| OrganisatieNaam | Huisartsenpraktijk Pulver & Partners | |||
| Adresgegevens | Werkadres: Dorpsstraat 1 1234AA Ons Dorp | |||
1.24 TEST Medicatiegegevens MTD Scenarioset 13
| Patiënt | ||||
| Gegevenselement | Waarde | |||
| Naamgegevens | ||||
| Initialen | R. | |||
| Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik') | |||
| Geslachtsnaam | ||||
| Achternaam | XXX_Smitsz | |||
| Identificatienummer | 999901072 [BSN] | |||
| Geboortedatum | 19 nov 1985 | |||
| Geslacht | Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender') | |||
1.24.1 Scenario 13.4 - MBH_300_contactepisode-mgb
| Medicatietoediening MBH_300_contactepisode_MTD1-mgb | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_contactepisode_MTD1-mgb (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.18629005.1) | ||
| RegistratieDatumTijd | T - 20 dagen om 20:30 uur | ||
| ToedieningsDatumTijd | T - 20 dagen om 20:30 uur | ||
| ToegediendeHoeveelheid | |||
| Aantal | 2 | ||
| Eenheid | stuk (code = '245' in codeSystem 'G-Standaard thesaurus basiseenheden') | ||
| Toedieningsweg | ORAAL (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
| Toediener | |||
| Zorgverlener | Zie Zorgverlener: PETER_VAN_PULVER | ||
| Geneesmiddel - primaire code | ACENOCOUMAROL CF TABLET 1MG (code = '856126' in codeSystem 'G-Standaard HPK') | ||
| Geneesmiddel - generiekere code | ACENOCOUMAROL TABLET 1MG (code = '7323' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | ACENOCOUMAROL TABLET 1MG (code = '20303' in codeSystem 'G-Standaard GPK') | ||
| RelatieMedicatieafspraak | |||
| Identificatie | MBH_300_contactepisode_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| RelatieWisselendDoseerschema | |||
| Identificatie | MBH_300_QA1_WDS1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.632.1) | ||
| RelatieContact | |||
| Identificatienummer | MBH_300_contactepisode_CONTACT2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.66.2709) | ||
| RelatieZorgepisode | |||
| Identificatienummer | MBH_300_contactepisode_EPISODE1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.66.9200) | ||
| MBH identificatie | MBH_300_contactepisode-mgb (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
1.24.2 Bouwstenen
| Bouwstenen | ||||
| Gegevenselement | Waarde | |||
| Zorgverlener PETER_VAN_PULVER | ||||
| ZorgverlenerIdentificatienummer | 000001111 (in identificerend systeem: UZI Personen) | |||
| Naamgegevens | Peter van Pulver | |||
| Specialisme | Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') | |||
| Zorgaanbieder | ||||
| Zorgaanbieder | Zie Zorgaanbieder: HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS | |||
| Zorgaanbieder HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS | ||||
| ZorgaanbiederIdentificatienummer | 00001111 (in identificerend systeem: URA) | |||
| OrganisatieNaam | Huisartsenpraktijk Pulver & Partners | |||
| Adresgegevens | Werkadres: Dorpsstraat 1 1234AA Ons Dorp | |||
1.25 TEST Medicatiegegevens MTD Scenarioset 16
| Patiënt | ||||
| Gegevenselement | Waarde | |||
| Naamgegevens | ||||
| Voornamen | J | |||
| Geslachtsnaam | ||||
| Achternaam | XXX_Valkenet | |||
| Adresgegevens | Knolweg 1000 9999XA STITSWERD 3 Woon-/verblijfadres | |||
| Identificatienummer | 999911089 [BSN] | |||
| Geboortedatum | 25 jul 1964 | |||
| Geslacht | Man (code = 'M' in codeSystem 'HL7 AdministrativeGender') | |||
1.25.1 Scenario 16.1 - MBH_300_redenvanafwijken-mgb
| Medicatietoediening MBH_300_redenvanafwijken_MTD-mgb | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_redenvanafwijken_MTD-mgb (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.18629005.1) | ||
| RegistratieDatumTijd | T - 28 dagen om 13:04:22 uur | ||
| ToedieningsDatumTijd | T - 28 dagen om 13:04:22 uur | ||
| ToegediendeHoeveelheid | |||
| Aantal | 0 | ||
| Eenheid | stuk (code = '245' in codeSystem 'G-Standaard thesaurus basiseenheden') | ||
| Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
| Toediener | |||
| Zorgverlener | Zie Zorgverlener: JANTIEN_TOEDIEN | ||
| MedicatietoedieningRedenVanAfwijken | niet in staat om medicatie te gebruiken (code = '408366001' in codeSystem 'SNOMED CT') | ||
| Geneesmiddel - primaire code | OXAZEPAM ACTAVIS TABLET 10MG (code = '613401' in codeSystem 'G-Standaard HPK') | ||
| Geneesmiddel - generiekere code | OXAZEPAM TABLET 10MG (code = '353' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | OXAZEPAM TABLET 10MG (code = '1023' in codeSystem 'G-Standaard GPK') | ||
| RelatieMedicatieafspraak | |||
| Identificatie | MBH_300_redenvanafwijken_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| RelatieToedieningsafspraak | |||
| Identificatie | MBH_300_redenvanafwijken_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
| MBH identificatie | MBH_300_redenvanafwijken-mgb (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
1.25.2 Bouwstenen
| Bouwstenen | ||||
| Gegevenselement | Waarde | |||
| Zorgverlener JANTIEN_TOEDIEN | ||||
| ZorgverlenerIdentificatienummer | 222220000 (in identificerend systeem: UZI Personen) | |||
| Naamgegevens | Jantien Toedien | |||
| Specialisme | Verpleegkundigen, niet nader gespecificeerd (code = '9100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') | |||
| Zorgaanbieder | ||||
| Zorgaanbieder | Zie Zorgaanbieder: THUISZORG_OM_EN_BIJ | |||
| Zorgaanbieder THUISZORG_OM_EN_BIJ | ||||
| ZorgaanbiederIdentificatienummer | 11110000 (in identificerend systeem: URA) | |||
| OrganisatieNaam | Thuiszorg Om en Bij | |||
| OrganisatieType | Thuiszorg (code = 'T2' in codeSystem 'HL7 RoleCodeNL Care provider type (organizations)') | |||
1.26 TEST Medicatiegegevens MTD Scenarioset 16
| Patiënt | ||||
| Gegevenselement | Waarde | |||
| Naamgegevens | ||||
| Voornamen | J | |||
| Geslachtsnaam | ||||
| Achternaam | XXX_Valkenet | |||
| Adresgegevens | Knolweg 1000 9999XA STITSWERD 3 Woon-/verblijfadres | |||
| Identificatienummer | 999911089 [BSN] | |||
| Geboortedatum | 25 jul 1964 | |||
| Geslacht | Man (code = 'M' in codeSystem 'HL7 AdministrativeGender') | |||
1.26.1 Scenario 16.2 - MBH_300_adhoctoediening-mgb
| Medicatietoediening MBH_300_adhoctoediening_MTD-mgb | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_adhoctoediening_MTD-mgb (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.18629005.1) | ||
| RegistratieDatumTijd | T - 5 dagen om 13:05:33 uur | ||
| ToedieningsDatumTijd | T - 5 dagen om 13:05:33 uur | ||
| ToegediendeHoeveelheid | |||
| Aantal | 1 | ||
| Eenheid | stuk (code = '245' in codeSystem 'G-Standaard thesaurus basiseenheden') | ||
| Toedieningsweg | Intramusculair (code = '2' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
| Toediener | |||
| Zorgverlener | Zie Zorgverlener: JANTIEN_TOEDIEN | ||
| Geneesmiddel - primaire code | EPIPEN INJVLST 1MG/ML PEN 0,3ML (code = '786993' in codeSystem 'G-Standaard HPK') | ||
| Geneesmiddel - generiekere code | ADRENALINE INJVLST PEN 0,3MG=0,3ML (1MG/ML) (code = '145262' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | ADRENALINE INJVLST 1MG/ML (code = '170925' in codeSystem 'G-Standaard GPK') | ||
| MBH identificatie | MBH_300_adhoctoediening-mgb (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
1.26.2 Bouwstenen
| Bouwstenen | ||||
| Gegevenselement | Waarde | |||
| Zorgverlener JANTIEN_TOEDIEN | ||||
| ZorgverlenerIdentificatienummer | 222220000 (in identificerend systeem: UZI Personen) | |||
| Naamgegevens | Jantien Toedien | |||
| Specialisme | Verpleegkundigen, niet nader gespecificeerd (code = '9100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') | |||
| Zorgaanbieder | ||||
| Zorgaanbieder | Zie Zorgaanbieder: THUISZORG_OM_EN_BIJ | |||
| Zorgaanbieder THUISZORG_OM_EN_BIJ | ||||
| ZorgaanbiederIdentificatienummer | 11110000 (in identificerend systeem: URA) | |||
| OrganisatieNaam | Thuiszorg Om en Bij | |||
| OrganisatieType | Thuiszorg (code = 'T2' in codeSystem 'HL7 RoleCodeNL Care provider type (organizations)') | |||
1.27 TEST Medicatiegegevens MTD Scenarioset 16
| Patiënt | ||||
| Gegevenselement | Waarde | |||
| Naamgegevens | ||||
| Voornamen | J | |||
| Geslachtsnaam | ||||
| Achternaam | XXX_Valkenet | |||
| Adresgegevens | Knolweg 1000 9999XA STITSWERD 3 Woon-/verblijfadres | |||
| Identificatienummer | 999911089 [BSN] | |||
| Geboortedatum | 25 jul 1964 | |||
| Geslacht | Man (code = 'M' in codeSystem 'HL7 AdministrativeGender') | |||
1.27.1 Scenario 16.3 - MBH_300_afwijkendeToediener-mgb
| Medicatietoediening MBH_300_afwijkendeToediener_MTD_Patient-mgb | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_afwijkendeToediener_MTD_Patient-mgb (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.18629005.1) | |||
| RegistratieDatumTijd | T - 2 dagen om 20:00 uur | |||
| ToedieningsDatumTijd | T - 2 dagen om 20:00 uur | |||
| ToegediendeHoeveelheid | ||||
| Aantal | 1 | |||
| Eenheid | stuks (code = '245' in codeSystem 'G-Standaard thesaurus basiseenheden') | |||
| Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
| Toediener | ||||
| Patiënt | ||||
| ToedienerIsPatient | Ja | |||
| Geneesmiddel - primaire code | MIRTAZAPINE MYLAN TABLET 15MG (code = '1680862' in codeSystem 'G-Standaard HPK') | |||
| Geneesmiddel - generiekere code | MIRTAZAPINE TABLET 15MG (code = '75211' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | MIRTAZAPINE TABLET 15MG (code = '93521' in codeSystem 'G-Standaard GPK') | |||
| RelatieMedicatieafspraak | ||||
| Identificatie | MBH_300_afwijkendeToediener_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
| RelatieToedieningsafspraak | ||||
| Identificatie | MBH_300_afwijkendeToediener_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
| MBH identificatie | MBH_300_afwijkendeToediener-mgb (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
1.28 TEST Medicatiegegevens MTD Scenarioset 16
| Patiënt | ||||
| Gegevenselement | Waarde | |||
| Naamgegevens | ||||
| Voornamen | J | |||
| Geslachtsnaam | ||||
| Achternaam | XXX_Valkenet | |||
| Adresgegevens | Knolweg 1000 9999XA STITSWERD 3 Woon-/verblijfadres | |||
| Identificatienummer | 999911089 [BSN] | |||
| Geboortedatum | 25 jul 1964 | |||
| Geslacht | Man (code = 'M' in codeSystem 'HL7 AdministrativeGender') | |||
1.28.1 Scenario 16.4 - MBH_300_afwijkendeToediener-mgb
| Medicatietoediening MBH_300_afwijkendeToediener_MTD_Mantelzorger-mgb | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_afwijkendeToediener_MTD_Mantelzorger-mgb (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.18629005.1) | |||
| RegistratieDatumTijd | T - 1 dag om 20:00 uur | |||
| ToedieningsDatumTijd | T - 1 dag om 20:00 uur | |||
| ToegediendeHoeveelheid | ||||
| Aantal | 1 | |||
| Eenheid | stuks (code = '245' in codeSystem 'G-Standaard thesaurus basiseenheden') | |||
| Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
| Toediener | ||||
| Mantelzorger | ||||
| Contactpersoon | Zie Contactpersoon: TOOS_DE_BAKKER | |||
| Geneesmiddel - primaire code | MIRTAZAPINE MYLAN TABLET 15MG (code = '1680862' in codeSystem 'G-Standaard HPK') | |||
| Geneesmiddel - generiekere code | MIRTAZAPINE TABLET 15MG (code = '75211' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | MIRTAZAPINE TABLET 15MG (code = '93521' in codeSystem 'G-Standaard GPK') | |||
| RelatieMedicatieafspraak | ||||
| Identificatie | MBH_300_afwijkendeToediener_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
| RelatieToedieningsafspraak | ||||
| Identificatie | MBH_300_afwijkendeToediener_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
| MBH identificatie | MBH_300_afwijkendeToediener-mgb (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
1.28.2 Bouwstenen
| Bouwstenen | |||
| Gegevenselement | Waarde | ||
| Contactpersoon TOOS_DE_BAKKER | |||
| Naamgegevens | Toos de Bakker | ||
| Rol | Mantelzorger (code = '100001' in codeSystem '2.16.840.1.113883.2.4.3.11.60.40.4.23.1') | ||
1.29 TEST Medicatiegegevens MTD Scenarioset 16
| Patiënt | ||||
| Gegevenselement | Waarde | |||
| Naamgegevens | ||||
| Voornamen | J | |||
| Geslachtsnaam | ||||
| Achternaam | XXX_Valkenet | |||
| Adresgegevens | Knolweg 1000 9999XA STITSWERD 3 Woon-/verblijfadres | |||
| Identificatienummer | 999911089 [BSN] | |||
| Geboortedatum | 25 jul 1964 | |||
| Geslacht | Man (code = 'M' in codeSystem 'HL7 AdministrativeGender') | |||
1.29.1 Scenario 16.5 - MBH_300_toedieningRelatieMA-mgb
| Medicatietoediening MBH_300_toedieningRelatieMA_MTD-mgb | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_toedieningRelatieMA_MTD-mgb (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.18629005.1) | ||
| RegistratieDatumTijd | T - 2 dagen om 09:10 uur | ||
| ToedieningsDatumTijd | T - 2 dagen om 09:10 uur | ||
| ToegediendeHoeveelheid | |||
| Aantal | 1 | ||
| Eenheid | stuks (code = '245' in codeSystem 'G-Standaard thesaurus basiseenheden') | ||
| Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
| Toediener | |||
| Zorgverlener | Zie Zorgverlener: MARCHA_VAN_PARTNERS | ||
| Geneesmiddel - primaire code | SUPRIMAL TABLET 12,5MG (code = '19259' in codeSystem 'G-Standaard HPK') | ||
| Geneesmiddel - generiekere code | MECLOZINE TABLET 12,5MG (code = '450' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | MECLOZINE TABLET 12,5MG (code = '1309' in codeSystem 'G-Standaard GPK') | ||
| RelatieMedicatieafspraak | |||
| Identificatie | MBH_300_toedieningRelatieMA_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| MBH identificatie | MBH_300_toedieningRelatieMA-mgb (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
1.29.2 Bouwstenen
| Bouwstenen | ||||
| Gegevenselement | Waarde | |||
| Zorgverlener MARCHA_VAN_PARTNERS | ||||
| ZorgverlenerIdentificatienummer | 000001115 (in identificerend systeem: UZI Personen) | |||
| Naamgegevens | Marcha van Partners | |||
| Specialisme | Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') | |||
| Zorgaanbieder | ||||
| Zorgaanbieder | Zie Zorgaanbieder: HUISARTSENPRAKTIJK_ITIS | |||
| Zorgaanbieder HUISARTSENPRAKTIJK_ITIS | ||||
| ZorgaanbiederIdentificatienummer | 00005111 (in identificerend systeem: URA) | |||
| OrganisatieNaam | Huisartsenpraktijk Itis | |||
| Adresgegevens | Werkadres: Langelaan 1 1234ZZ Onze Stad | |||
